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ABSTRACT 
 Prioritizing zoonotic and/or sapronotic pathogens of domestic animal populations and 
initiating ongoing surveillance of such pathogens is needed in Canada. From a One Health 
perspective, gathering and recording more comprehensive disease data on the population of 
animals most closely associated with humans is extremely valuable and necessary.  Therefore, the 
purpose of this thesis was to identify a subset of domestic canine pathogens of public health 
significance specific to the Prairie Provinces of Canada and to establish a framework for a 
companion animal surveillance initiative to the region.  This research was conducted within a two-
year period from September 2019 to April 2021.   
 The first component of this research involved the creation of a comprehensive list of any 
pathogen historically reported in the domestic dog by reviewing several companion animal 
infectious disease textbooks, which resulted in 594 pathogens total.  This list was then pared down 
to identify only those pathogens that were significant from a public health perspective in Canada 
and the prairies.  This was accomplished using a formulated stepwise approach that pathogens only 
moved on to the final list if: (1) the pathogen was zoonotic/sapronotic/anthroponotic, (2) the 
domestic dog was involved in transmission, maintenance or detection of the pathogen, and (3) 
there was a level of risk for occurrence of the pathogen in Canada.  Following this stepwise 
approach, of the initial 594 canine pathogens 84 pathogens were deemed important in Canada and 
the prairies from a public health perspective. 
 A follow-up study to this research involved a prioritization exercise using experts in the 
field of veterinary medicine, public health, and epidemiology to identify the top 5 highest priority 
pathogens from the final list of 84 canine pathogens upon which to focus a companion animal 
surveillance program specific to the Prairie Provinces.  The exercise was accomplished through a 
 iii  
voluntary survey using a semi-quantitative ranking strategy.  The resulting top 5 pathogens to 
come out of the exercise were: (1) Echinococcus spp. (granulosus, multilocularis), (2) MRSA, (3) 
Salmonella enterica, (4) MRSP, and (5) Borrelia burgdorferi.   
 The final component of this research examined the utility of clinical veterinarians and 
veterinary clinics in a companion animal surveillance program.  In addition, responses from 
clinical veterinarians were used to formulate case definitions for the top 5 highest priority 
pathogens intended for surveillance.  Assessing dogs as sentinels for pathogens of public health 
concern using Lyme disease as an example was also conducted in this research chapter.  Data was 
gathered through a voluntary survey disseminated to clinical veterinarians in the provinces of 
Alberta, Saskatchewan, and Manitoba.  The results of this survey identified that clinical 
veterinarians are willing to participate in a surveillance program, that there is important in-clinic 
veterinary data not currently being captured from a population or disease monitoring standpoint, 
and that domestic dogs can serve as good sentinels for Lyme disease risk in humans, specific to 
the prairies. 
 This thesis provided the foundational steps for a companion animal surveillance initiative 
specific to the Prairie Provinces of Canada.  It identified which pathogens involving the domestic 
dog pose a significant public health risk in Canada and the prairies, prioritized these pathogens 
from highest to lowest concern using expert opinion, and established the importance of cooperation 
with practicing veterinarians and veterinary clinics for a companion animal surveillance program 
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CHAPTER 1: INTRODUCTION & LITERATURE REVIEW  
1.1       Introduction 
The relationship between humans and companion animals has become increasingly 
intimate in modern society.  Several benefits to pet ownership include but are not limited to 
companionship, increased mental welfare, and physical well-being.  In addition, many pets are 
trained working animals or serve as therapy aids1–4.  Unfortunately, pet ownership also comes with 
certain public health risks including the potential for zoonotic pathogen exposure1–3.  This is of 
particular importance to individuals who are immunocompromised5–8.  Indigenous communities 
are also vulnerable to companion animal zoonoses as a result of limited access to veterinary and 
medical resources9–12.   
It is well established that a large proportion of infectious diseases originate from animal 
sources.  In fact, Taylor et al. states that of the approximately 1500 pathogens known to cause 
human illness, greater than 60% of these are zoonotic13.  Furthermore, 75-85% of emerging 
pathogens are also zoonotic4,14,15.  As the relationship with domesticated animals has changed in 
Canada, so should the response to achieving a “One Health” approach to public health risks from 
the animals with which humans spend the most time and closest contact.  This concept of One 
Health has become particularly prominent in recent years, seeking to unify the following: human, 
animal, environmental, and ecosystem health4.  Several strategies have been adopted in 
epidemiology to monitor zoonotic disease threats including pathogen prioritization and the 
creation of surveillance programs16–19.  This helps to bridge the gap between human health and 
animal health as part of an overarching One Health strategy. 
The following literature review has three main objectives.  First, to provide an overview 






current methods of pathogen prioritization using human and animal examples.  And third, to assess 
the current knowledge on surveillance systems as they relate to companion animal zoonoses with 
a particular relevance to Canada.  Because rabies is one of the few canine zoonotic pathogens 
monitored in Canada and has been heavily researched, it will not be the focus of this literature 
review. 
1.2       An Overview of Canine Zoonoses and Public Health Implications in Canada 
1.2.1 An Introduction to Canine Zoonotic Pathogens in Canada 
1.2.1.1 Zoonotic Terminology and How it Relates to the Role of the Dog 
Zoonoses are defined as pathogens that are transmitted from animals, or animal tissue, to 
people and result in human disease.  This includes direct transmission to humans (by skin, 
inhalation or ingestion), as well as indirect transmission through vectors, fomites or environmental 
contamination5,20,21.  Sapronoses are defined as pathogens that can infect both animals and humans 
from a shared environment, without direct transmission between hosts.  Sapronoses survive on 
abiotic substrates but can replicate in the environment, making their classification different than 
environmental contamination alone21.  Anthroponoses are defined as pathogens that are transmitted 
from human to human.  This term was previously used interchangeably with anthropozoonoses 
and the term zooanthroponoses defined human to animal transmission (reverse zoonoses)21,22.  It 
is now widely accepted that zoonoses represent those diseases that pass naturally between humans 
and vertebrate animals in either direction22,23.  In general, once humans are infected with a zoonotic 
pathogen they do not typically transmit from person to person21.  This is excluding anthroponoses 
where human to human transmission can occur5,21.   
When addressing the role of dogs from a One Health perspective and the effect of canine 






because dogs can play several roles in the spread of disease from a public health perspective.  These 
roles include the direct transmission of a pathogen from dogs to humans6,15,24–26, dogs maintaining 
a pathogen in the environment as a definitive or reservoir host6,15,27,28, and finally, that dogs may be 
used to detect a pathogen in the environment as sentinels for human exposure6,26,29–32.  Canine 
pathogens that are strictly zoonotic should always be considered a public health concern.  Although 
sapronoses are not directly zoonotic, dogs can serve as sentinels for sapronotic pathogens revealing 
a risk for human exposure from a shared environment, and thus are also important from a public 
health perspective33.  If a pathogen can be transmitted in the direction of human to dog, it is 
considered possible for transmission to occur in the other direction6,22,24,25.  Therefore, primarily 
anthroponotic pathogens and reverse zoonoses are important to recognize from the canine 
perspective as well.  Because it is often challenging to verify zoonotic transfer versus shared 
environmental exposure6, it is useful to consider dogs as sentinels for many pathogens of human 
importance.  
1.2.1.2 Important Canine Zoonoses in Canada  
Several examples of canine zoonoses are emphasized and well documented in Canada 
through prevalence studies.  In addition to rabies, the literature on canine zoonoses in Canada 
appears to focus on gastrointestinal pathogens, vector-borne diseases, dog bites, and antimicrobial 
resistance.   
1.2.1.2.1 Gastrointestinal Pathogens 
Dogs can serve as a source of parasitic infection in humans and have also been evaluated 
as sentinels for parasitic risk in both human and wildlife populations within Canada34,35.  Examples 
of zoonotic helminths historically reported in dogs in Canada include Echinococcus spp. and 






common9,10,26.  These parasites have also been identified specifically in shelter dogs through 
prevalence studies36.  One study however, reported Echinococcus granulosus (alternatively 
referred to as E. canadensis) in one canine fecal sample obtained in the more urban location of 
Winnipeg, Manitoba37. Additional but less commonly identified helminths include 
Diphyllobothrium spp., Toxascaris leonina, Uncinaria stenocephala, Alaria spp., Strongyloides 
spp., Trichuris spp., as well as unidentified roundworms, hookworms, tapeworms and 
whipworms10,26,38,39    
Other gastrointestinal protozoal and bacterial pathogens documented in dogs in Canada 
include Giardia duodenalis, Cryptosporidium spp., Campylobacter spp., Salmonella spp., Yersinia 
spp., and Escherichia coli 9,38–41.  While increased prevalence in free-roaming dogs is apparent for 
many of these studies, in comparison, Julien et al. discovered prevalence of Giardia spp. and 
Cryptosporidium spp. in fecal samples to be highest in sled-dogs when compared to shelter or 
community dogs in Iqaluit, Nunavut40.  Like many canine gastrointestinal helminths, these 
protozoal and bacterial pathogens also have zoonotic potential9,40,41. 
1.2.1.2.2 Vector-borne Diseases 
 The majority of vector-borne disease research in Canada, where the role of the domestic 
dog is also examined, is largely based in Lyme disease research.  This is because Lyme disease is 
the most common tick-borne disease plaguing North America42.  Many Canadian studies propose 
the use of dogs as sentinels for Borrelia burgdorferi as a way to assess disease risk in humans in 
a given population.  This is because dogs have a higher chance of tick exposure, clinical impact is 
much lower in dogs, and serology testing is common and inexpensive26,29,42–44.  In areas of Canada 
where Lyme disease is emerging, dogs are typically identified as sero-positive sooner than humans 






a role in detection of the pathogen as sentinels for human exposure include Anaplasma spp., 
Ehrlichia spp., Rickettsia rickettsia and Dirofilaria immitis1,15,29,44–47. 
            Although the exact incidence of B. burgdorferi in dogs in Canada is unknown, in one study, 
the mean seroprevalence was calculated as 0.72% in the overall Canadian dog population, but as 
high as 2.15% in dogs residing in Nova Scotia42,47.  Furthermore, 2/3 of all infections were 
suspected to be infections acquired within Canada and were not related to international travel42.  In 
a Saskatchewan study, where Lyme disease is not endemic, 3.0% (2/77) of dogs tested in a 
southeastern Indigenous community were positive for B. burgdorferi26.  A second Saskatchewan 
study found a positive rate of 2.3% (12/515) in dogs, with and without travel history48.  Evason et 
al. reported an overall prevalence of 2.0% for Lyme disease in dogs in Canada46.  This study 
evaluated 753,468 canine serological test results over a 7-year period.  Finally, Herrin et al. 
reported a total of 2.5% prevalence of borreliosis in dogs in Canada over a 1-year study period44.  
Dogs should continue to be part of the surveillance strategy to detect Lyme disease in Canada, in 
addition to tick surveillance and human testing1,29,43,44.   
1.2.1.2.3 Dog Bites 
Dog bites are a common canine public health concern reported in Canada.  Dog bites are 
examined from both the perspective of zoonotic disease transmission as well as physical injury 
rates in people.  Normal oral bacteria present in dogs can be transmitted to humans through bites 
leading to infection.  This includes Pasteurella spp., Streptococcus spp., Staphylococcus spp., 
Moraxella spp., Capnocytophaga canimorsus, Fusobacterium spp., Neisseria spp., Clostridium 
spp., Bacteroides spp., Prevotella spp., and Porphyromonas spp.6,11,15,49,50.  Bacteria, however, are 






transmission of Rabies virus from dog bites is a world-wide concern due to its fatal disease 
progression3,11.   
The frequency of dog bites as well as fatalities related to dog attacks in Canada is also 
significantly higher in Indigenous communities compared to urban centers3,10,11,39.  This could be 
related to higher populations of free-roaming dogs in some communities3,11,39. A 2015 study which 
looked at animal bite records over a 7-year period from two Indigenous communities revealed that 
out of 57 individuals who sought medical attention 27 were specific to a dog bite related injury39.  
This was higher than any other animal bite injury.  A survey conducted in the Nunavik region of 
Quebec reported that 40.3% (27/67) of participants suffered from dog bites.  Of these, 22 
individuals were Inuit and 5 individuals were Non-Inuit3.  In an urban study conducted in Ontario, 
of 641 survey participants, 15 individuals reported being bitten by their own dog, while 5 
individuals reported being bitten by another dog; none resulted in fatalities51.  Dog bite data 
obtained from such studies is likely an under-representation of dog-bite prevalence in Canada due 
to under-reporting39.   
1.2.1.2.4 Antimicrobial Resistance 
Antimicrobial resistance (AMR) in both veterinary and human medicine is a growing area 
of concern.  The use of antibiotics in veterinary medicine, including the use in companion animals, 
has a direct impact on public health52.  This is because antimicrobial resistant and multi-drug 
resistant (MDR) pathogens can be shed from household pets to humans within a shared 
environment6,53.   
In Canada, a large proportion of companion animal related AMR research is focused on 
methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistance Staphylococcus 






samples in Saskatoon from the years 2006-2008 and found resistance to 10 antimicrobial classes 
and multi-drug resistance in several samples24.  Isolates were not resistant to vancomycin.  
Furthermore, canine and human isolates shared genetic similarities, indicating interspecies 
transmission to be likely24.  This interspecies relatedness supports possible reverse zoonotic 
transmission of MRSA from humans to their pets which has been documented in the literature 
extensively5,6. Weese et al. identified MRSA in 5 canine patients with clinical infections in an 
Ontario study where interspecies transmission was suspected in both directions.  Of note, 
vancomycin resistance was not observed in any sample25.     
Another Canadian study tested 193 dogs admitted to the Ontario Veterinary College (OVC) 
Veterinary Teaching Hospital for coagulase positive staphylococcal infections54.  MRSP was 
identified in 2.1% (4/193) of samples, while MRSA and methicillin-resistant Staphylococcus 
schleiferi subsp. coagulans (MRSS) were isolated in 0.5% (1/193) of samples respectively.  All 
dogs in this study were non-clinical for methicillin-resistant coagulase positive staphylococcal 
infections and presented to the hospital for unrelated medical concerns. The role of colonization 
of MRSA/MRSP/MRSS in dogs without clinical signs and potential carrier status is still not well 
understood54.   
In 2002, Prescott et al. examined canine urinary isolates over a 15-year period in Ontario 
and found changes to the susceptibility patterns of both S. aureus and S. pseudintermedius55.  These 
changes reflected the shift in antimicrobial classes more likely to be used during this time frame.  
An alarming finding included marked increased resistance to enrofloxacin.  In addition, this study 
also found increases in the resistance patterns of several other bacterial species, including 






Other AMR pathogens of concern in dogs in Canada include vancomycin-resistant 
enterococci (VRE), extended-spectrum beta-lactamase (ESBL) E. coli, extended-spectrum 
cephalosporinase (ESC) E. coli, and Salmonella spp.  Lefebvre et al. examined fecal pathogen 
shedding in therapy dogs fed raw food diets in Ontario and Alberta56.  ESC E. coli was detected in 
106 fecal samples.  ESBL E. coli, MRSA and VRE were not observed56.  In a 2019 study that 
looked at both companion animal and food animal isolates in both the United States and Canada, 
resistance patterns were discovered in pathogenic E. coli isolates to macrolides, fluoroquinolones 
and cephalosporins57.  One E. coli isolate was resistant to cephalosporins, macrolides, 
fluoroquinolones, aminoglycosides, and tetracyclines.  This study also observed resistance genes 
in S. pseudintermedius samples to several classes of antimicrobials including beta-lactam 
antibiotics, tetracycline, aminoglycosides, streptothricin, streptomycin and fluoroquinolones.  
Resistance genes were not identified in Salmonella isolates for this particular study57.  Leonard 
examined canine fecal samples in a 2012 southwestern Ontario study and found 14% (17/120) of 
Salmonella isolates and 10% (41/395) of E. coli isolates were resistant to two or more classes of 
antimicrobials58.  The most common classes of antimicrobials that exhibited resistance patterns 
included the beta-lactam antibiotics and cephalosporins58.  Each of these studies highlight the 
growing risk of AMR and MDR in companion animal bacterial isolates that also have zoonotic 
potential.   
1.2.2 Public Health Considerations with Companion Animal Ownership 
1.2.2.1 The Human-Canine Bond and Benefits of Pet Ownership 
It is well documented that there are many benefits to companion animal ownership.  As the 
domestication of animals has evolved throughout history, companion animals (including but not 






and psychological standpoint1,2,6.  Studies have shown that caring for pets creates a sense of 
nurturing in people, and pets have become well-established members of the family that benefit all 
age groups including children and the elderly2.  Children who are raised with pets have improved 
social skills and self-esteem.  Furthermore, they develop a sense of identity and have increased 
empathy toward others2,6,59.   
Pets have also been associated with improved physical health and well-being in humans.  
This includes but is not limited to: reduced stress levels, reduced risk of cardiovascular related 
illness, and reduced risk of asthma in children who are exposed to a pet within the first year of 
life2.  The relationship between animal ownership and decreased incidence of cardiovascular 
disease has been attributed to increased physical activity and reduced stress levels.  This in turn 
decreases the risk of obesity, hypertension, hyperlipidemia and depression which can exacerbate 
cardiovascular events4.   
Additionally, companion animals can support humans in other ways.  Working and therapy 
animals assist with both mental and physical needs.  For example, studies show that the use of 
dogs during cancer treatment can aid in the patient’s overall morale and attitude toward treatment4.  
Dogs have also been utilized in therapy for Autism spectrum disorder4.  In Inuit cultures in Canada, 
dogs are used for travel and hunting purposes and are an important part of the Inuit history and 
ancestry3.  Although several companion animal diseases can impact human health, efforts to 
minimize human disease should not take away from the important benefits of owning a pet.   
1.2.2.2 The Effects of Dog Ownership on the Immunocompromised 
Individuals who are immunocompromised are at an increased risk of canine zoonotic 
disease transmission that comes with pet ownership.  Shedding of gastrointestinal pathogens by 






including fungal and viral infections5,8,60. Immune status has become particularly concerning in 
recent years as the popularity of owning a pet continues to rise.  Immunocompromised individuals 
include children, the elderly, pregnant woman, individuals on immunosuppressive medications, 
and those with diseases that affect the immune system8,59.   However, it is also important to consider 
pets who are immunosuppressed themselves to be an increased public health risk8.  Dogs with 
immunodeficiencies are a risk to human health because they are less likely to mount their own 
immune response to infectious agents and therefore can shed large quantities of harmful zoonotic 
pathogens in a shared environment.  Furthermore, these dogs are also less likely to mount an 
immune response to preventative measures like vaccinations8.  
There is an evident gap in communication between veterinary and medical professionals 
when it comes to companion animal zoonoses and immunocompromised individuals8,59,60.  Studies 
show that physicians do not regularly ask patients about pet ownership or discuss zoonotic disease 
risk59.  In a study on immunocompromised children and pet ownership, 73% of households 
obtained a high-risk pet shortly after their child was diagnosed with diabetes61.  In addition, 77% 
of households obtained a high-risk pet shortly after a cancer diagnosis in their child61.  Furthermore, 
there is a lack of communication between veterinarians and clients in terms of immunosuppression 
and increased zoonotic disease risk from companion animals6. Less than 1% of HIV positive 
individuals reported receiving information from their veterinarian on dog ownership and zoonotic 
diseases8. Client education from veterinarians and human physicians, as well as better 
communication between the two professions, is of the upmost importance in addressing the risk of 
canine zoonoses in immunocompromised individuals8,59,60. 
Immunocompromised individuals can still benefit greatly from pet ownership as 






in those who are immunocompromised5,7.  This benefit has been established in studies on HIV 
patients and newly diagnosed cancer patients6,8,59,61.  Although the risk of pet ownership in 
immunocompromised individuals should not outweigh the benefits, open communication between 
the veterinarian and owner can contribute toward safe interaction.  Several recommendations can 
be adopted by immunocompromised individuals looking to own a dog or pet which include 
improved hygienic practices, acquiring a dog greater than 6 months of age, feeding appropriately 
cooked diets, avoiding bites/scratches, as well as keeping the dog or pet up to date on 
immunizations and parasitic control7,8,59.  Improved surveillance on this population of animals 
should also be part of the solution as it can further inform these recommendations. 
1.2.2.3 Public Perceptions of Zoonotic Risk in Companion Animals 
Few Canadian studies have examined the general public’s knowledge on zoonotic disease 
risk with companion animal ownership.  In a 2012 survey conducted in the city of Waterloo, 
Ontario, Stull et al. examined the public’s perception of pet-related zoonoses51.  Of the 641 
participants, 64% owned at least one pet.  In participants who did not own a pet, 37% still had 
regular contact with animals outside of the home at least once a week.  Furthermore, 55% of 
individuals who owned at least one pet were classified as “high-risk”.  This group was defined by 
age (under 5 or greater than 65 years of age) or immune status of the participant.  A large proportion 
of participants (64%) revealed that they had not received any information on companion animal 
zoonoses and other risks from either a veterinarian, physician, or self-motivated resource.  The 
remaining 36% of participants who acknowledged receiving some information on pet-related risks 
were able to correctly identify zoonotic pathogens at a significantly higher proportion than 
individuals who had no prior knowledge.  Despite this, scores for both groups were considered 






associated diseases.  The majority of participants, regardless of pet ownership, identified rabies as 
a high concern.  There was no difference in perceived risk to companion animal zoonoses in 
participants who identified as high-risk compared to individuals who were categorized as low 
risk51.  A follow-up study by the same authors examining pet husbandry practices in Ontario 
reported 46-57% of participants (n = 401) who owned a pet to be high-risk owners62.  Thirteen 
percent of participants revealed that the household dog slept in their child’s bed, while 24% of 
participants admitted to allowing the dog to lick their child’s face.  Furthermore, 28% of 
respondents fed their dog raw-food diets or treats62.   
Lefebvre evaluated the knowledge of Ontario dog owners who enrolled their dogs in 
hospital and health care visitation programs63.  Hospital requirements for admittance of dogs into 
these programs was also examined.  Ninety individuals and 231 hospitals participated in this study.  
Seventy-nine percent of owners (71/90) revealed that their dogs were allowed to lick patients.  In 
addition, 73% (66/90) allowed their dog to be on patients’ beds.  Despite 89% (80/90) of 
participants indicating that they had told their veterinarian of their dog’s enrollment in a visitation 
program, only 14% (13/90) reported any conversations with their veterinarian on zoonotic disease 
risk.  When asked to name “two diseases that people can catch from dogs”, 40% (36/90) of 
participants could not answer the question.  Twenty-five owners could identify one pathogen, with 
rabies being the most common answer.  Only 40% of hospitals who participated in this study 
expressed interest in free testing of all dogs included in visitation programs.  The most common 
requirement from hospitals for inclusion of a dog in the program was proof of current core-
vaccination status.  Only 2 owners reported that deworming was necessary to be admitted into the 
hospitals they visited.  Temperament testing and health certification from a veterinarian were 






wander hospital wards without any supervision from hospital staff63.  These studies reveal an 
overall lack of public awareness on the potential severity of companion animal pathogens and 
public health implications in Canada. 
1.2.2.4 Veterinary Perceptions of Zoonotic Risk in Companion Animals 
There is an evident disconnect in the communication between veterinarians and their 
clients with regard to public education on zoonotic diseases.  It is therefore important to assess the 
overall knowledge of veterinarians on zoonotic disease risk. One study in Canada that has 
evaluated the perceptions of veterinarians on companion animal zoonoses looked at endoparasitic 
zoonoses specifically64.   
An examination of this study showed that of the 545 veterinarians surveyed in western 
Canada, only 13% recommended a deworming protocol for puppies, while 39% recommended a 
deworming protocol for kittens64.  Over 85% of respondents did not use an appropriate deworming 
protocol for puppies and 60-90% of deworming protocols were inappropriate for kittens 
(dependent on age of kitten at time of deworming).  Veterinarians who perceived a high risk for 
Toxocara canis were more likely to have an appropriate deworming protocol for puppies.  
Similarly, individuals who perceived a high risk of Toxocara cati were also more likely to have an 
appropriate deworming protocol for kittens.  Ninety-seven to ninety-nine percent of participants 
followed appropriate guidelines for adult dogs and cats64.  
Only 44% of veterinarians in this study reported discussing zoonotic endoparasitic disease 
risk with every client64.  Of the remaining veterinarians, 10% discussed zoonoses with clients if 
they perceived the client to be high risk.  Forty percent of veterinarians reported rare discussions 
with clients on companion animal zoonoses if “prompted by the client” or “when worms were 






zoonotic disease risk with their clients on any occasion64.  Although veterinarians and veterinary 
professionals should be a wealth of knowledge on canine zoonoses and associated public health 
risks, this study highlighted the gaps in deworming protocols by veterinarians as well as overall 
client education.  Addressing such gaps can benefit both human and animal health.  
1.2.3 The Overall Canadian Context 
1.2.3.1 The Role of Climate Change and Canine Zoonoses 
Because Canada is situated in a northern part of the globe, it is more dramatically affected 
by climate change compared to other parts of the world, particularly its northernmost arctic 
regions65.  Climate change plays a crucial role in zoonotic diseases for several reasons.  A warming 
climate can increase the range and number of reservoir animals and vector species in a given area.  
The importation of vectors, reservoirs and pathogens that would not ordinarily survive in the 
harsher climate is also intensified.  Furthermore, climate change can prolong pathogen 
transmission cycles66.   
In terms of vector distribution, ticks are a good example of the role climate change has 
played.  The distribution of ticks in Canada, and therefore Lyme disease, has changed substantially 
due to climate change42,65–67.  This is because changes in climate have altered how ticks survive, 
act and develop within the changing environment42.  Leishmaniasis is a second example where the 
distribution of sandfly vectors can be altered by climate change and therefore geographical 
distribution of the pathogen66.  Other pathogens affected by changes to climate include fungal 
agents like Blastomyces dermatitidis and Cryptococcus gatti which rely heavily on soil ecology 
and the temperature.  In addition, heavy rainfall can increase the distribution of water-borne 






Climate change also disrupts the ecology of wildlife and therefore the distribution of 
pathogens carried by wildlife reservoirs66.  For example, climate change has affected the habitats 
and therefore distribution of arctic and red foxes who are the sylvatic reservoirs for Rabies virus28.  
Other examples include the distribution of parasites like Echinococcus spp. commonly seen in 
wild canids10,28,66.  Warmer climates will lead to longer survival times of environmental stages for 
canid parasites.  Furthermore, the distribution and densities of these wild canids will also shift as 
a result of climate change10,28.  Jenkins et al. predicts the introduction of Diphyllobothrium latum, 
Toxocara canis and E. multilocularis into new regions as a product of Canada’s changing climate10.  
The distribution of freshwater fish, the intermediate host in many parasitic life cycles, will also be 
significantly affected by climate change10,28.  Particularly in northern communities, dogs can act as 
a bridge between wildlife and humans, and therefore increase the exposure risk of many of these 
pathogens to humans10.   
The effects of climate change will impact northern communities within the Artic 
substantially3,10.  Milder climates in the north will also cause growth in tourism, agriculture, and 
local businesses.  This will further promote the movement of dogs into these communities, and 
with them, parasites they may be carrying that are foreign to the area10.  Several authors agree that 
establishing a One Health initiative is part of the solution.  As climate change continues to effect 
ecosystems and the health of vegetation, fish, wildlife and humans (particularly the Indigenous), 
health professionals, public health officials, veterinarians, environmental scientists, ecologists, 
geographers, biologists and epidemiologists will all play a role in the solution to combatting the 








1.2.3.2 The Impacts of Canine Zoonoses on Indigenous Communities in Canada 
Dogs represent valued members of Indigenous communities and are used for a variety of 
reasons including companionship, protection, social status, tradition, hunting, and travelling3,10,39.   
Increased zoonotic risk is largely due to the profound effects of climate change (particularly in 
northern regions), cultural and lifestyle practices, as well as the increased likelihood of free-
roaming dogs3,10,26,66.  From the Indigenous perspective, allowing dogs to roam does not indicate 
abandonment, but provides increased opportunities for exercise in their dogs as well as 
socialization with other dogs in the community3.  Additionally, a large proportion of dogs in remote 
communities are often of a young age, where the rate of parasitism is high26,30.  Schurer et al. 
identified a high proportion of parasitic infections in members of an Indigenous community who 
did not directly own a dog, indicating environmental exposure as a source of canine zoonotic 
disease spread30.  Because dogs are more likely to be free-roaming in Indigenous and Inuit 
communities, the widespread risk of pathogen exposure, including canine endoparasites, is 
comparatively greater than in urban centers3. 
  When dogs from 5 Indigenous communities in Saskatchewan were surveyed for T. canis, 
a positive rate of 11% from 321 fecal samples was considerably higher than the 0.2% prevalence 
rate found in client-owned dogs in Saskatoon around the same time10.  Risk of parasitic disease 
transmission from dogs to humans is also higher in Indigenous communities because these dogs 
are often not on endoparasitic preventatives.  For example, in one Canadian study, less than 1/3 of 
individuals living in the Northwest Territories reportedly dewormed their dogs68.  A Saskatchewan 
study that examined a northern Indigenous community found that only 1 out of 22 households who 






extremely limited access to veterinary services, further exacerbating the risk of canine zoonotic 
disease transmission3,10,11,26,39.   
Several studies have revealed a disproportionally higher rate of zoonotic parasitic 
infections in Indigenous peoples compared to the general population10,26,28.  For example, a 
Canadian study from the 1950’s found that out of 141 human cases of cystic hydatid disease (E. 
granulosus) 139 of these were Indigenous people10,70.  Today, Indigenous people are still diagnosed 
at a proportionally higher rate than other Canadians30.  A more recent 2010 study found that 11% 
of Indigenous residents (n=106) were seropositive for Echinococcus spp. in Saskatchewan10,69.  
According to Dudley et al., an alarming 40% of tapeworm infections are reported in Alaska Native 
and Inuit communities in northern parts of Canada.  In particular, echinococcal infections remain 
significantly higher in these communities compared to the general population28.   
Although a heavy focus is placed on northern Indigenous communities in Canada, southern 
Indigenous communities must not be overlooked.  Prevalence of canine zoonotic parasites obtained 
from canine and environmental samples in two southern Saskatchewan Indigenous communities 
were comparable to northern studies26.  In general, the rate of parasitism in dogs was ten times 
higher than what’s been documented in more urban locations.  Of interest, the overall human risk 
to zoonotic exposure was found to be lower in southern Indigenous communities when compared 
to northern Indigenous communities of the same province.  This was attributed to major differences 
in lifestyles and diet26.  In addition to Echinococcus spp., other parasites of growing concern in 
both northern and southern Indigenous communities include Toxoplasma spp., Trichinella spp. 
and Toxocara spp26,30.   
There are numerous factors that contribute to why communities are without access to 






by air to receive spay and neuter procedures at the nearest veterinary clinic3.   Resources often do 
not allow for the delivery of preventatives or treatment aids, and there is an overall lack of training 
for personnel in these remote locations10.  Furthermore, community members may disagree with 
intervening methods from a cultural standpoint, which includes deworming, vaccinations and 
surgical desexing3,26,39.  In addition, socioeconomic factors often inhibit the success of educational 
tools or public health measures3,10. All of this highlights a lack of trust and communication between 
collaborators within and outside the community and a need for “transdisciplinary partnerships”3.  
While surveillance of canine zoonoses in these populations would be of significant benefit to 
dealing with zoonotic disease threats, lack of veterinary and medical services remains a huge 
limitation for ongoing disease surveillance in these regions10. Additional work and support are 
required to combat canine zoonotic pathogens and public health risks in Indigenous communities 
throughout Canada in a sensitive and collaborative manner3,39.   
1.3       Current Methodologies for Pathogen Prioritization 
1.3.1 The Purpose of Pathogen Prioritization 
Pathogen prioritization is a necessary first step in the development of any surveillance 
system71,72.  Whether acquiring public health or animal health data, limited resources must be 
allocated in a way that is meaningful, while avoiding potential biases16,17,19,71,73–77.  In addition to 
this, it is simply not possible to obtain survey data on every zoonotic disease present in a 
country19,76,78.  Finances and personnel required to gather such information are both finite 
resources18,79–81.  This is why only certain infectious diseases are nationally notifiable in Canada80,81.  
In addition, pathogen prioritization is crucial for emerging disease preparedness to predict where 
to invest resources as part of an early warning system for novel disease threats16,71 .   Efforts are 






Ultimately, the final goal of a pathogen prioritization exercise is to identify where prevention and 
control efforts should be utilized17,18,65,77,81,83.   
Pathogen prioritization strategies will vary greatly between countries and must 
continuously evolve over time.  Furthermore, pathogens of interest will vary depending on research 
or surveillance objectives16.  Therefore, it is important to establish which pathogens are relevant to 
the project, for a particular region, at the time of study.  Lastly, pathogen prioritization is a way to 
inform decision-makers, stakeholders, and members of the public invested in a project18,67,71,81,83.   
1.3.2 A Lack of Universal Methods for Pathogen Prioritization 
Prioritization methods have been well studied and adapted over the years.  A continued 
challenge is the lack of a “universal” method which would improve objectivity and reduce biases 
in prioritization exercises71,73.  This is because prioritization methods need some degree of 
flexibility.  Project and surveillance goals will vary by region, research interests, and time of 
study71,74.  In addition, variability in incidence, transmissibility, clinical manifestations, social and 
economic impacts, and prevention and control capabilities vary greatly between diseases, making 
universal methods for individual prioritization exercises implausible73.  In other words, the 
methods used need to also reflect the pathogens of interest.  To help combat these challenges, 
prioritization exercises should be repeated at regular intervals and adjusted accordingly based on 
the purpose of the program and stakeholder needs16,19,71,76,78,81.   
1.3.3 Current Prioritization Examples 
The majority of prioritization examples described in the literature are for human diseases.  
Many prioritization exercises focus on communicable diseases in humans, including some 






only one companion animal specific example in the literature which prioritized pathogens from 
cats, dogs, pet pigs, hobby sheep and goats, as well as reptiles78.   
In general, there are three approaches to prioritization: quantitative, semi-quantitative and 
qualitative methods18,71.  Quantitative methods rely strictly on numerical scales that allow ranking 
of selected pathogens to be based on objective values, such as incidence and prevalence18.  
Qualitative methods are much more subjective, relying on individual preferences or group 
consensus for pathogen ranking.  Although semi-quantitative methods still rely on subjective 
preferences, choices are ranked relative to each other on a numerical scale, offering a combination 
of qualitative and quantitative methods18.   
Quantitative methods offer the most objectivity and reduce biases in a prioritization 
exercise; however, they are reliant on established scientific evidence and data already available in 
the literature74.  Therefore, semi-quantitative and qualitative methods are recommended when there 
is limited information on a disease71,78.  This is often the case for animal diseases, particularly 
companion animal zoonoses.  For example, the prevalence of many companion animal diseases is 
unknown.  Additionally, the incidence of human illness attributed to companion animal zoonoses 
is not well established78.  Qualitative methods are more subjective because there can be variability 
in scoring decisions due to individual opinions and lack of scientific evidence71,78.  Ng et al. argues 
that pathogen scores are always somewhat arbitrary, even when quantitative methodologies are 
used73.  Different methods may be better suited for different needs and this should be established 
during the planning phase of the prioritization exercise71. 
Although several methods and prioritization strategies have been described, the overall 
steps of pathogen prioritization remain relatively consistent between many studies.  These steps 






disease, weighing the criteria based on level of importance, scoring each disease for every criteria 
selected, multiplying these scores by the weighted value, and finally ranking the diseases based on 
the total summed scores16–19,71,73,75,77.  In addition to these steps, certain methodologies also choose 
a cut-off point within the final list to determine the inclusion or exclusion of diseases in a 
surveillance system17,80.  Several authors emphasized that the final numerical score is not the most 
important factor, but rather, it is where diseases fall in relationship to one another that is most 
valuable16,74,80.   
Selection of the initial pathogen list is often based on pre-existing documents such as 
notifiable disease lists or other surveillance data16,71,73,75.  Where data is lacking, expert opinion can 
be used to select pathogens of interest71.  The initial disease list may consist of individual pathogens 
or groups of pathogens (ex. food-borne pathogens, vector-borne diseases, etc.)18.  Although criteria 
selection should reflect each individual exercise, many studies have employed similar criteria.  
Examples of comparable criteria between studies included: burden of disease (incidence, 
prevalence, mortality), case-fatality rate, transmissibility, epidemic potential, socioeconomic 
impact, public perception, disease emergence potential, availability of diagnostic tests, and 
treatment and preventative options17,19,72,76,81.  The objectives of the organization or group 
performing the prioritization exercise will alter the criteria used71,74,79.  Several authors 
recommended that the number of criteria used should be limited, ranging from 5 to 12 criteria per 
exercise17–19,75.   
In general, experts with a background in human and animal health, such as doctors, 
veterinarians, public health officials, researchers and epidemiologists, are more commonly 
engaged in prioritization exercises16,83.  Specialization of experts can make it difficult to prioritize 






increase objectivity78.  Alternatively, some studies used the general public for similar ranking 
exercises71,76,84.  Ng et al. found that the general public still produced meaningful results; however, 
better-fit models were produced by health professionals who partook in a similar prioritization 
exercise73,84.  Similarly, Kadohira et al. found that the top 6 pathogens established in their ranking 
exercise were consistent between all stakeholder groups, including local citizens who participated 
in the study76.  Regardless of the public’s involvement in a ranking exercise, it is important to 
acknowledge public concern and improve risk communication because priorities for the general 
public may differ from that of stakeholders82.   
For each pathogen, criteria scoring typically followed a 3 (-1, 0, +1), 4 (0, 1, 3, 5), or 5-
point (1-5) system in reported examples17.  Each point value corresponded to a specific definition 
for the criteria of interest.  For example, in Krause et al.’s 3-point system, under the criteria 
“mortality” a pathogen was awarded a score of -1 if “< 50 deaths/year” occurred in Germany as a 
result of the disease75.  If “between 50 and 500 deaths/year” or “more than 500 deaths/year” 
occurred in Germany as a result of the disease, a score of 0 or 1 was awarded respectively75.  In 
some methods, individual scoring is completed initially, then final pathogen scores and ranking 
are discussed as a group19,78.  If group consensus is not reached for the final disease list, then re-
ranking may be required where participants can adjust their scores19. 
Weights for criteria are also usually established by an expert panel16,65,67,71,72,74,77,82.  Experts 
may be hand selected based on specific requirements72,74 or randomly chosen16,65,67,71,77,82.  These 
may be the same individuals participating in pathogen scoring or different individuals may be 
utilized between weighing criteria and pathogen scoring16,65,71,72,75,79.  Clear definitions of each 
criteria, as well as weighing the criteria, can help to reduce bias16,71,74.  Nonetheless, differing 






et al. found that between epidemiologists, public health specialists, laboratory specialists, and 
clinicians, groups weighted some criteria differently based on varied motivations and priorities.  
Other criteria were weighted similarly between all expert groups16. Among several studies, the 
criteria “case-fatality rate” was often weighted with the highest importance16,65,67,73,76,84.  Despite 
the variability in examples described here, prioritizing pathogens of interest is always a crucial 
step in the development of disease surveillance programs. 
1.4       A Closer Look at Surveillance Systems 
1.4.1 An Overview of Surveillance 
1.4.1.1 Defining Surveillance 
Surveillance is defined by the World Health Organization (WHO) as “the process of 
systematic collection, collation and analysis of data with prompt dissemination to those who need 
to know, for relevant action to be taken”85.  A key difference between surveillance and disease 
monitoring is that surveillance should lead to a public health response19.   
Surveillance systems can be described as either “active” or “passive”.  In active 
surveillance, health agencies directly seek out data of interest.  Although this collects more 
accurate information, active surveillance is timely and costly14.  Alternatively, passive surveillance 
requires voluntary reporting from individuals enrolled in a surveillance program.  While cost-
efficient and relatively easy to execute, passive surveillance is prone to under-reporting, 
incomplete data, biases, and lack of a true denominator (the population at risk)14.  Regardless of 
the approach used, surveillance systems should be evaluated at regular intervals14,81.  Data obtained 
from companion animal surveillance programs can increase the understanding of zoonotic disease 







1.4.1.2 The Importance of Establishing Case Definitions 
Once diseases of interest are determined through prioritization exercises, uniform case 
definitions for each disease are required for any surveillance system to be successful.  This is true 
at both the provincial and national levels in Canada80,81,87,88.  This is because case definitions create 
a level of standardization for what constitutes a case that is therefore eligible for reporting87.  
Usually, only confirmed cases are reported, using clinical, laboratory and epidemiological criteria; 
however, both “confirmed” and “probable” case definitions can be created for a disease81,87,89.  As 
new pathogens are added to notifiable disease lists, or as knowledge on a disease increases, case 
definitions need to be periodically updated88,89.  
Rijks et al. performed a risk assessment on several companion animal zoonotic pathogens 
selected through a prioritization exercise as part of a European initiative called the Companion 
Animal Multisectorial Interprofessional Interdisciplinary Strategic Think Tank on Zoonoses 
(CALLISTO) Project90.  The purpose of the risk assessment was to determine the role companion 
animals may play in disease risk to humans and livestock for their selected pathogens.  A key 
finding to this study was inconsistencies between case definitions for several pathogens.  This 
made risk analysis and therefore targeted prevention incredibly challenging.  For example, the 
authors found that leptospirosis cases in one study would have been classified as controls in a 
second study.  Therefore, Rijks et al. recommended the standardization of case definitions for 
pathogens shared between humans, companion animals and livestock.  To assess the status of 









1.4.1.3 Gaps in Surveillance from the Companion Animal Perspective 
Surveillance systems are well established for human, production animal, and wildlife 
diseases throughout the world at national and global levels1,15,91–93.  In comparison, companion 
animal surveillance, including zoonotic, animal health, and welfare surveillance, is still 
underdeveloped worldwide1,91,93–95.  Animal disease data currently collected for companion animal 
species is not representative of the massive pet population worldwide96.  The majority of 
companion animal surveillance includes only a small number of diseases, with a particular 
emphasis on rabies1,15,89,91,92,95.  Additionally, international health agencies are not required to 
coordinate companion animal disease reporting between countries.  In production animals, this 
task is completed by the World Organisation for Animal Health (OIE)1.  Companion animal 
surveillance is often only performed at national or regional levels, usually as part of a specific 
research objective.  Standardization of nomenclature, case definitions, and laboratory testing are 
often not included in these efforts1,92.   
Furthermore, there is lack of integrated surveillance and public health collaboration at the 
human and veterinary interface, and these systems operate independent of one another1,97.  In fact, 
Day et al. reported that only 19% of zoonotic surveillance systems included both humans and 
animals in a 2012 review1.  A 2018 study used leptospirosis cases in humans and animals from 
Washington State to highlight how collaborative surveillance efforts for both human and animal 
cases would be beneficial97.  The overall lack of companion animal surveillance data must be 
addressed “as a priority of the One Health perspective”92.  Without companion animal surveillance, 
overall disease burden from pets remains unknown and the quick identification of emerging or 
novel disease threats is not possible96.  Surveillance systems are also critical for developing 






modern society, improving companion animal surveillance systems in Canada and across the globe 
is essential for public health advancement93,94.    
In Canada, there is no national directive for companion animal disease surveillance and 
only a small number of companion animal diseases are reportable at provincial and federal 
levels15,89,98,99.  At the federal level, rabies is the only companion animal disease that is nationally 
reportable100.  Although brucellosis is also federally reportable in Canada, it is specific to B. 
abortus, B. suis, and B. melitensis from a livestock perspective100, excluding B. canis which is an 
emerging issue94,101. 
At the provincial level reportable diseases vary by province.  For example in Alberta, Lyme 
disease and Salmonella spp. are reportable companion animal related diseases89.  In Manitoba, 
brucellosis (including but not limited to B. canis) is provincially reportable102.  While Smith et al. 
commends Canada’s “robust” surveillance system for reportable diseases like rabies, similar 
surveillance efforts should be considered for non-reportable diseases15.  This is emphasized by 
Smith et al. because 68% (28/41) of the companion animal zoonoses described in the 2012 review 
were non-reportable15. 
1.4.1.4 Current Examples of Companion Animal Surveillance Systems 
There are only a small number of ongoing companion animal surveillance systems 
described in the literature.  The Small Animal Veterinary Surveillance Network (SAVSNET) is a 
successful companion animal surveillance system in the United Kingdom (UK) that captures real-
time surveillance on canine and feline infectious disease outbreaks by region96,103.  The goal of 
SAVSNET is to understand breed distribution, susceptibility and trends, spread of diseases and 
“hotspots”, to improve the prevention and treatment of infectious diseases among pets in the UK104.  






in conjunction with national laboratories to obtain companion animal surveillance data96.  Across 
Australia, VetCompass offers real-time surveillance data using electronic medical records from 
participating small animal veterinary clinics105.  A drawback to this system is that inconsistencies 
in medical record keeping can make data extraction from these large datasets inaccurate105,106.  In 
addition, only a subset of the total population of animals is included in the program which may 
lead to selection biases105.   
Other smaller companion animal surveillance projects have also been described.  An Italian 
program called Veterinary Surveillance of Pets (SVETPET) was a web-based reporting system for 
transmissible and non-transmissible diseases of cats and dogs in the country92.  This system ran on 
voluntary submissions by veterinarians.  Although the focus of this project was companion animal 
health, analyzing general pet health on a population scale contributed to human and public health 
concerns.  Similarly to VetCompass, this program only represented a subset of the pet population92.  
Disease WatchDog was a previous national disease surveillance project created in Australia for 
dogs and cats, however, poor compliance from participating veterinary clinics lead to inaccurate 
data105,107.  It is unclear whether SVETPET and Disease WatchDog are still operating at present. 
  Although the primary purpose of the 2-year CALLISTO project in Europe was to evaluate 
the role companion animals play in zoonotic disease transmission to humans, this project also 
proposed the development of a storage system using implanted patient microchips as part of an 
internationally accessible online database housing companion animal data108.  In the United States, 
the Companion Animal Parasite Council is a national surveillance program that displays up to date 
tick-borne disease, intestinal parasite, and heartworm distribution data by month or year1,109.  
Currently, the only Canadian example of continuing companion animal surveillance is the Ontario 






animal health and disease trends in Ontario for several animal species, including companion 
animals.  This is accomplished by collecting data from a network of veterinary professionals 
(through private practice, industry, academia, government, and producer groups) using quarterly 
surveys.  Data obtained through these surveys are summarized and disseminated back to 
veterinarians with quarterly reports published directly on the OAHN website110.   
1.4.2 Surveillance Strategies Related to Public/Companion Animal Health 
1.4.2.1 Dogs as Sentinels 
One such method for using companion animals in a surveillance program is to use them as 
animal sentinels86.  The use of pets as sentinels for assessing disease risk in humans has been well 
described in recent literature.  For both infectious and non-infectious hazards, pets can be used as 
part of an early warning system for estimating disease risk in humans sharing the same 
environment1,14,29,31,92,99.  Dogs in particular have served as sentinels for both human and wildlife 
populations29,34,35.  Sentinel dogs can estimate disease risk for certain wildlife species, which in 
turn provides data for conservation efforts35. 
Sentinels can be further described as “incidental” or “intentional”.  For example, a dog 
sharing the same tap water as an owner may serve as an incidental sentinel for a hidden water-
borne illness31.  When the dog becomes sick, the owner may be incidentally alerted to the hazard 
in a shared water supply.  Alternatively, intentional sentinels are consciously placed in an area to 
assess a suspected risk factor as the cause of disease29,31.  For example, if researchers were 
interested in obtaining epidemiological data for a particular pathogen, they may elect to use a 
specific sentinel to estimate exposure potential29.   
There are several key factors that make an animal a good sentinel for the disease of interest.  






risk factor, and mount a response to the disease that can be detected quickly and easily (with 
observable clinical signs or through diagnostic testing)29–31.  In addition, a good sentinel should not 
pose a direct transmission risk to humans, amplify and spread the pathogen, or act as a reservoir 
host29,31.  Pets make good sentinels for several infectious diseases because they are in close contact 
with their owners.  Therefore, disease risk from a shared environment is similar between pets and 
their owners because the source of infection will be the same29,31,86,89.  Furthermore, the popularity 
of pet ownership means dogs and cats are easily accessible across many locations89.  Ideally, 
sentinel data for the purpose of surveillance should be collected, analyzed and reported in real-
time to act as an early warning system.  Depending on the disease of interest, certain species will 
function as better sentinels than others86.      
Dogs are particularly good sentinels for vector-borne and other emerging disease threats, 
including Lyme disease and Rocky Mountain spotted fever1,31,32,111,112.  This is because dogs are 
more susceptible to tick exposure than humans.  They are closer to the ground, readily exposed, 
and are more likely to seek densely wooded areas32,111.  Hunting dogs in particular have been shown 
to be at the greatest risk for contracting Lyme disease32.  In addition, dogs do not present a direct 
transmission risk of Lyme disease to humans, although they may transport ticks into an owner’s 
environment32.  Not only are dogs good for assessing tick-borne disease risk in a population, 
collecting ticks from dogs through passive surveillance can reveal what species of ticks are present 
in a geographical area111.  Because it is difficult to estimate the overall burden of Lyme disease in 
a human population, using dogs as sentinels for Lyme disease risk is an excellent alternative.  In 
fact, a 2012 study in the UK demonstrated that the tick population is much higher than previous 






Other vector-borne disease examples where dogs have been used as sentinels include 
Leishmaniasis and Trypanosomiasis.  In non-endemic regions, a sudden increase in canine cases 
can serve as an early warning sign that geographical distribution of vectors has changed, or that 
vector control programs are inadequate.  In endemic regions, dogs are main reservoir hosts for 
both Leishmaniasis and Trypanosomiasis, making them less ideal as sentinels once disease is 
established in an area31.  In addition to vector-borne disease threats, dogs have also been used as 
sentinels in syndromic surveillance86,113.  A sudden increase in cases of canine gastrointestinal 
disease in a particular region can signal a food or water-borne infectious disease risk to humans113.  
Utilizing dogs as sentinels through surveillance programs is all part of a cohesive One Health 
strategy1,14,29.   
Dogs may also act as sentinels for environmental hazards and non-communicable disease 
threats29,31,89,92,112,114.  For example, domestic dogs have been used as incidental sentinels for lead 
toxicity in contaminated residential pipes or other household items31.  In particular, dogs are good 
sentinels for environmental risk factors in children, as young children are more likely to exhibit 
similar behaviours to dogs31.  Dogs and cats acted as incidental sentinels in 2007 when pet food 
containing melamine-contaminated gluten was detected after a rise in the number of renal failure 
cases was observed in the pet population.  This alerted public health authorities to additional 
contaminated feed that had been fed to pigs and chickens destined for human consumption29,31.  
Pets as sentinels for bioterrorism and chemical terrorism has also been proposed29,31.   
In Canada, the use of dogs as sentinels from a public health perspective is currently 
underutilized29.  A 2018 review evaluating the use of dogs as sentinels discovered only 6 Canadian 
studies out of 142 worldwide examples29.  The most common examples of dogs as sentinels in 






access to wild game, fish and garbage, and are subsequently exposed to many zoonotic 
pathogens29,30.  Because these dogs are potentially consuming the same food as individuals in the 
community, these dogs are excellent sentinels30,34.  Schurer et al. proposed the use of dogs as 
sentinels for parasitic exposure risk in humans living in Saskatchewan Indigenous communities30.  
More research is needed to assess the utility of dogs as sentinels for several pathogens emerging 
in Canada29.  Using dogs as sentinels for public health purposes may be an efficient and 
economically viable solution to obtaining surveillance data relevant to both human and animal 
populations29,30.    
1.4.2.2 Syndromic Surveillance  
Syndromic surveillance is a surveillance strategy that uses clinical signs specific to a 
“syndrome” of interest, rather than focused surveillance on a specific disease, in a defined region14.  
Syndromic surveillance may encompass several diseases that produce similar symptoms. The 
purpose of syndromic surveillance is to act as an early warning system86, therefore, the benefit of 
syndromic surveillance is that it signals the possibility of an outbreak quickly without the need for 
laboratory confirmed diagnoses14,98.  The drawbacks of syndromic surveillance programs are that 
they are costly, heavily dependent on available resources, and a higher false positive rate compared 
to disease-focused surveillance programs14.  As with any surveillance system, clear definitions for 
the syndrome of interest is required prior to the start of the program86,115.  When appropriate, 
syndromic surveillance can evolve into a disease-specific surveillance system86. 
SAVSNET has several examples where syndromic surveillance has been utilized.  
Arsevska et al. reported on canine and feline respiratory disease data that were identified via 
SAVSNET over the course of 2017116.  In addition, temporal patterns for gastrointestinal illness 






to obtain animal health related data, the zoonotic respiratory pathogen Streptococcus equi subsp. 
zooepidemicus was cultured in 198 samples (from dogs, cats and Guinea Pigs) from 2010 to 2017.  
Seventy-five percent of the canine samples were isolated from the upper respiratory tract (nose, 
trachea, or oropharynx).  This demonstrated the public health benefits of syndromic surveillance 
in companion animal species116.  Additionally, from May 2010 to August 2011, gastrointestinal 
data from SAVSNET was used to evaluate cases of diarrhea in companion animals from 42 
veterinary clinics throughout the UK113.  Surveillance data on dogs and cats presenting to clinics 
for diarrhea included species, gender, breed, duration of illness, severity of disease, diagnostic tests 
performed, and treatment given.  Furthermore, this data was available in near real-time.  In this 
example, companion animals were used as sentinels for zoonotic and emerging gastrointestinal 
pathogens113.   
A 2017 piloted surveillance program created in Washington, D.C. involved both disease-
specific surveillance and syndromic surveillance117.  The syndromic surveillance system identified 
spikes in companion animal respiratory infections and dead-on arrival cases over the course of one 
year.  The goal of this pilot program was to provide evidence that companion animal surveillance 
data (disease-specific and syndromic) may be useful from a public health perspective117.  Lastly, 
Anholt et al. investigated the use of electronic medical records (EMR) in small animal veterinary 
clinics as a tool for gathering syndromic surveillance data on gastrointestinal diseases in pets living 
in Calgary, Alberta98,115.  This data was used to assess possible animal and public health threats in 
the region of interest.  While clustering of gastrointestinal cases in pets from enrolled clinics could 
be captured, the utility of EMR data extraction for surveillance purposes had some limitations.  
This was largely related to non-standardised medical nomenclature within medical records or lack 






enteric cases at a sensitivity of 87.6% and a specificity of 99.3% when compared to human 
reviewers of the same data115. 
1.4.2.3 Surveillance of Antimicrobial Resistant Pathogens 
The majority of current AMR surveillance systems focus on antimicrobial use (AMU) and 
AMR in humans and production animal species24,57,118,119.  As previously identified, companion 
animals can also be a transmission source for AMR pathogens to humans6,24,53,118.  Several authors 
recommend the inclusion of companion animal AMU and AMR data in surveillance 
programs24,53,57,118,120,121.  Historically, data on AMU and AMR in the pet population has been 
extremely limited52.   
Because of the zoonotic potential of resistant pathogens, including but not limited to 
MRSA, MRSP, VRE, Salmonella spp., and ESBL E. coli, AMR in companion animal species is a 
serious public health threat6,52,53,94,118.  Companion animal surveillance data on AMR would help 
establish the role of pets as possible reservoirs for these pathogens118.  In addition, surveillance 
data on AMU in small animal veterinary clinics would help address where antimicrobial 
stewardship efforts need to be focused94,122.  For example, SAVSNET has gathered prescribing 
data from more than 22,000 companion animal veterinary consultations throughout the UK122.  
This baseline data can be combined with susceptibility data from laboratory surveillance to better 
assess public health risks related to AMU in companion animals57,122.  In Canada, the Canadian 
Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) is a national surveillance 
system that monitors AMU and AMR in humans, animals (largely livestock) and food119,123.  AMR 
surveillance regulated at the provincial level has also been suggested to help prevent gaps in data24.  
Regardless, including companion animals in AMR surveillance systems is required to successfully 






1.4.3 The Role of Veterinarians and Veterinary Clinics 
There are several examples where the utility of veterinarians and veterinary clinics in 
surveillance programs have been explored.  The first examination is the use of veterinary clinics 
as part of a sentinel network1,89,106,111,124.  This involves the enrollment of willing participants to 
share companion animal health data of canine and feline patients.  Surveillance data from 
veterinary laboratories are often incorporated53,124.  Establishing the willingness of veterinarians to 
participate in such surveillance programs is a key initial step to creating a surveillance system117,125.  
Companion animal surveillance systems have the opportunity to incorporate primary-care facilities 
and/or referral practices106. 
One area that has been well studied is the use of electronic medical records (EMR) for 
syndromic surveillance data14,89,98,99,105,106,111,115,124.  The goal of such systems is to extract data from 
medical records to uncover and evaluate disease trends in the companion animal population.  This 
is for a defined geographical area where disease patterns identified in the pet population may be 
relevant from a public health perspective (for example, enteric pathogens of zoonotic potential).  
A major obstacle for the utility of these surveillance systems is a lack of standardization in medical 
record keeping and incomplete records14,89,98,105,106.  This means that data may not be properly 
captured by extraction software if nomenclature used between medical records is inconsistent.   
Additionally, the overall management and analysis of large datasets can be challenging106.  
The National Companion Animal Surveillance Program (NCASP) designed in 2004 by Purdue 
University attempted to gather and use EMR data from more than 500 Banfield Veterinary 
Hospitals across the United States124.  O’Neil et al. indicated that “NCASP surveillance was limited 
by confidentiality issues, delayed dissemination of results and difficulties in managing such large 






recognize that sentinel practices enrolled in surveillance programs represent only a subset of the 
canine and feline population89,106.  In syndromic surveillance, data is only being captured from 
animals for which owners sought medical attention.  Therefore, owners have to be willing to seek 
out veterinary services when their animal is exhibiting signs of illness; but also suggests that 
subclinical cases are likely not identified106.   
Alternative methods that have been explored include the utility of web-based systems 
where participating veterinarians input surveillance data directly1,53,92,117.  Although this involves a 
larger time commitment from the veterinarian92, it avoids the limitations surrounding 
standardization of medical record keeping.  Participation of veterinarians for the web-based 
reporting system developed by Martini et al. was completely voluntary92.  A key feature of this 
system was that whatever level of clinical detail was available could be included in the submission, 
from symptoms and presumptive diagnoses to definitive diagnoses92.  Web-based surveillance 
platforms are favorable for the real-time dissemination of surveillance data, for example, in the 
form of disease-distribution maps or disease alerts1.  A few limitations of these systems is often 
low compliance from participating veterinary clinics, and data is also not representative of the 
entire population92,117.  Other methods that have been described include active surveillance using 
veterinary practice questionnaires106,110.  Veterinarians, staff, and clients can contribute data.  While 
clinic questionnaires are a quick, inexpensive and reliable method for obtaining surveillance data, 
limitations include poor response rates and recall bias.  Similarly to other methods, only a portion 
of the pet population can be captured106.   
It is evident that veterinarians can play a crucial role in contributing data to a companion 
animal surveillance program.  In addition, veterinarians will be able to use gathered surveillance 






particularly relevant for AMR surveillance data52.  Veterinarians are also essential in surveillance 
programs as client educators; to help raise public awareness for the human health risks associated 
with animal ownership42,53.  In addition, veterinarians are critical for One Health collaboration, to 
bridge the gap between human and animal health14,53.  Veterinary medical associations should be 
included in the conversation, as a resource for veterinarians in regard to companion animal disease 
reporting14. 
1.5       Conclusions and Rationale for Study 
This literature review has addressed three main objectives.  First, it provided an overview 
of canine zoonoses and public health considerations in Canada.  Zoonotic terminology, the role of 
dogs in disease spread, and the benefits and risks of dog ownership were examined, with a 
particular emphasis on the immunocompromised and Indigenous groups.  Furthermore, the role of 
climate change as it pertains to canine zoonotic disease transmission and emerging risks within 
Canada was also explored. 
The second and third objectives of this review looked at current pathogen prioritization 
strategies and surveillance systems, revealing an overall lack of research in prioritization and 
surveillance programing for companion animals specifically.  The only companion animal 
prioritization example identified was the European CALLISTO project78.  In addition, there are 
few examples of companion animal surveillance programs, particularly within Canada.  This 
included but is not limited to dog bite and AMR surveillance.  No formal reporting strategies exist 
for such public health concerns in Canada.  The only formal companion animal surveillance system 
in Canada can be found in the OAHN110.  The Prairie Provinces specifically have minimal ongoing 






Collaboration between veterinary and medical professionals is required to improve both 
animal and human health as part of a One Health approach.  The role of veterinarians in companion 
animal surveillance programs from a public health perspective also needs to be further explored.  
Although companion animal surveillance can identify animal health trends and promote action that 
improves the lives of animals, a large portion of any surveillance initiative is to inform public 
health.  This is why there was a heavy focus in this review on the public health significance of 
canine pathogens and companion animal surveillance.  The implications and importance of public 
health will be a strong focus in the research chapters to follow.   
 
Based on the knowledge gaps outlined above, this study was designed with the following 
research objectives in mind:   
• First, to create a comprehensive list of canine pathogens and establish a shortlist of 
important canine zoonotic pathogens relevant to the Prairie Provinces of Canada from a 
public health perspective. 
• Second, to prioritize this shortlist using combined expert opinion to identify pathogens that 
should be considered in a companion animal surveillance initiative. 
• Third, to investigate the role of veterinarians and veterinary clinics in a companion animal 
surveillance system in the region of interest, to use veterinarians to develop case definitions 
for canine pathogens of interest, and to assess domestic dogs as sentinels for human health 
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CHAPTER 2: DEFINING IMPORTANT CANINE ZOONOTIC PATHOGENS WITHIN 
THE PRAIRIE PROVINCES OF CANADA 
 
2.1  Abstract 
The goal of this study was to establish a shortlist of zoonotic pathogens involving the 
domestic dog that can be prioritized for a companion animal surveillance program specific to the 
Prairie Provinces of Canada.  A list of pathogens ever documented in canines was created through 
a comprehensive review of infectious disease textbooks for the following taxonomical categories: 
bacteria, ectoparasites, fungi, helminths, protozoa, rickettsia and viruses.  This created an initial 
list of 594 pathogens that was then pared down through an extensive review of the literature using 
the following criteria: (1) the pathogen is zoonotic/sapronotic/anthroponotic, (2) the dog is 
involved in transmission to humans, maintenance, or detection of the pathogen, and (3) there is a 
level of risk for occurrence of the pathogen in Canada.  This process yielded a final list of 84 
pathogens and three supplementary lists of canine zoonotic/sapronotic/anthroponotic pathogens 
that may become relevant to future surveillance programs.  The next phase of study will include 
prioritization of these pathogens using experts in the field to advise public/animal health policy 
and the investment of resources1,2 
2.2  Introduction 
The relationship between humans and companion animals has become increasingly 
intimate over time3,4.  According to the Canadian Animal Health Institute, there were an estimated 
8.2 million dogs and 8.3 million cats residing in Canada in 2018.  It is reported that 41% of 
Canadian households own at least one dog and 38% own at least one cat5.   Unfortunately, there is 
limited information on zoonotic disease prevalence in the animals with which people share the 
most time and closest contact3.  Thus, there is a growing need in the Prairie Provinces of Canada 






1500 infectious organisms known to cause human disease, it is reported that 60% of these are 
zoonotic and originate from animal sources6.  Exploring companion animal zoonotic pathogens 
from a One Health perspective becomes especially important for the most vulnerable populations.  
This includes those who are immunocompromised7, and remote communities with limited access 
to both medical and veterinary resources8,9. 
There is currently little to no data on the prevalence of canine zoonotic pathogens within 
the Prairie Provinces of Canada.  While several studies exist in the Prairie Provinces for individual 
canine pathogens8,10–12, those most significant from a public health standpoint, as well as 
prioritization of these pathogens to guide public/animal health policy has yet to be explored.  
Determining pathogens of significance is a foundational step in developing a surveillance program.   
Surveillance systems are already well established in human medicine3,6.  Several examples 
also exist in the Canadian livestock industry from both a veterinary and public health perspective13–
15.  In addition, wildlife surveillance occurs in Canada at both the provincial and federal level16,17.  
Currently, rabies is one of the only companion animal zoonotic pathogens that is routinely 
monitored through federal and provincial surveillance programs18,19.  The Ontario Animal Health 
Network (OAHN) is the first provincial initiative to collectively monitor companion animal 
disease trends in this nation20.  While companion animal surveillance programs are well established 
in other parts of the world21, there is a clear gap that needs to be filled for companion animal health 
data in the Prairie Provinces.  A companion animal surveillance program can provide both animal 
health data (demographic and disease data) in addition to relevant public health data.   
The first step to establishing a companion animal surveillance program in the location of 
interest was to determine which pathogens are significant, focusing on the domestic dog.  The 






population that have public health implications within the Prairie Provinces.  A secondary 
objective was to formulate any additional pathogen lists that represent those pathogens that may 
be important to future surveillance initiatives.   
2.3 Materials and Methods 
2.3.1 Initial List and Stepwise Approach 
A list of pathogens in the taxonomical categories bacteria, ectoparasites, fungi, helminths, 
protozoa, rickettsia and viruses ever documented in canines was created by reviewing the most up 
to date, authoritative veterinary infectious disease textbooks7,22–24.  If a pathogen was listed as 
having been identified in domestic canines in any of these textbooks, it was included in this initial 
list.  In addition, the list was supplemented with the pathogen Sars-CoV-2 (Covid-19)25.  Several 
ectoparasites were also included but were limited to mites and fleas.  Pathogens were classified to 
species level whenever possible.  This was often dependent on how taxonomic ranking was 
documented in the literature.   When a number of species were involved (for example, with dog 
bite and enteric pathogens), or when the species level was not reported, pathogens were 
characterized no further than the genus level.    
A subsequent extensive and structured literature search followed a stepwise approach (Fig. 
2.1)  to narrow down this initial pathogen list using the following steps.  The first step was to assess 
any evidence that the pathogen was zoonotic, sapronotic, or anthroponotic.  The second step was 
to assess any evidence that the dog played a role in how humans acquire the pathogen.  Roles 
included the direct transmission of the pathogen from dogs to humans, dogs maintaining the 
pathogen in the environment as a definitive or reservoir host, and finally, that dogs can be used to 
detect the pathogen in the environment as a sentinel for human exposure.  The third step was to 






publications were known to exist specifically for the Prairie Provinces.  These steps were 
developed through in-depth discussions by the primary researchers. 
2.2.2 Defining Zoonotic/Sapronotic/Anthroponotic (Step 1) 
For the purposes of this study, pathogens advanced from Step 1 if they were zoonotic, 
sapronotic or anthroponotic.  Zoonotic was defined as any pathogen that is transmitted from 
animals (or animal tissue) to people and results in human illness26.  Transmission can include direct 
contact (by skin, inhalation, or ingestion), indirect contact through fomites or a contaminated 
environment, as well as vector transmission7,23,26.  Sapronotic represented any pathogen that 
replicates on abiotic substrates in the environment with the ability to infect both animals and 
humans without direct transmission between hosts7,26.    Finally, in this study, anthroponotic 
represented predominantly human pathogens that have the potential to be transmitted from humans 
to animals (as reverse zoonoses)7.  
An extensive search of the literature and infectious disease textbooks7,22–24 was done to 
determine if a pathogen from the initial canine list was zoonotic, sapronotic or anthroponotic.  This 
included searches using the pathogen name, followed by “human illness”, “in humans” or “human 
disease” in research databases Google Scholar and PubMed.  There were no limitations placed on 
publication year during searches.  If at least one source identified the pathogen as 
zoonotic/sapronotic/anthroponotic, or if the pathogen was reported to cause clinical illness in  
humans, then the pathogen was not discarded (this included opportunistic pathogens).   Pathogens 
were assessed in Step 1 regardless of whether or not the dog was involved in transmission of the 
pathogen to humans. If a pathogen did not meet the definition of 
zoonotic/sapronotic/anthroponotic, or if evidence in the literature to support infection in humans 






2.2.3 Role of the Dog (Step 2) 
An extensive review of the literature and infectious disease textbooks7,22–24,27 was used to 
evaluate the role of the dog for all of the pathogens that advanced from Step 1.  This included 
searches using the pathogen name, followed by “dog to human”, “dog transmission” and “dog 
sentinel” in research databases Google Scholar and PubMed.  Pathogens advanced if the dog was 
involved in direct transmission of the pathogen, acted as a reservoir host and helped to maintain 
the pathogen in the environment (for example, acted as a definitive host in a parasitic life cycle), 
or acted as a sentinel for human infection and detection of the pathogen.  If the dog was historically 
involved in transmission to humans, maintenance or detection of the pathogen, regardless of how 
common the pathogen is, it advanced to Step 3.  If there was not enough evidence in the texts or 
literature, such that the role of the dog was still largely unknown, it was discarded from the list.  
For several pathogens, there was not enough evidence in the literature to prove or disprove the role 
of the dog in transmission to humans, maintenance or detection of the pathogen from a public 
health perspective.  Therefore, a supplementary list denoted Grey-Zone Pathogens was created to 
highlight these particular pathogens for their possible public health significance in the domestic 
canine population. 
2.2.4 Presence in Canada (Step 3) 
Once it was established that the dog was involved in transmission to humans, maintenance, 
or detection of the pathogen, Step 3 was to determine the level of risk for occurrence in Canada of 
each remaining pathogen using a four-tiered approach (Fig. 2.2).  These tiers included (1) the 
pathogen has been reported in dogs in Canada historically at least once, (2) the pathogen has been 
reported in Canada historically at least once, but canine-specific reports are lacking, (3) the 






a level of risk for occurrence of the pathogen in Canada due to appropriate climate, vectors, 
reservoir hosts, and lifestyle, and (4) the pathogen is unlikely to occur in Canada because the main 
reservoir host is missing, the current climate in Canada would not support survival of the pathogen 
or vector, or lifestyle does not fit with pathogen occurrence. 
The purpose for using a four-tiered approach allowed for the recognition of those pathogens 
that may not be significant to the Canadian canine and human population currently but could 
become relevant in the future.  Information about each pathogen’s presence or capacity for 
occurrence in Canada was obtained through an extensive search of the literature using the pathogen 
name followed by “in Canada” and “in Canada in dogs” in research databases Google Scholar and 
PubMed.  This step included reports of pathogens in all of Canada because of the limited research 
available for the Prairie Provinces exclusively.  If a Canadian report specifically involved the dog, 
the pathogen was placed in Tier 1.  If canine-specific reports were not identified but the pathogen 
has been documented in Canada (in human studies or other species, as well as environmental 
examples) these pathogens were placed in Tier 2.  If the pathogen was not documented in Canada 
at the time of this study, additional searches were performed to identify whether the pathogen had 
the potential to occur in Canada.  For example, searches were completed to determine the 
geographical distribution of vectors, or first and second intermediate hosts depending on the 
pathogen.  If this information supported possible survival of the pathogen in Canada (ie. the vector 
or intermediate hosts have been reported in Canada), then these pathogens were placed in Tier 3.  
It was assumed that bacterial pathogens not currently reported in Canada (such as several dog bite 
pathogens) have the capacity to occur in Canada since they are not reliant on vectors or 
intermediate hosts.  For this reason, additional searches were not required for bacterial pathogens 






there was no evidence at the time of this study to support survival of the pathogen in Canada, or 
the distribution of vectors and intermediate hosts did not include Canada, these pathogens were 
placed in Tier 4.  Pathogens grouped in Tier 1 represented the final shortlist.  Tier 2 and Tier 3 
pathogens represented supplemental shortlists to highlight pathogens that may become significant 
to canine surveillance initiatives in the future.  Grey-Zone Pathogens identified in Step 2 were also 
further categorized as being present in Canada or having the potential to occur in Canada using the 
same search strategy. 
2.4 Results 
A total of 594 infectious pathogens were identified in canines (Appendix A; Fig. 2.3).  Of 
these, 235 were bacteria (40%), 14 were ectoparasites (2%), 79 were fungi (13%), 109 were 
helminths (19%), 62 were protozoa (10%), 19 were rickettsia (3%), and 76 were viruses (13%).  
From this initial list, a total of 486 pathogens (82%) were then identified as 
zoonotic/sapronotic/anthroponotic.  Of these 486 pathogens, 71 were specifically classified as 
sapronoses (15%).   
From the previous 486 pathogens, a total of 241 pathogens (50%) were further identified 
as involving the dog in human infection through either direct transmission, maintenance of the 
pathogen in the environment, or as sentinels for human exposure (Appendix A).  An additional 29 
pathogens were classified as Grey-Zone Pathogens.  This represented pathogens where there was 
evidence to suggest the dog’s role in transmission to humans, maintenance or detection of the 
pathogen but there was not enough evidence to prove or disprove the role of the dog at this time.  
Of these 29 pathogens, 19 were present in Canada and 7 had the potential to occur in Canada 






Of the previous 241 pathogens, 84 pathogens were identified in canines in Canada (Tier 1; 
Table 2.1), 74 were reported in Canada but canine-specific reports were lacking (Tier 2; Appendix 
C), and 31 pathogens were classified as having the potential to occur in Canada (Tier 3; Appendix 
D).  A total of 52 pathogens were identified as unlikely to occur in Canada (Tier 4).   
2.5 Discussion 
Using a stepwise approach, an initial list of 594 pathogens identified in canines was created 
and reduced to 84 pathogens (Tier 1) relevant to the Prairie Provinces from a public health 
perspective.  In addition, three supplemental lists (Tier 2 & 3, and Grey-Zone Pathogens) were 
formulated to highlight several other groups of pathogens that may become relevant to future 
surveillance initiatives.  To the best of the author’s knowledge this is the first study in Canada to 
summarize and list important canine zoonotic/sapronotic/anthroponotic pathogens with the intent 
to prioritize these pathogens to help establish a companion animal surveillance program.  A follow-
up study will rank the final pathogen list using combined expert opinion to advise public/animal 
health policy on which pathogens should be prioritized for a companion animal surveillance 
program in the Prairie Provinces of Canada. 
The initial list may not be completely exhaustive and there is an opportunity for rare 
pathogens to be missed.  The veterinary infectious disease textbooks used to create the initial 
pathogen list are comprehensive and well-founded, and are likely to capture the majority of the 
pathogens identified in dogs.  Because the world is constantly changing it is also possible that 
emerging pathogens will arise during the course of this research.  Depending on how one chooses 
to define zoonotic, classification of a pathogen may be subjectively based on who is creating the 
list and their personal objectives.  Therefore, the final shortlist is not completely rigid but is not 






down the list and doing so may have altered the final shortlist.  Follow-up ranking exercises will 
provide the opportunity to revise pathogens on the list.  
A significant portion of this review became an exercise on what constitutes a zoonotic 
pathogen.  There were several instances of contradicting views in the literature on whether or not 
a pathogen was categorized as zoonotic7,23,24,28.  This was why having a clear definition of 
zoonotic/sapronotic/anthroponotic prior to condensing the list was extremely important.  A 
priority for this study was to ensure that if a canine pathogen impacted human health in any way 
it was not overlooked if it was not zoonotic in the traditional sense (direct animal to human 
transmission).  Several definitions were utilized to explore how a pathogen related to human 
disease.  For example, sapronoses were assessed in Step 1 because although they are not directly 
zoonotic, dogs can serve as sentinels for sapronotic pathogens and reveal a risk for human exposure 
from a shared environment7.  Anthroponoses were also assessed in Step 1 to explore the idea that 
if a human pathogen can be transmitted from human to canine, there is also a concern for 
transmission to occur in the other direction.  Unfortunately, it is often challenging to verify 
zoonotic transfer versus shared environmental exposure27, which is why it is also important to 
consider dogs as sentinels for many of these pathogens. 
Several ectoparasites were included in the initial list of pathogens.  Many ectoparasites 
(including fleas, ticks and sandflies) are important from a public health perspective because they 
can act as vectors for zoonotic disease transmission29–31.  This exercise explored whether the 
ectoparasite itself should be classified as zoonotic.  This became particularly relevant for the flea.  
Fleas are known to transmit several very serious pathogens to humans31–34 but they can also cause 
clinical signs in humans on their own.  This includes erythema, pruritis and dermatitis24,35.  Because 






harbor and transmit to humans.  While the clinical signs caused by the flea are far less severe than 
many of the pathogens they harbor, based on the extensive definitions employed in this study, the 
flea was included in the zoonotic category. 
In exploring how the dog plays a role in transmission to humans, maintenance and detection 
of these zoonotic/sapronotic/anthroponotic pathogens, a subcategory denoted Grey-Zone 
Pathogens was also created.  This represented pathogens where there was some evidence in the 
literature that dogs are likely to contribute to human infection, either directly or as sentinels, 
however nothing has been definitively proven at this time.  This is either because there has not 
been enough research done on the pathogen, or it could not be determined whether transmission 
or shared environmental exposure occurred if infection in the dog was not explicitly identified27.  
These pathogens may play a role in canine zoonoses in the future and should not be overlooked.  
Step 2 in particular exposed an overall lack of research in canine transmission of zoonotic 
pathogens.  Several pathogens were excluded from Step 2 because there is simply not enough 
evidence at this time for the dog’s role in transmission, maintenance or detection of the pathogen.  
These Grey-Zone pathogens were further assessed for presence in Canada, and the potential to 
occur in Canada as a way to help highlight those pathogens that may become most important to 
the Prairie Provinces.   
There was limited research available specific to the Prairie Provinces, therefore, literature 
encompassing all of Canada was included in Step 3 to evaluate occurrence of a pathogen in 
Canada.  This lack of research emphasizes the need to identify pathogens relevant for surveillance 
programs because companion animal zoonotic disease prevalence is so limited in local regions.  It 
is important to note, that inclusion of a pathogen in Step 3 was based on what is currently available 






some of the pathogens listed in the third and fourth tiers may become more relevant to Canada in 
the future and should not be completely discounted for prospective surveillance studies.  For 
example, non-native species of snails that act as first intermediate hosts in several parasitic life 
cycles have invaded regions of the world where they were not previously seen36.  In particular, 
climate change also impacts the distribution of many important vectors37,38.  Pathogens in Tier 2 
and Tier 3 were highlighted as a reminder that just because a pathogen hasn’t been recorded in 
Canada, or identified specifically in the dog in Canada, doesn’t mean the pathogen isn’t relevant 
for canine surveillance.  It could simply mean these canine pathogens haven’t yet been identified 
in this region because researchers haven’t been looking for them.  It is important to also 
acknowledge the effect of canine zoonotic pathogens on rural populations within the Prairie 
Provinces and the challenges these areas face with limited access to both medical and veterinary 
services8,9. 
Several other interesting findings emerged during the course of this study including dog-
bite relevance in Canada.  During the review process it became apparent that specific information 
on dog bite pathogens and reports in Canada are limited.  Although it is suspected that several dog 
bite pathogens are present in Canada, for many of these pathogens there were no reports to confirm 
this.  This is likely related to the challenges associated with bacterial isolation from contaminated 
bite wounds.  Often initial cultures are not representative of true infection39,40.  The recommended 
treatment for dog bite wounds is wound management alone and cultures are only performed in 
persistent infections39,40.  In cases where the wound persists and cultures are collected, a 
surveillance program to monitor pathogens isolated in unresolving dog bite wounds may be worth 
exploring.  This is of particular importance for dog bite pathogens such as Capnocytophaga 






of dog bites and degree of injury in children; however, the pathogens involved in these wounds 
were not the focus of the study39.  
Additionally, antimicrobial resistant pathogens in canines became significant in this study 
as this continues to be a growing area of concern and research.  Canine bacterial isolates of interest 
on the final shortlist included MRSA, MRSP, VRE, E. coli, Salmonella spp., and urinary isolates 
Klebsiella spp. and Pseudomonas aeruginosa.  Pathogens that are resistant to antimicrobials, 
particularly multi-drug resistant (MDR) pathogens, are a major public health concern.  Dogs living 
in close contact with their owners can potentially shed these pathogens in the environment and act 
as a source for human infection42–46.  For a large number of pathogens identified in this study, 
including antimicrobial resistant and MDR pathogens, emphasis should be placed on the 
consequences of these infections in immunocompromised individuals7,27.  Surveillance of 
antimicrobial resistance in canines and other companion animals is an area where additional 
research should be considered. 
The current study chose to focus on the domestic dog only.  Other companion animals such 
as cats, exotic pets, small mammals, and birds were excluded.  These species should be considered 
for future research.  Because the primary goal of this research is to advise a companion animal 
surveillance program, the current study focused on evidence in the literature based specifically on 
the domestic canine.  The author recognizes that several of the zoonotic pathogens identified here 
are also relevant to wild canids within Canada47–50.  This is an additional area to be explored for 
provincial surveillance programs.  The methods applied in this study can be used for any of the 
above-mentioned species.  
Challenges in this study included reclassification of pathogen names or several names 






it challenging to find accurate information in the literature and many pathogens have been 
potentially misclassified in older studies.  For example, with over 2500 serovars for Salmonella 
spp. and variations between authors on naming, it was difficult to find consistent reports on which 
Salmonella species were actually isolated in each particular case51.  For simplicity, Salmonella 
enterica was grouped together and emphasis was placed only on serovars enteritidis and 
typhimurium where distinct reports related to the dog were found52–54. 
2.6 Conclusions 
This study successfully identified 84 pathogens present in canines that are of possible 
public health importance within the Prairie Provinces of Canada.  In addition, several other groups 
of pathogens were highlighted that may become important in the Prairie Provinces for future 
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Table 2.1. Shortlist of 84 canine pathogens (Tier 1) identified as having public health 




Bacteria Actinomyces viscosus c 
Bartonella henselae 
Bartonella vinsonii subsp.       
     berkhoffii 
Bordetella bronchiseptica  
Borrelia burgdorferi senso  











Escherichia coli a 




Leishmania infantum  




Neisseria weaver c 
Pasteurella canis c 
Pasteurella multocida c 
Pasteurella spp.c 
Pseudomonas aeruginosa 
Salmonella enterica   
(enteritidis,            
typhimurium) 
Staphylococcus aureus c 
Staphylococcus  
     pseudintermedius c 









Sarcoptes scabiei var canis 
 








Helminths Acanthocheilonema  





















Protozoa Cryptosporidium canis 
Giardia duodenalis assemblage A1 
Giardia duodenalis assemblage B 
Trypanosoma cruzi 
Rickettsia Anaplasma phagocytophilum 
Ehrlichia canis 
Rickettsia rickettsia 
Viruses Rabies  
aEscherichia coli pathovars enterohemorrhagic E. coli (EHEC), enteropathogenic E. coli (EPEC), adherent invasive E. coli (AIEC), 
uropathogenic E. coli (UPEC), necrotoxigenic E. coli (NTEC), enterotoxigenic E. coli (ETEC)   
bLeptospira interrogans serovars autumnalis, bratislava, canicola, grippotyphosa, hardjo, icterohaemorrhagiae, pomona 







Figure 2.1.  Stepwise approach used to pare down initial pathogen list to identify important 
canine pathogens from a public health perspective in Canada (including the Prairie Provinces). 
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Figure 2.3.  Resulting number of pathogens that fulfilled the criteria for each step.  Tier 1 = final 
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CHAPTER 3: CANINE ZOONOTIC SURVEILLANCE IN THE PRAIRIE PROVINCES 
OF CANADA: PRIORITIZING PATHOGENS  
 
3.1  Abstract 
A pathogen prioritization exercise was performed using experts in the field of veterinary 
medicine and public health to establish 3-5 canine pathogens of public health concern for 
consideration in a companion animal surveillance initiative specific to the Prairie Provinces of 
Canada.  A list of 51 diseases specific to the domestic dog was provided to participating experts 
to select and rank their top 10 pathogens of concern from a public health perspective.  In addition, 
participants were required to select 5 pathogens from the list of lowest public health concern in 
their opinion.  Scores were assigned to each pathogen selected based on ranking position and a 
total sum of these scores provided the final ranking.  Based on this final ranking, the overall top 5 
canine pathogens of public health concern in the Prairie Provinces were: (1) Echinococcus spp., 
(2), MRSA, (3) Salmonella enterica, (4) MRSP, and (5) Borrelia burgdorferi.  These pathogens 
should be considered for a companion animal surveillance initiative specific to the prairies.  A 
follow-up study will define case definitions for these pathogens to assist in developing the best 
surveillance system indicators for informing public health decision making.   
3.2 Introduction 
 Companion animal surveillance data is extremely limited in the Prairie Provinces of 
Canada from both the animal health and public health perspective. Currently, rabies is one of the 
only canine specific pathogens that is routinely monitored through federal and provincial 
surveillance programs1,2.   Data on other relevant canine zoonoses with implications to human 
health are not monitored in a centralized or ongoing surveillance system.  As the popularity and 
intimacy of pet ownership continues to grow, the impacts of canine zoonoses on public health 






important for individuals who are immunocompromised4; or locations with high populations of 
free-roaming dogs and/or limited access to veterinary and medical resources, such as northern or 
Indigenous communities5.    
 The first step to formalizing a companion animal surveillance system is to determine which 
pathogens to focus surveillance on.  The primary purpose of pathogen prioritization is to identify 
where to invest finite resources6.  Additionally, pathogen prioritization is used for emerging disease 
preparedness, and can guide prevention and control efforts for diseases of concern6–8.  
Unfortunately, there is an overall lack of standardization for pathogen prioritization methods in 
Canada8.  This is largely because objectives vary based on stakeholder interests and the region of 
concern; therefore, some flexibility and adaptation is required6.   
 Approaches to pathogen prioritization are often described as quantitative, semi-
quantitative, or qualitative6,7.  Quantitative methods use a numerical scale for ranking selected 
pathogens based on objective criteria, such as incidence and prevalence7.  An example of a strictly 
quantitative prioritization method includes Multi-Criteria Decision Analysis (MCDA)6,7.  
Alternatively, qualitative methods rely more heavily on individual or group opinions for pathogen 
ranking, such as the Delphi method, and expert opinion or focus group consensus6,7.  Semi-
quantitative methods offer a combination of the two approaches where pathogen scoring is 
subjective, but choices are ranked relative to each other on a numerical scale7.   
           While quantitative methods have become more common due to their increased objectivity, 
they are only possible if existing evidence and surveillance data is available.  For example, if 
prevalence, mortality, or transmissibility are selected criteria used to score each pathogen during 
a prioritization exercise, this information must be readily accessible based on previous research6,9.  






they can increase bias and subjectivity of the prioritization exercise6,9.  For most companion animal 
zoonoses, data is extremely limited because surveillance is not well established, and qualitative or 
semi-quantitative methods must be utilized.  Currently, only one example of companion animal 
pathogen prioritization exists in the literature9.      
 The primary objective of this study was to identify the top 3-5 canine pathogens of public 
health significance experts in the fields of veterinary medicine and public health would be most 
interested in seeing in a companion animal surveillance program specific to the Prairie Provinces 
of Canada using a semi-quantitative approach.  Because extensive surveillance data already exists 
for rabies, rabies was deliberately excluded from this prioritization exercise.  Rather, the goal was 
to define which other canine zoonotic pathogens should be included in a companion animal 
specific surveillance initiative. 
3.3 Materials and Methods 
3.3.1  Pathogen Selection 
 Eighty-four individual canine pathogens of possible public health significance in the Prairie 
Provinces of Canada were selected based on previously described methods10.  This list was further 
condensed by organizing pathogens into logical groupings to limit redundancy (Appendix F).  For 
example, it seemed unnecessary to list all Campylobacter species individually for the prioritization 
exercise, therefore, individual Campylobacter species were grouped together as a single entry.  
Similarly, individual Leptospira interrogans serovars were grouped as one entry.  This was applied 
to several genera where more than one species was included on the initial list of 84 pathogens.  
Additionally, a collection of bacteria specific to dog bites were categorized together as “dog bite 
pathogens”, as were groupings for “dermatophytes”, “fleas”, and “mites”. These groupings were 






health perspective, favoring collective examination for the purposes of prioritization.  In the end, 
51 pathogens and groups of pathogens/parasites were established for the prioritization exercise.  
For simplicity, these 51 pathogens and groups of pathogens/parasites will collectively be referred 
to as “canine pathogens” from this point forward.   
3.3.2  Recruiting Experts and Survey Dissemination 
 An expert was defined as anyone with veterinary, epidemiology, or public health 
knowledge within Canada, but particular emphasis was placed on anyone residing or working in 
Alberta, Saskatchewan and Manitoba.  A list of colleagues with varying backgrounds in these 
disciplines from both research/academic and governmental institutes was compiled for an initial 
email invitation to participate in the survey.  The intent of this initial email was to also have 
participants further disseminate the survey to their networks as a “snowball” method to recruit 
additional experts in their field.  The email included the survey invitation, survey introduction, 
intent of study, and ethics approval.  A description as to why rabies was excluded from the 
prioritization exercise was also provided.  Participation in the survey was completely voluntary.  
In addition, survey invitations were provided through each of the three veterinary medical 
associations in Alberta (ABVMA), Saskatchewan (SVMA), and Manitoba (MVMA) by inclusion 
in their weekly E-Newsletters so that private practice veterinarians were included in the 
conversation.  The SurveyMonkey platform was used to create, disseminate and record survey 
data.  The survey remained open from October 5 to November 2, 2020.   
3.3.3  Designing Survey 
 Survey questions were formulated with the intent to score and rank 51 canine pathogens of 
possible public health significance within the Prairie Provinces using expert opinion.  Based on 






surveillance initiative.  Identifying 3-5 high priority pathogens was deemed a feasible starting point 
for the surveillance initiative by investigators.  The main objective in survey question design was 
to identify which canine pathogens experts in the field (veterinary medicine, epidemiology, and 
public health) within the region of interest (the Prairie Provinces) would be interested in seeing in 
a companion animal surveillance system.  The survey was piloted by 5 veterinary epidemiology 
colleagues prior to dissemination.  Any recommendations or suggestions for the survey design 
were considered and adjusted accordingly.   
The final survey consisted of 11 questions, including 3 initial questions related to 
respondent demographics (Appendix G).  The demographic questions required participants to 
specify occupation, his/her primary location by province, and experience in canine zoonoses 
specifically.  The remainder of the survey asked participants to choose a top 10 from the list of 51 
canine pathogens and then rank those choices from 1 to 10, with 1 being the most important 
pathogen in his/her opinion from a public health perspective.  Participants were also required to 
elaborate on his or her reasoning for pathogen selections.  In addition, survey respondents were 
asked to select 5 bottom canine pathogens from the list and elaborate on why these pathogens were 
selected as unimportant from a public health perspective.  
Participants were also given the opportunity to comment on importance of pathogens from 
a taxonomical standpoint, if any zoonotic canine pathogens were missing from the initial list, and 
if there were any additional non-zoonotic canine pathogens that should be included in a companion 
animal surveillance program from an animal health perspective.  To aid in the selection process, 
participants were provided with a supplementary chart that could be referred to for pathogen 
information if needed (Appendix H).  The supplemental chart included background information 






(including if the pathogen is fatal in humans), and treatments if applicable.  If the pathogen was 
considered common or rare this was also stated.   
3.3.4  Data Analysis 
3.3.4.1 Pathogen Scoring: A Semi-Quantitative Approach 
 Final pathogen scores were generated using a point-system, culminating in a total sum of 
points for each pathogen.  Each time a pathogen was ranked as a participant’s top pathogen it 
received 10 points.  Pathogens ranked second position received 9 points, pathogens ranked third 
position received 8 points, and this point-system continued up to the tenth ranking position upon 
which a pathogen received only 1 point (Table 3.1).  Additionally, every time a pathogen was 
placed in a participant’s “bottom 5” it received negative 1 point, irrespective of rank.  A pathogen’s 
final score was the summation of all points accumulated.  Pathogens were then ranked relative to 
each other from highest to lowest score.   
3.3.4.2 Stratification 
 Pathogen selections were also stratified by demographic variables (province, occupation, 
and experience level) with re-calculation of scores based on these categories.  The purpose of 
stratification was to assess whether the highest priority pathogens changed depending on the 
experts’ demographics.   
3.3.4.3 Open-Ended Questions 
 All open-ended questions were analyzed by grouping repeated or similar answers into 
themes regardless of respondent demographics.  In addition, open-ended responses were compared 
between public health participants and animal health participants (veterinarians in 
research/academia, government, or private practice) to assess whether themes were similar or 






provinces to assess whether location altered answers.  Repeated themes from the open-ended 
responses for why pathogens were placed in a participant’s top 10 or bottom 5 were further 
assessed against the overall “top 5” and “bottom 5” ranking pathogens.  This was to establish 
whether prominent themes for pathogen selections coincided with which pathogens ultimately 
scored the highest and lowest. 
3.4 Results 
3.4.1 Demographic Data 
 A total of 36 completed surveys were collected; any incomplete surveys were discarded 
resulting in a 65% (36/55) completion rate for survey participation.  Of the 36 usable surveys, 42% 
(15/36) of participants were from Alberta, 28% (10/36) were from Saskatchewan, 19% (7/36) were 
from Manitoba, and11% (4/36) were from “other” (Table 3.2).   
            Occupational data revealed that 14% (5/36) of participants worked in the public health 
sector through government or laboratory settings while 6% (2/36) worked within the government 
as veterinarians.  Additionally, 11% (4/36) of participants identified as working in veterinary 
medicine within research/academia.  The largest group of participants were companion animal 
veterinarians at 44% (16/36), while 25% (9/36) of participants classified themselves as mixed 
animal veterinarians.  No large animal veterinarians participated in the survey (Table 3.2).  
Participants were also arranged into two larger stakeholder groups: public health participants 
versus animal health participants regardless of more specific occupational descriptions.  This 
revealed that 14% (5/36) of individuals were from the public health sector and 86% (31/36) of 
individuals were from the animal health sector. 
           In terms of experience related to canine zoonoses specifically, 0 participants said they had 






participants had moderate experience, and only 11% (4/36) of participants felt they had significant 
experience (Table 3.2).    
3.4.2 Pathogen Scoring 
 Each of the 51 canine pathogens received a final score during the prioritization exercise 
ranging from 221 to -14 (Table 3.3).  A natural break in final scores provided a rational overall 
“top 5”.  The top 5 highest scoring pathogens in descending order were Echinococcus spp. 
(granulosus, multilocularis), methicillin-resistant Staphylococcus aureus (MRSA), Salmonella 
enterica, methicillin-resistant Staphylococcus pseudintermedius (MRSP), and Borrelia 
burgdorferi senso stricto.  Escherichia coli (E. coli), dog-bite pathogens and Campylobacter spp. 
also had notable scores.  The 5 lowest scoring pathogens in descending order included Alaria spp., 
Cryptocotyle lingua, Dirofilaria immitis, Acanthocheilonema reconditum, and Malassezia 
pachydermatis.  There was a single participant who ranked a pathogen (Bordetella bronchiseptica) 
in both the top 10 (ranked #10) and bottom 5.  Therefore, the score for B. bronchiseptica from this 
participant was not included.  This did not happen with any of the remaining 35 survey responses. 
3.4.3 Stratification 
 Scores for pathogens stratified by province, occupation and level of experience in canine 
zoonoses showed minor variations between the top 5 scoring pathogens (Table 3.4).  Both 
Echinococcus spp. and MRSA remained consistently in the top 5 list of pathogens regardless of 
demographic input.  Salmonella enterica was also repeated in several top 5 stratified groups.  
Echinococcus spp. remained in either the first or second position regardless of a respondent’s 
occupation or level of experience in canine zoonoses.  The largest discrepancies in the top 5 
pathogens selected were seen when pathogens were stratified by province, where participants from 






3.4.4 Open-Ended Questions 
 Several responses to the open-ended questions were common in terms of reasoning for why 
a canine pathogen was placed in an individual’s top 10 regardless of demographics.  Repeated 
responses included: prevalent in the prairies, severity of disease in humans, fatal in humans, lack 
of treatment, high transmission or exposure from dogs to humans, high risk in the 
immunocompromised, lack of public awareness, and the pathogen is emerging (Table 3.5).  These 
responses were repeated regardless of stakeholder interests (individuals from public health versus 
animal health) or province of origin.  Perceived prevalence in the prairies was particularly common 
for practicing veterinarians if they had personally diagnosed the pathogen in a clinic setting (n=15).  
Unique responses of note included an interest in pathogens where the dog acts as a sentinel, or 
pathogens as they may relate to public health decision making.  One respondent from the public 
health group selected pathogens “that have an unclear epidemiology”.  An additional notable 
response from a public health official suggested pathogen selection be based on surveillance 
systems already in place that would provide compliments to a companion animal surveillance 
system in the Prairie Provinces, such as PulseNet Canada and FoodNet for enteric pathogens.  
Public health stakeholders were more likely to comment on pathogens of importance from a 
reservoir, common-source exposure, or sentinel perspective.  Three respondents within the animal 
health stakeholder group expressed that concern for zoonoses surrounding raw food diets 
contributed to their choices. 
 Common reasons experts placed canine pathogens in the bottom 5 included: the respondent 
has never diagnosed the pathogen, perceived low prevalence in the prairies or that the pathogen is 
rare, low severity of disease (in dogs and humans), the pathogen wasn’t recognized by the 






from dogs to humans (Table 3.5).  Having never diagnosed the pathogen or being unfamiliar with 
the pathogen was a particularly common answer from private veterinarians (n=11).  One 
respondent’s rationale from the public health sector was the “practicality” of monitoring certain 
pathogens in a companion animal surveillance system.   
 Thirty-nine percent (14/36) of respondents placed equal weight on all taxonomical 
categories, and this did not affect whether or not a pathogen was selected in his or her top 10.  
Common rationale from participants was that pathogens from several categories could have serious 
consequences to humans.  Of the individuals who placed higher importance on some taxonomical 
categories over others, “bacteria” was the most popular choice (11/36).  Even more specifically, 6 
respondents emphasized antimicrobial resistance (AMR) as a primary concern.  In addition, a 
concern for AMR pathogens was expressed by at least one individual in each stakeholder group 
(public health and animal health) and within each province.  There were 3 participants (from both 
stakeholder groups) who specified particular concern for viruses due to severity of disease, the 
possibility for direct transmission from dogs to humans, and difficulties in treating viral diseases.  
In terms of taxonomical categories that experts felt were less important, 12 individuals specified 
ectoparasites.  Comments for why ectoparasites were perceived as a less important category 
included that preventatives exist, they are easily treatable, and severity of disease in people is low. 
 The greatest variability in open-ended responses occurred from participants who placed 
variable importance on taxonomical categories.  Although there were several repeated answers 
(bacteria as more important, ectoparasites as less important), there were several contradictions for 
particular taxonomical categories like helminths, and fungi for why one group may or may not be 
important.  For example, one individual placed more importance on helminths because of poor 






as less important because standard hygienic practices and preventatives help reduce the risk of 
infection in humans.  Aside from ectoparasites being a common choice, there were many variations 
in which additional taxonomical categories were perceived as less important in participants who 
placed different weights on each category.   
 When asked if any canine zoonotic pathogens were missing from the prioritization 
exercise, 81% (29/36) of respondents did not have any additional pathogens to add.  There were 2 
participants who specified Sars-CoV-2 and 2 participants requested canine influenza.  
Additionally, 1 participant included toxoplasmosis and 2 respondents requested rabies.  For the 
inclusion of non-zoonotic canine pathogens to a companion animal surveillance program, 61% 
(22/36) of respondents did not have any additional pathogens to add.  Repeated answers from those 
with suggestions included parvovirus, distemper, and canine influenza.  A few non-communicable 
examples were also suggested including allergic skin disease, transitional cell carcinoma, and 
dental malocclusions.  The majority of pathogen suggestions came from the animal health 
stakeholder group (n = 13). 
 Repeated themes (responses) from open-ended questions on why a pathogen was placed in 
a participant’s top 10 or bottom 5 (Table 3.5) were examined against the overall top 5 highest 
scoring pathogens and bottom 5 lowest scoring pathogens.  The final ranking was both agreeable 
with the common themes for top 10 selections and bottom 5 selections.  Several participants felt 
echinococcosis was “on the rise”, particularly in wild canid populations making it a more emerging 
concern in domestic dog and human populations.  Additionally, the disease is severe in humans 
and participants perceived an overall lack of public awareness.  For MRSA/MRSP severity of 
disease in humans is high, treatment options are limited, and disease risk is even greater in those 






humans as a result of raw food diets.  Furthermore, there is lack of treatment in resistant and 
emerging strains.  For Lyme disease, severity of disease in humans is high and prevalence of the 
disease is prominent in certain regions.  There is also an increased chance of exposure to humans 
because dogs may bring infected ticks into a shared environment.  The lowest scoring pathogens 
(M. pachydermatis, A. reconditum, D. immitis, C. lingua, Alaria spp.) are all either extremely rare 
in the prairies, easily treatable/preventable, and transmission from dogs to humans is considered 
low.  It is important to note that the supplemental chart provided to experts included some of the 
above details for pathogens included in the exercise. 
3.5 Discussion 
 Based on simple summation of final pathogen scores, the top 5 collective canine pathogens 
selected by veterinary and public health experts in the Prairie Provinces and other parts of Canada 
were: (1) Echinococcus spp. (granulosus, multilocularis), (2) MRSA, (3) Salmonella enterica, (4) 
MRSP, and (5) Borrelia burgdorferi senso stricto.  These pathogens were selected from a public 
health perspective for the possible inclusion in a companion animal surveillance system.  In 
addition, several non-zoonotic canine pathogens were of interest for inclusion in a companion 
animal surveillance initiative including parvovirus, distemper, and canine influenza.   
Stratification of pathogen scores based on location, occupation and level of experience in 
canine zoonoses revealed only minor variations in the top 5 canine pathogens selected.  Of 
particular note, the top 5 pathogens did not change substantially regardless of a respondent’s area 
of interest (occupation).  For example, it would be expected that a researcher may have very 
different motivations for companion animal surveillance than a private practitioner.  Contrary to 
this perception, the top 3 pathogens (Echinococcus spp., MRSA, and Salmonella enterica) were 






stratified top 5 pathogen lists were seen from respondents living in British Columbia and Ontario, 
which were not the primary locations of interest in this study.   
 It is also important to consider how surveillance data would be obtained for these pathogens 
of interest.  Based on pathogen scoring, including stratified scores, a strong consideration is to 
group certain pathogens together for the purposes of surveillance.  For example, several enteric 
pathogens (Salmonella enterica, E. coli, Campylobacter spp.) scored high during the prioritization 
exercise and were repeated in stratified scores regardless of demographic data.  For the intent of 
surveillance, “enteric pathogens” as a group could be a consideration.  Additionally, diagnostic 
testing for enteric diseases in dogs often tests for multiple pathogens.  Therefore, if a dog presents 
for gastrointestinal illness and a full diarrhea panel is being submitted, then reporting would occur 
for any of the zoonotic pathogens Salmonella spp., E. coli, and Campylobacter spp.  Similarly, 
vector-borne diseases are another grouping to be considered.  B. burgdorferi was included as a 
final top 5 pathogen.  A common test used to diagnose Lyme disease in dogs is the IDEXX SNAP 
4Dx Test (IDEXX Laboratories, Inc.).  Anaplasma spp., Ehrlichia spp., and heartworm are 
included in this test and could therefore also be considered in a surveillance program11–13.  Concern 
regarding AMR in general (including but not limited to MRSA and MRSP) was a recurring topic 
throughout the prioritization exercise in both pathogen scoring and open-ended responses. 
With these considerations in mind, the following 4 groups of canine pathogens for a 
companion animal surveillance initiative in the Prairie Provinces are recommended: (1) 
Echinococcus spp., (2) AMR pathogens (ex. MRSA/MRSP), (3) enteric pathogens (Salmonella 
spp., E. coli, Campylobacter spp.), and (4) vector-borne pathogens (B. burgdorferi, Anaplasma 






surveillance program and the development of case definitions for canine pathogens of interest will 
be examined in a follow-up study.    
“Dog bite pathogens” scored relatively high in general and was repeated in several 
stratified top 5 groups.  The majority of dog bite pathogens are commensals of the canine mouth 
or human skin, leading to polymicrobial infections following a bite14,15.  In addition, because of 
high contamination in dog bite wounds, cultures are very rarely performed as they may not be 
representative of true infection, and therefore the true etiological agent is never determined16,17.  
For these reasons, monitoring of such pathogens from a surveillance perspective is meaningless. 
While it may not be feasible or useful to retain surveillance data on individual dog bite pathogens, 
there is currently limited surveillance data within Canada on the frequency of dog bites15.  The 
high ranking of “dog bite pathogens” during this prioritization exercise highlights an interest for a  
centralized database on dog bite prevalence, which could be addressed within our public health 
sector. 
 Responses from open-ended questions on why a pathogen was included in a participant’s 
top 10 mimicked the criteria that are commonly used in more quantitative prioritization exercises.  
Common criteria reported in the literature include: burden of disease (incidence, prevalence in 
humans, mortality), case-fatality rate, transmissibility, disease emergence potential, public 
perception, and treatment and preventative options18.  Prior examples focus heavily on 
communicable diseases in humans, including some zoonoses, and food-borne diseases6,18,19.  Very 
few animal specific examples are described, particularly companion animal examples9.  In this 
study, participants emphasized their perceived prevalence of a pathogen in the dog population, 
severity of disease in dogs and humans, if it is fatal to humans, transmissibility from dogs to 






scoring pathogens appeared to correlate with these common criteria based on available or 
perceived information.  Once a companion animal surveillance system is established, more 
concrete data on prevalence, incidence, mortality-rates and transmissibility of these pathogens as 
they relate to the dog will be available.  Pathogens included in the surveillance program can then 
be prioritized from a quantitative perspective using specific criteria to ensure that relevant 
pathogens continue to be monitored.   
 A few open-ended responses requested the inclusion of Sars-CoV-2 in a companion animal 
surveillance system within the Prairie Provinces.  Given the current situation at the time of this 
writing, although COVD-19 research is incredibly relevant, there is no evidence at this time that 
dogs play a role in the transmission of Sars-CoV-2 to humans, nor do they maintain the virus in 
the environment as a reservoir host20,21.  In addition, because dogs do not exhibit clinical signs of 
disease when infected with Sars-CoV-2, they are poor sentinels for the pathogen22,23.  Because of 
this current knowledge, Sars-CoV-2 did not move on to the final pathogen short list described in 
the preceding study and was not provided to experts for the prioritization exercise10.   
           In addition, rabies was mentioned on two occasions by respondents for inclusion in a 
companion animal surveillance system.  Because surveillance data already exists for rabies both 
provincially and federally in Canada, it was not included in this exercise.  Although this was stated 
in the survey introduction, it is likely that this information was missed by some participants.  
Several feline focused pathogens were also recommended by participants for companion animal 
surveillance including toxoplasmosis and panleukopenia.  While not the focus of this study, feline 
pathogens will also eventually be explored for a companion animal surveillance initiative in the 






was of interest to many participants during the exercise and could be considered as a non-zoonotic 
pathogen for canine surveillance efforts.   
 The lowest scoring pathogens identified during the prioritization exercise were Alaria spp., 
C. lingua, D. immitis, A. reconditum, and M. pachydermatis.  Reasons for placing a pathogen in a 
participant’s bottom 5 included a perceived low prevalence of the pathogen in his/her region, low 
severity of disease, as well as easily treatable.  Additionally, if respondents didn’t recognize the 
pathogen this was a common reason for a low ranking.  It was important that pathogens of minimal 
importance to those contributing to a surveillance program also be established.  This is in part to 
help motivate veterinarians to participate in a surveillance system.  It is worth noting that just 
because a pathogen is rare, does not mean it should not be considered in a companion animal 
surveillance program if severity of disease is high.  Rabies is increasingly rare due to vaccination 
programs, but its fatal nature makes it a high priority for surveillance within Canada2.  
Furthermore, rare but dangerous canine pathogens may be present in the Prairie Provinces, but 
lack of surveillance data simply means researchers are unaware of true distributions.  In addition, 
canine pathogens that seem relatively benign in pathogenicity can still have profound 
consequences in the immunocompromised.  Although M. pachydermatis was the lowest scoring 
pathogen from the prioritization exercise (score of -14), there is at least one report in the literature 
of an outbreak in a neonatal intensive care unit that was traced back to a nurse and her infected pet 
dog25.   
 This study would have benefited from a larger sample size.  Because the majority of this 
exercise did not utilize more quantitative methods there is a degree of subjectivity and bias in the 
results.  Ng et al. argue that regardless of the approach used, there is always some level of 






from companion animals, especially within Canada9,27.  An alternative qualitative method to the 
study described here would be to prioritize pathogens using a focus group.  
            The breadth of participation by various stakeholders was deemed important by the primary 
researchers. Since the focus was on pathogens of importance to public health, including 
stakeholders with a background in public health was essential.  More representation from the 
public health stakeholder group in both study size and diversity of occupations within the public 
health sector could be beneficial in future prioritization exercises.  It was also critical that 
practicing veterinarians be involved in the conversation as they would be the source of surveillance 
data.  Without their input into pathogens of concern, there is a greater chance that veterinarians 
will not be interested in participating in a surveillance program.  The general public was not 
involved in the ranking exercise as a level of scientific and clinical knowledge was required to 
contribute opinions on canine zoonotic pathogens.  Contrary to this, other study authors have 
reported meaningful results from the general public during prioritization exercises on human 
communicable diseases28,29.   
          “Weighing” the participant scores was considered during data analysis.  For example, 
weights could be applied to scores from individuals who classified themselves as “experienced” 
in canine zoonoses so that their choices would have a greater impact on final pathogen scores.  
Since there were only 4 respondents in the current survey who classified themselves as 
“experienced” and because this is a subjective classification, these responses were not weighted 
more heavily than other participants.  Future exercises may benefit from doing so if a larger and 
broader sample size is utilized.  Additionally, the author acknowledges that the supplemental chart 
provided to experts on an as needed basis had the potential to bias a participant’s responses.  This 






supplemental material if a pathogen was unfamiliar to the respondent.  During the pilot phase of 
this study the supplemental chart was deemed a necessary component by pilot participants; 
however, there is no way to tell who in the survey used the chart and who did not.  It is possible 
that the supplemental chart provided a level plane of knowledge for all those participating in the 
study, experienced as compared to unexperienced with reliance on the chart.    
3.6 Conclusion 
 In conclusion, based on the following prioritization exercise using experts from both 
veterinary and public health disciplines, the following groups of canine pathogens are 
recommended for a companion animal surveillance initiative in the Prairie Provinces of Canada 
from a public health perspective: (1) Echinococcus spp., (2) AMR pathogens (including 
MRSA/MRSP), (3) enteric pathogens (Salmonella spp., E. coli, Campylobacter spp.), and (4) 
vector-borne diseases (B. burgdorferi, Anaplasma spp., Ehrlichia spp., D. immitis).  Several non-
zoonotic canine pathogens including parvovirus, distemper, and canine influenza are further 
recommendations for inclusion in the surveillance program from an animal health perspective.  A 
companion animal surveillance program within the Prairie Provinces should be evaluated at 
regular intervals and prioritization exercises should be repeated as necessary to ensure that relevant 
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Table 3.1. Point-system used for pathogen scoring 
Ranking Position Associated Score 
#1 10 points 
#2 9 points 
#3 8 points 
#4 7 points 
#5 6 points 
#6 5 points 
#7 4 points 
#8 3 points 
#9 2 points 
#10 1 point 
 
Table 3.2.  Demographic data for survey respondents, including count and % total of 
respondents 





   Alberta 15 42 
   Saskatchewan  10 28 
   Manitoba 7 19 
   Othera 4 11 
Occupation 
   Public Health Governmentb 5 14 
   Veterinary Medicine Government 2 6 
   Veterinary Medicine Research/Academia 4 11 
   Veterinary Medicine Companion Animal 16 44 
   Veterinary Medicine Mixed Animal 9 25 
Experience Level 
   None 0 0 
   Minimal 8 22 
   Moderate 24 67 
   Experience 4 11 
a 2 respondents were from BC and 2 respondents were from Ontario 













Table 3.3. Final scores in descending order for each pathogen from prioritization exercise 
Pathogen Score 
Echinococcus spp. (granulosus, multilocularis) 221 
Methicillin-resistant Staphylococcus aureus 199 
Salmonella enterica (enteritidis, typhimurium) 143 
Methicillin-resistant Staphylococcus pseudintermedius 133 
Borrelia burgdorferi senso stricto 119 
Escherichia coli 109 
Dog bite pathogens 108 
Campylobacter spp. (coli, jejuni, upsaliensis) 103 
Leptospira interrogans 84 
Toxocara canis 78 
Baylisascaris procyonis 68 
Giardia duodenalis (assemblage A1, assemblage B)  65 
Dermatophytes (Microsporum canis, Trichophyton spp.) 57 
Clostridium spp. (difficile, perfringens)  52 
Brucella canis  39 
Bartonella spp. (henselae, vinsonii subsp. berkhoffii)  29 
Cryptosporidium canis  29 
Pseudomonas aeruginosa 28 
Blastomyces dermatitidis 27 
Anaplasma phagocytophilum 26 
Enterococcus spp. (faecium; VRE) 22 
Taenia spp. (serialis)  22 
Mites (Cheyletiella yasguri, Sarcoptes scabiei var canis) 20 
Rickettsia rickettsii  17 
Yersinia spp. (enterocolitica, pestis)  16 
Cryptococcus gattii  13 
Klebsiella spp.  9 
Francisella tularensis  8 
Leishmania infantum  7 
Histoplasma capsulatum  6 
Dipylidium caninum 5 
Coxiella burnetii  5 
Helicobacter heilmannii 4 
Ehrlichia canis  4 
Trypanosoma cruzi  4 
Bordetella bronchiseptica 2 
Streptococcus canis 2 
Unicaria stenocephala  1 
Diphyllobothrium spp.  -1 
Fleas (Ctenocephalides canis, C. felis, Pulex irritans) -2 
Nanophyetus salmincola  -3 
Mesocestoides spp.  -3 
Paragonimus kellicotti  -4 
Sporothrix schenckii  -5 
Apophallus donicus  -5 
Metorchis conjunctus  -6 
Alaria spp. (alata, americana, canis, marcianae)  -8 
Cryptocotyle lingua  -9 
Dirofilaria immitis  -12 
Acanthocheilonema reconditum  -12 






Table 3.4. Top 5 pathogens when stratified by province, occupation and experience 
Stratified Demographic Data Top 5 Pathogens Score 
Province 
   Alberta 
   (n=15)  
Echinococcus spp. (granulosus, multilocularis) 
Salmonella enterica (enteritidis, typhimurium) 
Methicillin-resistant Staphylococcus aureus  
Dog bite pathogens 






   Saskatchewan  
   (n=10) 
Methicillin-resistant Staphylococcus aureus  
Methicillin-resistant Staphylococcus pseudintermedius  
Echinococcus spp. (granulosus, multilocularis) 
Borrelia burgdorferi senso stricto  






   Manitoba 
   (n=7) 
Methicillin-resistant Staphylococcus aureus  
Echinococcus spp. (granulosus, multilocularis) 
Escherichia coli 
Campylobacter spp. (coli, jejuni, upsaliensis) 
Methicillin-resistant Staphylococcus pseudintermedius  







   Othera 
   (n=4)    
Campylobacter spp. (coli, jejuni, upsaliensis) 
Leptospira interrogans  
Borrelia burgdorferi senso stricto  
Escherichia coli 
Methicillin-resistant Staphylococcus aureus  








   Public Health Government 
   (n=5) 
Echinococcus spp. (granulosus, multilocularis)  
Borrelia burgdorferi senso stricto  
Methicillin-resistant Staphylococcus aureus 







   Veterinary Medicine Government 
   (n=2) 
Methicillin-resistant Staphylococcus aureus  
Echinococcus spp. (granulosus, multilocularis) 
Salmonella enterica (enteritidis, typhimurium)  
Campylobacter spp. (coli, jejuni, upsaliensis) 








   Veterinary Medicine Research/Academia 
   (n=4) 
Echinococcus spp. (granulosus, multilocularis) 
Methicillin-resistant Staphylococcus pseudintermedius   
Methicillin-resistant Staphylococcus aureus  
Salmonella enterica (enteritidis, typhimurium) 






   Veterinary Medicine Companion Animal 
   (n=16) 
Methicillin-resistant Staphylococcus aureus  
Echinococcus spp. (granulosus, multilocularis) 
Dog bite pathogens 
Methicillin-resistant Staphylococcus pseudintermedius  
Salmonella enterica (enteritidis, typhimurium) 







   Veterinary Medicine Mixed Animal 
   (n=9) 
Echinococcus spp. (granulosus, multilocularis) 
Methicillin-resistant Staphylococcus aureus  
Borrelia burgdorferi senso stricto  
Campylobacter spp. (coli, jejuni, upsaliensis) 













   Minimal 
   (n=8) 
Echinococcus spp. (granulosus, multilocularis) 
Methicillin-resistant Staphylococcus aureus  
Salmonella enterica (enteritidis, typhimurium) 
Escherichia coli  






   Moderate 
   (n=24) 
Echinococcus spp. (granulosus, multilocularis) 
Methicillin-resistant Staphylococcus aureus  
Methicillin-resistant Staphylococcus pseudintermedius  
Salmonella enterica (enteritidis, typhimurium) 






   Experienced 
   (n=4) 
Echinococcus spp. (granulosus, multilocularis) 
Salmonella enterica (enteritidis, typhimurium) 
Borrelia burgdorferi senso stricto  
Dog bite pathogens 






a 2 respondents were from BC and 2 respondents were from Ontario 
 
Table 3.5. Themes from open-ended responses for why a pathogen was placed in a participant’s 
top 10 or bottom 5 
Top 10 Themes Bottom 5 Themes 
• Prevalent in the prairies 
• Severity of disease in humans 
• Fatal in humans 
• Lack of treatment 
• High transmission from dogs to humans 
• High risk in the immunocompromised 
• Lack of public awareness 
• Pathogen is emerging 
• Respondent has never diagnosed the pathogen 
• Low prevalence in the prairies/rare 
• Low severity of disease 
• Pathogen wasn’t recognized by the participant 
• Easily treatable 

















CHAPTER 4: INVESTIGATING THE ROLE OF CLINICAL VETERINARIANS IN A 
COMPANION ANIMAL SURVEILLANCE PROGRAM 
 
4.1 Abstract 
 Online surveys were disseminated to clinical veterinarians across the provinces of Alberta, 
Saskatchewan and Manitoba to investigate the role of veterinarians/veterinary clinics in a 
companion animal surveillance initiative specific to the Prairie Provinces of Canada and to develop 
case definitions for several canine pathogens of public health concern.  The utility of domestic 
dogs as sentinels using Lyme disease as an example was also explored.  Survey data revealed a 
moderate interest (median = 7.5/10) from veterinarians to participate in a companion animal 
surveillance program.  Furthermore, the number of cases reported by veterinarians for several 
canine zoonotic pathogens including Echinococcus spp., MRSA/MRSP, Salmonella spp., and 
Borrelia burgdorferi were recorded.  Preliminary case definitions for these pathogens were also 
formulated as a foundational step in the creation of a companion animal surveillance program.  In 
addition, veterinary data provided evidence to support domestic dogs as sentinels for assessing 
Lyme disease risk in humans.  Overall, this study emphasized the importance of collaborating with 
clinical veterinarians in a companion animal surveillance program. 
4.2 Introduction  
The World Health Organization (WHO) defines surveillance as “the process of systematic 
collection, collation and analysis of data with prompt dissemination to those who need to know, 
for relevant action to be taken”1.  While surveillance systems are well established for human, 
production animal, and wildlife diseases in Canada and worldwide, surveillance data on 
companion animal diseases, including diseases of public health significance, is extremely limited2–






pathogens companion animals harbour are zoonotic, it is important to obtain surveillance data on 
this population to address both animal health and public health concerns.   
 Because of finite resources, surveillance systems generally focus on predetermined 
pathogens of interest based on the objectives of the surveillance program5.  These objectives will 
vary based on stakeholder groups involved in the project.  While there are several methods for 
selecting pathogens upon which surveillance will be conducted, including pathogen prioritization 
exercises6, once a group of pathogens is selected for a surveillance program, creating uniform case 
definitions for each pathogen is an essential step.  By doing so, a level of standardization for what 
constitutes a “case” is established for reporting5,7.  Typically, only confirmed cases are reported 
based on clinical, laboratory or epidemiological indicators; however, both “confirmed” and 
“probable” (where probable refers to a lack of diagnostic confirmation) case definitions may be 
created for a particular pathogen or disease7.  As surveillance systems and the response to 
pathogens of interest evolve with time, case definitions need to be periodically reviewed and 
updated8. 
To obtain surveillance data on any companion animal population, practicing veterinarians 
and veterinary clinics are a potential source of surveillance data.  The use of veterinary clinics in 
companion animal surveillance programming has been previously explored2,8–11.  In particular, 
extracting data from electronic medical records (EMR) has been heavily researched8–12.  While 
possible to obtain valuable data from EMR for the purposes of surveillance, one major limitation 
includes a lack of standardization with medical record keeping and nomenclature that would allow 
for seamless data extraction regarding symptoms and/or clinical diagnoses8,11–13.  This means that 
data may not be properly captured by extraction software if there are inconsistencies in 






methods using veterinary clinics include interactive web-based systems or periodic dissemination 
of clinic questionnaires2,11,14–16.  While these methods avoid the limitations surrounding a lack of 
standardized medical record keeping, they require a larger time commitment from participating 
clinics and compliance or response rates may be low14,15.   Regardless of the method used, 
surveillance data acquired from companion animal veterinary clinics will not be representative of 
the entire domestic animal population, but only of those receiving veterinary services. 
Companion animals seen at veterinary clinics also offer a unique opportunity for sentinel 
surveillance17,18.  For several zoonotic pathogens, companion animals may serve as an early 
warning system for disease risk in humans2,19.  In particular, dogs have served as sentinels for both 
human and wildlife populations18,20; specifically, dogs have been described as good sentinels for 
vector-borne diseases2,10,19,21.  This is because dogs tend to be at greater risk of vector exposure 
(particularly ticks) and can serve as an early indicator for vector-borne disease prevalence and 
therefore human risk in a given area10,21. 
The primary objectives of this study were (1) to investigate the role of veterinarians and 
veterinary clinics in a companion animal surveillance system specific to the Prairie Provinces of 
Canada, and (2) to use veterinarians to develop case definitions for several canine pathogens of 
public health interest.  Establishing general interest from practicing veterinarians and associated 
veterinary clinics on their willingness to contribute companion animal surveillance data is a crucial 
step in the development of a surveillance program15,22.  In addition, a third objective was to explore 
the role of the dog as a sentinel of zoonotic disease risk in humans using Lyme Disease as an 
example.  The region of interest for this study was specific to the Prairie Provinces because this 







4.3 Materials and Methods 
4.3.1 Designing Survey 
The investigators chose to disseminate an online survey to clinical veterinarians in order to 
investigate the role veterinarians and veterinary clinics may play in a companion animal 
surveillance initiative.  The main objectives in survey question design were: (1) to identify the role 
practicing veterinarians may play in a companion animal surveillance program through willingness 
to participate, (2) to establish case definitions for several canine zoonotic diseases of public health 
interest, and (3) to explore the role of domestic dogs as sentinels using Lyme disease as an 
example.  The primary canine diseases of public health interest upon which case definitions would 
be formulated were based on results of a previously performed prioritization exercise and were 
echinococcosis, methicillin-resistant staphylococcal infections MRSA and MRSP, salmonellosis, 
and Lyme disease.  Survey questions were formulated through discussions by the investigators.  In 
addition, the survey was piloted by 5 clinical veterinary colleagues across Alberta (AB), 
Saskatchewan (SK) and Manitoba (MB) prior to dissemination.  Any recommendations or 
suggestions for the survey design were considered and adjusted accordingly.   
The final survey consisted of 35 questions, including 4 initial questions related to 
respondent demographics (Appendix I).  The demographic questions required participants to 
specify his/her clinic location, practice region, species treating, and experience in companion 
animal zoonoses (canine and feline) specifically.  The remainder of the survey was divided into 3 
main sections including: (1) overall interest and willingness to participate in a surveillance 
program, (2) knowledge and experience with several canine diseases of public health interest to 
aid in the development of case definitions, and (3) clinical experience with Lyme disease to create 






The intent of questions related to knowledge and experience with several canine diseases 
was to establish a baseline for whether practicing veterinarians are currently diagnosing serious 
canine zoonoses in the prairies.  It was also to quantify different sources of clinical data (such as 
results from in-clinic testing), for which there is no current surveillance platform to record this 
information.  These pathogens included Echinococcus spp. (granulosus, multilocularis), AMR 
pathogens (including MRSA/MRSP), enteric pathogens Salmonella spp., Campylobacter spp., and 
Escherichia coli (E.coli), and vector-borne pathogens including Borrelia burgdorferi, Anaplasma 
spp., and Ehrlichia spp.  These pathogens were selected based on prior results from a prioritization 
exercise using experts in the field of veterinary medicine, public health and epidemiology, and 
similar pathogens were grouped together for the purposes of surveillance.   
Respondents were also given a final opportunity to comment their ‘final thoughts’ at the 
conclusion of the survey.  It was stated here that additional non-zoonotic canine pathogens such as 
parvovirus, distemper and canine influenza would also be considered in a companion animal 
surveillance program from an animal health perspective.   
4.3.2 Survey Dissemination 
Only veterinarians residing in AB, SK or MB were eligible to participate in the survey to 
obtain data exclusive to the Prairie Provinces.  This was because surveillance data on companion 
animal zoonoses is limited in this region, and relevant pathogens are expected to be similar across 
the prairies due to comparable climate, temperatures and other environmental factors.  Survey 
invitations were provided through each of the three veterinary medical associations in Alberta 
(ABVMA), Saskatchewan (SVMA), and Manitoba (MVMA) by inclusion in their weekly E-
Newsletters and participation was completely voluntary.  In addition, the survey was also 






The SurveyMonkey platform was used to create, disseminate and record survey data, and the 
survey remained open from March 3 to March 31, 2021. 
Two weeks following this initial survey invitation, a reminder email for survey 
participation was sent directly to clinics throughout AB, SK and MB.  A list of clinics across the 
prairies was randomly compiled to include general practitioners in both companion animal and 
mixed animal practice, as well as small animal referral centers and emergency clinics.  This was 
to encourage a broad range of participating veterinarians.  Only clinics with an active email address 
were contacted.  The final compiled list included 79 randomly selected clinics (28 from SK, 30 
from AB, and 21 from MB).  The email included the survey invitation, survey introduction, intent 
of study, and ethics approval.   
4.3.3 Data Analysis  
4.3.3.1 Statistical Analysis of Survey Data 
 Descriptive statistics were performed for all demographic data, information on surveillance 
interest, and clinical experience with several canine diseases of public health concern.  This 
included all data contributed regarding Lyme disease.  Data on an individual’s willingness to 
participate in a surveillance program was further analyzed through stratification by province, 
practice region, and experience in companion animal zoonoses to assess whether a respondent’s 
demographics altered their interest in a surveillance program.  Furthermore, data specific to 
echinococcosis and Lyme disease were compared by province to examine possible differences in 
disease behaviour and management between regions. 
4.3.3.2 Open-Ended Questions 
All open-ended questions were analyzed by grouping repeated or similar responses 






to identify: (1) what would motivate participation in a surveillance system and what would deter 
participation, (2) where surveillance data may be lacking from laboratory sources if participants 
are not submitting samples for laboratory testing, (3) common symptoms related to canine 
pathogens of interest to aid in the development of case definitions, and (4) additional preventatives 
such as vaccination that may inhibit the utility of dogs as sentinels for Lyme disease.  Participants 
were also given the opportunity to comment any final thoughts on a companion animal surveillance 
program. 
4.3.3.3 Case Definitions  
 Using survey data collected on Echinococcus spp., MRSA/MRSP, Salmonella spp., and 
Lyme disease, preliminary case definitions for the purposes of surveillance were created.  Because 
more detailed data was gathered on Lyme disease, a more complete case definition incorporating 
specific clinical and diagnostic information was possible.  Further data on the remaining canine 
pathogens of interest may be required to establish complete case definitions for the purposes of 
surveillance; however, given the nature of testing to definitively diagnose echinococcosis, 
MRSA/MRSP and salmonellosis, collaboration with laboratories will be necessary.  Therefore, in-
clinic information gathered through the present survey served as a general starting point in 
exploring case definitions for these remaining pathogens.   
4.3.3.4 Assessing Domestic Dogs as Sentinels for Lyme Disease 
 Using survey data collected on Lyme disease, responses on observable canine symptoms 
and preventative measures used (such as ectoparasitic treatment and/or Lyme vaccination) were 
examined to assess the utility of domestic dogs as sentinels for Lyme disease risk in humans.  This 
was done using the following requirements: that a sentinel must be susceptible to the disease in 






and mount a response to the disease that can be readily detected through either observable clinical 
signs or diagnostic testing. 
4.4 Results 
4.4.1 Demographic Data 
 A total of 76 participants engaged in the survey at a 79% completion rate (60/76).  Any 
incomplete surveys were discarded.  Of the 60 usable surveys, the largest proportion of participants 
were from AB at 55% (33/60), 17% (10/60) were from SK, and 28% (17/60) were from MB (Table 
4.1).  Responses pertaining to practice region revealed that 55% (33/60) of participants worked in 
an urban setting, 33% (22/60) worked in rural practice, and 12% (7/50) split their time between 
both urban and rural practice (Table 4.1).   
When respondents were asked to specify their experience with companion animal zoonoses 
(canine and feline) specifically, 9% (5/59) claimed to have minimal experience, 64% (38/59) 
claimed to have moderate experience, and 27% (16/59) claimed to be experienced .  There were 0 
participants who felt they had no experience with companion animal zoonoses (Table 4.1).  When 
asked to report on time spent with individual species in practice, 100% (60/60) of participants saw 
canine and feline patients in some capacity with an average time of 55% spent with dogs and 34% 
spent with cats (Table 4.2).   
4.4.2 Surveillance Interest 
 On a scale from 1 to 10 with 10 being most likely to and 1 being least likely to, the median 
willingness to participate in a companion animal surveillance program specific to the Prairie 
Provinces was 7.5/10 (Table 4.3).  Responses ranged from 2/10 to 10/10.  In terms of a 
respondent’s willingness to participate in a surveillance program if he/she had to input data into 






When ratings were stratified by province, participants from AB or MB had the highest scores for 
willingness to participate in a surveillance program at medians of 8/10 (Table 4.3).  When stratified 
by practice region and experience in companion animal zoonoses, individuals who split their time 
between urban and rural settings and individuals who felt they had minimal experience or were 
greatly experienced in companion animal zoonoses had the highest scores for willingness to 
participate at a median of 9/10.  Individuals who split their time in terms of practice region and 
those experienced in companion animal zoonoses also had the highest scores for willingness to 
input data themselves at a median of 8/10 (Table 4.3). 
 When asked to rank his/her preferred frequency for contributing surveillance data, the top 
choice from participants was ‘monthly’ reporting with the majority of participants (41%) rating 
this as their number 1 choice (Table 4.4).  The bottom choice was ‘annual’ reporting with 51% of 
participants ranking this option as their least preferred choice.  When asked to rank his/her 
preferred frequency for reports coming out of the surveillance program the top choice was 
‘monthly’ reports with 66% of participants ranking this option as their number 1 choice.  The 
majority of participants at 65% ranked updates ‘in real-time’ as their lowest choice (Table 4.4). 
 Participants were also given the opportunity to elaborate on why they would or would not 
be willing to participate in a companion animal surveillance program.  Repeated responses for why 
an individual would participate included feeling a professional responsibility, to establish local 
relevance and prevalence of diseases in the prairies, to assess risk in both patients from an animal 
health perspective and clients from a public health perspective, because it would be beneficial for 
evidence-based medicine, that it would aid in client education, and that practitioners are the first 
line of defence from a One Health perspective.  A recurring theme was also a general interest in 






participant acknowledged that there is currently no place to report concerning companion animal 
zoonoses.  In addition, 2 participants emphasized that surveillance data would provide them an 
opportunity to learn.  The most common response for why participants were not willing to 
participate in a companion animal surveillance program was time commitment and increased 
workload (n=13).  Only one participate had cost concerns and felt compensation was necessary.  
In addition, anonymity concerns and ease of data input were specified by one individual.   
4.4.3 Canine Pathogens of Interest 
 Survey responses provided baseline data for the proportion of veterinarians having seen 
previously identified canine pathogens of public health interest specific to the Prairie Provinces 
within the past 5 years (Table 4.5).   
4.4.3.1 Echinococcosis  
 Overall, 16.7% (10/60) of respondents reported diagnosing at least one case of 
Echinococcus spp. (granulosus, multilocularis) within the past 5 years (Table 4.5).  Of particular 
note, 70% (7/10) of these respondents were from AB while the remaining 30% (3/10) were from 
MB.  No respondents from SK reported cases of Echinococcus spp. within the last 5 years.  The 
participants who reported diagnosing Echinococcus spp. did not need to specify number of cases 
seen or testing used to definitively diagnose the parasite, only that they did or did not diagnose at 
least one case of Echinococcus spp. (granulosus, multilocularis) within the past 5 years. 
 The most common method for diagnosing tapeworms and other enteric helminths was by 
fecal floatation at 80% (48/60) (Table 4.6).  Of the participants who specified using fecal floatation 
to diagnoses helminths, 31% (15/48) performed the test in-clinic, 25% (12/48) only submitted fecal 
floatation through a laboratory, and 44% (21/48) used both in-clinic fecal floatation and laboratory 






to diagnose helminths (including tapeworms) are performing the test in-clinic; therefore, this is 
data that is not currently captured through any type of surveillance programming.  
Of the individuals using laboratory testing for fecal floatation, 43% (14/33) specified using 
Prairie Diagnostic Services (PDS), 70% (23/33) specified using IDEXX Laboratories, and 21% 
(7/33) specified ‘other’ which included Antech (4/7) and Manitoba Veterinary Diagnostic Services 
(3/7).  Respondents were able to choose all laboratories that applied if they were submitting to 
multiple laboratories. The most common reasons that prevented participants from submitting 
samples for laboratory testing were cost (n=27) and poor owner compliance (n=19).  Six 
individuals specified that they do not submit laboratory testing for helminths in particular because 
treatment trials are a simple and cost-effective solution.  There were 9 respondents who said they 
don’t have any reasons that prevent them from submitting laboratory tests.   
 Only 2 respondents did not prescribe any dewormer (Table 4.7) because they worked 
outside of clinical practice and it was not applicable.  Interceptor Plus was the most common 
deworming choice of participants at 68% (41/60).  The majority of participants (66%) specified 
that frequency of deworming was case dependent (Table 4.7).   
 When provided with the opportunity for additional commentary on echinococcosis, several 
participants stated that it is likely more common than realized and a frustrating disease, and that 
guidance on prevalence, testing and treatment would be beneficial.  One individual specified that 
this is a disease they discuss with owners.  Additional unique comments included that promotion 
from the medical profession is lacking, and that surveillance maps on human, domestic animal, 








4.4.3.2 AMR Pathogens (MRSA/MRSP) 
 The majority of participants at 55% (33/60) did not report diagnosing any AMR pathogens 
within the past 5 years.  The percentage of individuals who had diagnosed AMR pathogens were 
reported at 23% (14/60) for MRSA and 22% (13/60) for MRSP (Table 4.5).  Respondents were 
not given the opportunity to specify the number of cases seen, only if he/she had diagnosed at least 
one case in the past 5 years for any AMR pathogens including MRSA/MRSP.  In addition to a 
large proportion of participants reporting MRSA/MRSP cases, when given the opportunity to 
specify any other AMR pathogens diagnosed in the past 5 years, responses included Bordetella 
bronchiseptica, Pseudomonas spp., Enterococcus spp., Enterobacter spp., and Proteus spp. 
 Of the 22 respondents who reported diagnosing MRSA and/or MRSP in the past 5 years, 
23% (5/22) specified using PDS for definitive diagnosis (culture and sensitivity testing) while the 
majority of respondents at 73% (16/22) specified using IDEXX.  In addition, 3 participants used 
Antech and 1 participant used Manitoba Veterinary Diagnostic Laboratories.  Participants were 
able to choose all laboratories that applied if they were submitting to multiple laboratories. 
 The most common symptom associated with a diagnosis of MRSA/MRSP was dermatitis 
(n=20); which included 2 respondents who specified otitis externa.  Additional but less common 
symptoms were reported to include unresolving urinary tract infections, and eye infections.  One 
respondent specified a positive culture related to an orthopedic implant while another respondent 
specified an incisional complication.  When given the opportunity to comment further on 
MRSA/MRSP, respondents discussed breed predispositions in Bulldogs and Pit Bulls.  In addition, 
the possible relationship to allergic skin disease, and the relationship to trauma such as bite wounds 
were discussed.  One respondent also discussed a correlation between positive canine patients who 






4.4.3.3 Enteric Pathogens (Salmonellosis) 
 Of participants diagnosing enteric pathogens within the past 5 years, the largest proportion, 
52% (31/60), specified E. coli (Table 4.5); likewise, 42% (25/60) of participants specified 
diagnosing Campylobacter spp., and 18% (11/60) specified Salmonella spp.  Forty percent of 
participants hadn’t diagnosed any of the 3 enteric bacteria listed.  Participants did not need to 
specify the number of cases diagnosed for these pathogens, only that they had diagnosed them 
within the past 5 years and participants could select all pathogens that applied.   
 Of the respondents who commented on symptoms observed in positive cases of canine 
salmonellosis, the most common clinical sign was diarrhea (n=9).   Additional but less common 
clinical signs included vomiting and urinary signs.  One respondent specified that history of a raw 
food diet pertained to his/her positive case(s).  The most common tests used for a definitive 
diagnosis of salmonellosis, were fecal PCR testing and/or fecal culture and sensitivity testing.  
Urine culture was also described by one participant.  Of the participants who specified which 
diagnostic laboratories they used for a definitive diagnosis of salmonellosis (n=10), the majority 
of respondents used IDEXX at 70% (7/10).  Only one individual specified each of the following: 
PDS, Antech and Manitoba Veterinary Diagnostic Laboratories. 
4.4.3.4 Vector-Borne Diseases  
 For the proportion of vector-borne diseases seen by respondents within the past 5 years, 
40% (24/60) specified Lyme disease, 42% (25/60) specified Ehrlichia spp., and 35% (21/60) 
specified Anaplasma spp. (Table 4.5).  A total of 42% (25/60) of individuals had not diagnosed 
any of the vector-borne diseases listed or specified other vector-borne diseases.  Respondents did 






pathogens that applied.  When given the opportunity to comment on any other vector-borne 
diseases diagnosed in the past 5 years, additional responses included D. immitis and Babesia spp.   
4.4.4 Lyme Disease Data 
 The majority of participants at 60% (36/60) had not diagnosed Lyme disease within the 
past 2 years (Table 4.8).  Twenty-three percent (14/60) of individuals reported diagnosing 1-10 
cases within the last 2 years while only 5% (3/60) and 12% (7/60) reported diagnosing 11-30 and 
>30 cases of Lyme disease in the past 2 years respectively.  Participants diagnosing 1-10 cases 
resided in all 3 provinces.  Only participants from MB reported seeing 11-30 or >30 cases in the 
past 2 years.  Furthermore, all respondents from MB reported seeing at least 1-10 cases of Lyme 
disease in the past 2 years (Table 4.8).  
 The most common reason for Lyme disease testing was ‘if the dog is exhibiting symptoms’, 
at 68% (41/60) across all three provinces (Table 4.8).  Only 8% (5/60) of participants tested ‘as 
part of every wellness visit’.  Alternatively, 8% (5/60) of participants admitted to ‘never’ testing 
for Lyme disease.  Four of these respondents were from AB and 1 respondent was from MB.  
Having a travel related history was a more likely reason for Lyme disease testing in AB and SK 
than in MB.  The most common response for ‘other’ reasons to test for Lyme disease was when it 
was performed in conjunction with annual or bi-annual 4Dx screening protocols (ex. for 
heartworm monitoring) (n=12) (Table 4.8).   
 Of the participants who diagnosed at least 1 case of Lyme disease in the past 2 years, 58% 
(14/24) described canine patients as being ‘asymptomatic’ (Table 4.8). Of the 2 SK participants 
who reported diagnosing Lyme disease, only asymptomatic cases were observed.  In clinical cases, 
the most common observable clinicals signs were lameness/joint pain/joint swelling or other 






AB and MB, a variety of less common symptoms were also described including anorexia, lethargy, 
renal symptoms, weight loss, immune mediate thrombocytopenia (ITP), lymphadenopathy, and 
polyuria/polydipsia (PU/PD) (Table 4.8). 
 When respondents were asked to specify which tests they used to screen for Lyme disease 
a resounding 70% specified the in-clinic IDEXX SNAP 4Dx Test (IDEXX Laboratories, Inc.) 
(Table 4.9).  This represents a large proportion of testing data that is not reported to any type of 
surveillance programming (such as is the case with veterinary laboratory databases).   When asked 
to report on frequency of Lyme vaccination, the majority of participants (58%) specified ‘only if 
the history of the pet warrants vaccination’.  A large proportion of participants (35%) also specified 
‘never’ using the Lyme vaccine as a preventative measure (Table 4.9).  The most common reason 
for not vaccinating against Lyme disease included low prevalence in the participant’s region 
(n=14).  Five participants also specified that using a tick preventative was their preference over 
the Lyme vaccine.  Less common reasons for not vaccinating against Lyme disease included side 
effects of the vaccine, questionable vaccine efficacy, lack of owner interest, cost, and low severity 
of disease in dogs.   
 The majority of respondents claimed to ‘always’ recommend tick prevention to clients, 
regardless of compliance, at 62% (37/60) (Table 4.9).  Of the available ectoparasitic treatments 
used, the most popular choices were Bravecto at 71% (41/58) and/or Nexguard at 67% (39/58).  
Respondents were able to choose as many ectoparasitic treatments that were applicable to them.   
4.4.5 Case Definitions 
Using statistical data from survey responses and commentary from open-ended questions, 
proposed case definitions for Echinococcus spp. (granulosus, multilocularis), MRSA/MRSP, 






extensive for Lyme disease specifically, a more comprehensive case definition was possible.  For 
the remaining pathogens, diagnosis through veterinary laboratory services would be required 
because definitive in-clinic testing does not currently exist for these pathogens.   
4.4.6 Dogs as Sentinels for Lyme Disease 
Dogs were assessed as sentinels based on the requirements that the sentinel must be 
susceptible to Lyme disease, survive the disease, be readily exposed to the risk factor (tick 
exposure), and mount a response to the disease that can be detected through clinical signs or 
diagnostic testing.  Therefore, even though participants established that many dogs are 
asymptomatic for Lyme disease, because the testing is quick, inexpensive, and non-invasive, dogs 
can still be good sentinels for assessing disease risk of Lyme disease in humans.  They are also 
good sentinels for Lyme disease because they are readily exposed to the risk factor (tick exposure).  
Despite preventatives being recommended by most vets, positive cases are still reported.  Not 
every owner is going to comply with recommendations (requesting a tick preventative but also 
administrating the medication appropriately); therefore, there is still a population of dogs that are 
or could test positive, serving as sentinels to assess disease risk for Lyme disease in humans.  
4.4.7 Open-Ended Questions: Final Thoughts 
 When given the opportunity to provide any final thoughts on a companion animal 
surveillance program in the Prairie Provinces, responses varied.  Two respondents commented on 
compensation for time or some other incentive for participation in the surveillance program.   In 
addition, one respondent emphasized that anonymity must be ensured.  Several participants also 
expressed additional zoonotic diseases for inclusion such as rabies, giardiasis, leptospirosis, 
brucellosis, ringworm, blastomycosis, sarcoptic mange, and several feline pathogens including 






with other surveillance programs such as laboratory surveillance.  One respondent specified 
collaboration with larger surveillance programs such as the Companion Animal Parasite Council 
(CAPC) in the United States.   
4.5 Discussion 
 In the present study, the role of veterinarians and veterinary clinics in a companion animal 
surveillance program was successfully explored.  The contribution of veterinarians and in-clinic 
data is vital for the success of a companion animal surveillance initiative in the Prairie Provinces 
of Canada.  In addition to highlighting the value practicing veterinarians bring to companion 
animal surveillance, this study identified the willingness of veterinarians to participate in a 
surveillance program, captured baseline reporting data on several canine pathogens of public 
health concern, created preliminary case definitions for canine pathogens that may be included in 
the surveillance initiative, and assessed domestic dogs as sentinels using Lyme disease as an 
example.   
 Veterinarians across all 3 provinces expressed moderate interest in participating in a 
companion animal surveillance program.  Survey data also promoted the importance of all practice 
regions being involved in companion animal surveillance as every participant, regardless of his/her 
background in practice region or species treating, saw dogs and cats in some capacity.  The greatest 
variability in surveillance interest was related to the frequency with which clinical data and 
surveillance data would be reported to and from the program.  While the overall consensus was 
‘monthly’ reporting in either direction, frequency of reporting may be adjusted at the discretion of 
primary stakeholders and veterinary clinics enrolled in the program.  More favorable reporting 






 The most common reason for hesitation to participate in a companion animal surveillance 
program was time commitment.  In addition, compensation or incentivization was suggested by 
some participants.  The investigators propose that incentives take the form of information sharing 
and targeted research as a direct result of surveillance data in lieu of monetary compensation.  This 
method of incentivization offers longer sustainability of the program.  While prior research has 
demonstrated the benefit of monetary compensation for cooperation by veterinarians, it still does 
not guarantee adequate participation in a surveillance program23.  Research on compliance and 
sustainability within animal health surveillance systems has explored monetary incentives through 
covered testing costs, but ultimately identified that “ease of data collection” was a primary reason 
for high compliance and long-term participation by veterinarians enrolled in the program24. 
 Results from this survey provided a baseline for the proportion of veterinarians reporting 
several canine pathogens of public health interest in the Prairie Provinces including Echinococcus 
spp. (granulosus, multilocularis), MRSA/MRSP, Salmonella spp., Campylobacter spp., E. coli, B. 
burgdorferi, Ehrlichia spp., and Anaplasma spp.  Though this information is not a true reflection 
of prevalence, it acts as an estimate for the number of veterinarians/veterinary clinics diagnosing 
these canine zoonoses in the prairies.  The data to come out of a companion animal surveillance 
program would provide more concrete data on prevalence for these canine zoonotic pathogens of 
public health concern.  
 Exploring the utility of veterinary clinics in providing surveillance data on serious canine 
zoonoses such as Echinococcus spp. (granulosus, multilocularis) was examined.  Echinococcus 
spp. was the overall highest scoring pathogen from a previously conducted prioritization exercise 
that used experts in the field of veterinary medicine, public health, and epidemiology.  A large 






disease in both animals and humans.  Although a keen interest in this pathogen from possible 
stakeholders was well established, the utility of surveillance data from veterinary clinics as a means 
to assess disease risk in humans for echinococcosis from domestic dogs required further 
exploration.  The present survey identified that a small proportion of veterinarians reach for 
endoparasitic treatment in lieu of definitively testing for helminths, due to ease of treatment and 
cost of treating versus testing.   Therefore, domestic dogs may not be a good representation of 
Echinococcus spp. prevalence from a surveillance perspective because of low testing and common 
deworming practices.  However, due to the high severity of disease in dogs and people, there is 
still value in reporting any positive canine cases to a surveillance program when/if echinococcosis 
is identified.   
From a public health perspective, dogs are only a source of infection to humans through 
fecal shedding of Echinococcus spp. eggs25, therefore definitive fecal analysis is the best way to 
accurately assess the transmission risk of Echinococcus spp. from dogs to humans in the prairies.  
Jenkins emphasized the need for an in-clinic veterinary test capable of detecting Echinococcus 
spp. antigens or DNA in canine feces for more timely and cost-effective diagnosis26.  Such a rapid 
in-clinic test would be extremely beneficial for the purposes of Echinococcus spp. surveillance in 
domestic dogs.  As definitive fecal testing for Echinococcus spp. currently stands (through fecal 
PCR or fecal coproantigen ELISA26), only laboratory confirmed cases can be utilized for 
companion animal surveillance from a public health perspective when considering only direct 
transmission risk from domestic dogs.   
 This survey highlighted that a large proportion of clinical veterinary data could be better 
utilized for surveillance purposes.  Of particular note, 70% of all respondents used the IDEXX 






performed in-clinic fecal floatation at some capacity.  Although fecal floatation alone cannot 
distinguish between several tapeworm species26, this represents another example of in-clinic 
diagnostic testing for possible zoonotic pathogens that is not recorded in any type of surveillance 
database.  In addition to recording in-clinic data to a companion animal surveillance program that 
would otherwise be lost, collaboration with veterinary laboratory services could be a valuable 
addition to a companion animal surveillance program in the prairies23,27.  Several veterinary 
diagnostic laboratories were highlighted in this survey including PDS, IDEXX, Antech and 
Manitoba Veterinary Diagnostic Services.  Currently there is no formal reporting from veterinary 
laboratories in place.  Where reporting occurs, at the level of the veterinarian or at the level of the 
diagnostic laboratory, would need to be explicit for surveillance purposes to avoid duplicate 
reporting of cases.  In addition, lack of communication between these various laboratory groups 
will remain a challenge for streamlining possible companion animal surveillance data from 
veterinary diagnostic laboratories across the prairies.  
 For the purposes of companion animal surveillance in collaboration with veterinary clinics, 
grouping certain canine pathogens of public health interest may be considered.  For example, since 
several other vector-borne diseases are included on the IDEXX SNAP 4Dx Test28 commonly 
performed in-clinic, reporting could include Ehrlichia spp., Anaplasma spp., and D. immitis in 
addition to Lyme disease if positive results occurred for any of these pathogens.  Similarly, several 
canine enteric pathogens of public health concern are tested for collectively through veterinary 
laboratory testing.  Therefore, reporting could occur for Salmonella spp., Campylobacter spp., 
and/or E. coli as these pathogens received high scores from experts in a previously conducted 
prioritization exercise.  For enteric pathogens specifically, several studies have explored 






human health risks29,30.  In the instance of syndromic surveillance, determining the etiological agent 
is less important than clinical signs alerting to a possible outbreak or public health concern.  The 
utility of syndromic surveillance in this companion animal surveillance initiative requires further 
exploration.  Lastly, because of the growing concerns surrounding AMR, any resistant bacterial 
pathogen, particularly multi-drug resistant (MDR) pathogens (including but not limited to 
MRSA/MRSP) could be reported to a companion animal surveillance program. 
 Case definitions will vary greatly when used for diagnostic, outbreak, or surveillance 
purposes.  The goal of this study was to create a case definition for Lyme disease from a 
surveillance perspective and to start formulating case definitions for several other canine zoonotic 
pathogens of public health concern for the inclusion in a surveillance program.  In the instance of 
Lyme disease, for the purposes of surveillance, having a positive diagnostic test was deemed 
important regardless of clinical signs, since the majority of dogs are asymptomatic.  Alternatively, 
using only clinical signs as the case definition (without a positive test result) was deemed 
meaningless, because many other canine diseases can cause similar clinical symptoms.  For the 
pathogens Echinococcus spp., MRSA/MRSP, and Salmonella spp., definitive diagnoses through 
laboratory testing would be required for confirmed cases.  If in-clinic testing capabilities continue 
to evolve, then more definitive clinical testing options can be included in these case definitions.  
As a companion animal surveillance program matures over time, case definitions should be 
periodically updated7.   
 Based on survey data from the present study, the investigators propose the use of dogs as 
sentinels for assessing Lyme disease risk in humans.  This conclusion is based on the following 
principles: that an ideal sentinel is susceptible to the disease of interest, survives the disease, is 






clinical signs or diagnostic testing18,19.  Although many dogs are asymptomatic, testing for Lyme 
disease is quick, inexpensive and non-invasive.  Furthermore, there were a variety of reasons that 
veterinarians screened for Lyme disease across all 3 provinces, including non-endemic regions; 
therefore, testing for Lyme disease is already a popular choice among practicing veterinarians.  
From a surveillance perspective, this is data that is readily accessible but is not being collected or 
used for public health advancement.    
Despite a high proportion of veterinarians endorsing tick prevention, positive cases of 
canine Lyme disease were still reported within the past 2 years across the prairies.  As tick 
prevention increases in popularity (with veterinarians and owners) a decrease in the incidence of 
canine Lyme disease may be observed over time, making them unsuitable sentinels; however, 
without ongoing surveillance monitoring, these trends in canine Lyme disease cannot be observed 
or adequately responded to.  Furthermore, if a decline in incidence of canine Lyme disease was 
not observed, then educational programs on tick prevention may be an appropriate reaction to the 
surveillance data.  Administration of the Lyme vaccine appears to be low at this time and is 
unlikely to inhibit the use of dogs as sentinels for Lyme disease.  While Lyme disease was used as 
a primary example in this study for the utility of domestic dogs as sentinels, dogs have also been 
proposed sentinels for many other zoonotic pathogens, particularly vector-borne19 and parasitic 
pathogens26,31. 
 Several open-ended responses to a participant’s ‘final thoughts’ on a companion animal 
surveillance program in the Prairie Provinces highlighted an overall communication gap in 
information sharing between research and/or government groups and practicing veterinarians.  
This was observed when several statements regarding more information on certain pathogens, such 






provincially and federally in Canada32,33.  Thus, a surveillance program could also provide a direct 
communication channel to share information more easily with practicing veterinarians. In addition, 
several participants suggested other canine pathogens for the surveillance program that were 
previously excluded from the initiative based on results from the prioritization exercise.  Because 
of finite resources, only a select group of high priority pathogens can be included in any 
surveillance program5.  In addition to canine pathogens of public health concern, feline zoonotic 
pathogens will also be assessed for this companion animal surveillance program in the future.   
 Prior research has identified limitations with data extraction from EMR for the purposes of 
surveillance.  This is largely due to a lack of standardization in nomenclature and medical record 
keeping by veterinary professionals8,9.  While such technology would provide little time 
commitment from participating veterinary clinics, these gaps in medical record keeping can cause 
incomplete or inaccurate data capture.  Other studies have explored the utility of web-based 
surveillance systems that require veterinarians to directly input surveillance data14.  In the present 
study, it was important to identify the willingness of veterinarians to input surveillance data into a 
proposed online database.  This type of surveillance programming can be particularly favorable 
for real-time dissemination of surveillance data2.  The largest limitation of this surveillance design 
is compliance from participating clinics due to an increased time commitment14,15.  Although an 
overall willingness to participate in a companion animal surveillance program using a web-based 
approach was moderate, incorporating some form of incentivization (including nonmonetary 
options) and ease of data entry will be crucial for the success of the program23,24.   
 The present study would have benefited from a larger sample size to obtain a wider variety 
of veterinary practitioners throughout the Prairie Provinces.  Based on 2015 published data34, there 






SK, and 101 in MB.  Therefore, the investigators acknowledge low survey participation when 
compared to number of practices within the region of interest.  Prior research also reports low 
response rates with web-based survey methods35,36.  Additionally, non-response bias34,37 exists in 
the present study.  Those veterinarians most interested in surveillance were more likely to 
participate in this survey and contribute data.  Therefore, results from the present survey are more 
likely to be representative of individuals already interested in a surveillance initiative.  Despite 
these limitations, there is still value in the baseline data gathered from this survey to gauge 
surveillance interest.  Furthermore, response rate and non-response bias did not impact the 
development of case definitions or assessment of dogs as sentinels for Lyme disease.   
Because only current practice location was recorded for each participant, the investigators 
could not rule out that a participant moved or practiced in multiple provinces within the past 5 
years.  This may have affected the accuracy of where reported cases actually occurred if 
participants recalled a case seen within the past 5 years in a different province to their current 
practice location.  Because this surveillance program will include data from all 3 prairie provinces, 
minor discrepancies in location of cases was not a primary concern.  A limitation of the 
surveillance program itself is that data gathered from veterinary clinics will not be representative 
of the entire domestic animal population11.  Rather, it will only provide data on the proportion of 
companion animals that receive veterinary care and diagnostic testing.  Regardless of this 
limitation with any surveillance system, such programming is still a means to gather data on a 
population of animals we currently have little to no information on. 
4.6 Conclusion 
 In conclusion, it was identified that in-clinic veterinary data, particularly from in-clinic 






established that veterinarians are a useful tool in the development of case definitions for 
companion animal diseases intended for surveillance.  Furthermore, it was concluded that domestic 
dogs may serve as good sentinels for assessing Lyme disease risk in humans.   
The use and cooperation of veterinarians and veterinary clinics for a companion animal 
surveillance program in the Prairie Provinces is essential to the success of such programming.   
Although surveillance data collected from participating veterinarians and veterinary clinics will 
not be representative of the entire companion animal population, it will provide baseline 
prevalence and disease trends in animals that pose a public health risk to humans.  In addition, 
collaboration with veterinary diagnostic laboratory services and better communication channels 
between laboratory groups will need to be addressed for retaining, sharing, and utilizing 
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Table 4.1. Demographic data for survey respondents, including count and % total of respondents 





   Alberta 33/60 55 
   Saskatchewan  10/60 17 
   Manitoba 17/60 28 
   Other 0/60 0 
Practice region 
   Urban (city or suburb; densely populated) 33/60 55 
   Rural (countryside, town; low population density) 20/60 33 
   Both (split time between urban and rural) 7/60 12 
Experience in companion animal zoonoses* 
   None 0/59 0 
   Minimal 5/59 9 
   Moderate 38/59 64 
   Experienced 16/59 27 
*One participant skipped question (n=59) 
 
 
Table 4.2. Summary of species veterinarians see in practice and percentage of time spent with 
each 







Average % of 









of time spent 
with species 
Canines 60/60 100 55 80 10 
Felines 60/60 100 33.9 50 1 
Pocket Pets*  16/60 26.6 2.4 70 1 
Reptiles 4/60 6.7 0.1 3 1 
Pet Birds 6/60 10 0.2 5 1 
Equines 9/60 15 1.0 15 2 
Beef Cattle 11/60 18.3 3.8 60 2 
Dairy Cattle 7/60 11.7 2.5 60 1 
Poultry 2/60 3.3 0.1 7 1 
Swine 2/60 3.3 0.1 5 1 
Small Ruminants 6/60 10 0.6 20 1 
Wildlife 3/60 5 0.2 5 2 
Game Cervids 0/60 0 0 0 0 
Other 0/60 0 0 0 0 















Table 4.3. Willingness to participate in a companion animal surveillance program on a scale of 1 
to 10 specific to the Prairie Provinces 
 Willingness to participate in a 
companion animal surveillance 
program 
 
Willingness to participate if inputting 
information yourself (or by a staff 
member) into an online database with 
a login code 
 Median Min Max Median Min Max 






































































Table 4.4.  Preferred frequencies of surveillance reporting from participants 
 With what frequency are you willing to 
report surveillance data? 
With what frequency would you like to see updates 





No. of participants 
(majority) selecting 
ranking position*  





No. of participants 
(majority) selecting 
ranking position* 
% of participants 
selecting ranking 
position 
1st  Monthly 24/59 41% Monthly 39/59 66% 
2nd  Weekly 22/54 41% Annually 22/55 37% 
3rd  In real-time 15/54 28% Weekly 28/54 52% 
4th  Annually 28/55 51% In real-time 36/55 65% 




Table 4.5. Proportion of respondents reporting several canine pathogens of interest in the past 5 
years within the Prairie Provinces 
Pathogen Proportion of respondents reporting (n = 60) % of all respondents 
Echinococcus spp. 10/60* 16.7 
MRSA 14/60 23.3 
MRSP 16/60 21.7 
Salmonella spp. 11/60 18.3 
Campylobacter spp. 25/60 41.7 
Escherichia coli 31/60 51.7 
Borrelia burgdorferi 24/60 40.0 
Ehrlichia spp. 25/60 41.7 
Anaplasma spp. 21/60 35.0 
*7/10 respondents (70%) were from AB and 3/10 respondents were from MB (30%); no respondents from SK reported diagnosing at least one 






Table 4.6.  Most common methods for diagnosing tapeworms 
Test No. of respondents using the test 
(n=60) 
% of respondents using the test 










Fecal wet mount 21/60 35 
ELISA/CELISA 19/60 32 
PCR 26/60 43 
Doesn’t test 7/60 12 













aIndividuals selecting ‘both’ are separate from individuals choosing ‘in-clinic’ or ‘laboratory’ only 
 
 
Table 4.7.  Tapeworm preventative used and frequency of deworming protocols 
 No. of respondents % of respondents 
















Frequency of deworming (n=58)*   
Monthly 
Every 3 months 













a2 respondents specified Droncit 
b2 participants worked outside of clinical practice and therefore prescribing dewormer is ‘not applicable’ 




















Table 4.8. Lyme disease cases, frequency of testing and symptoms associated with positive cases 
specified by province and total number of participants 








Canine cases diagnosed in past 2y     
     0 28/33 (85%) 8/10 (80%) 0/17 (0) 36/60 (60%) 
     1-10 5/33 (15%) 2/10 (20%) 7/17 (41%) 14/60 (23%) 
     11-30 0/33 (0) 0/10 (0) 3/17 18%) 3/60 (5%) 
     >30 0/33 (0) 0/10 (0) 7/17 (41%) 7/60 (12%) 
Frequency of testing     
     As part of routine wellness  1/33 (3%) 0/10 (0) 4/17 (24%) 5/60 (8%) 
     At request of owner 8/33 (24%) 1/10 (10%) 8/17 (47%) 17/60 (28%) 
     If dog is exhibiting symptoms 20/33 (60%) 9/10 (90%) 12/17 (70%) 41/60 (68%) 
     If travel related history 20/33 (60%) 6/10 (60%) 5/17 (29%) 31/60 (52%) 
     Never 4/33 (12%) 0/10 (0) 1/17 (6%)a 5/60 (8%) 
     Other 6/33 (18%)b 1/10 (10%)c 10/17 (59%)d 17/60 (28%) 
Symptoms with positive cases* (n=5) (n=2) (n=17) (n=24) 
     Asymptomatic 2/5 (40%) 2/2 (100%) 10/17 (59%) 14/24 (58%) 
     Lameness/joint pain/swelling 3/5 (60%) 0/2 (0) 13/17 (76%) 16/24 (67%) 
     Fever 1/5 (20%) 0/2 (0) 12/17 (71%) 13/24 (54%) 
     Anorexia 1/5 (20%) 0/2 (0) 3/17(18%) 4/24 (17%) 
     Lethargy 2/5 (40%) 0/2 (0) 6/17 (35%) 8/24 (33%) 
     Other 1/5 (40%)e 0/2 (0) 8/17 (47%)f 9/24 (38%) 
aNot applicable for 1 respondent who worked outside of clinical practice 
b4 respondents specified if history of tick; 2 respondents specified with 4Dx screening as part of annual exam or regular heartworm testing 
*’n’ corresponds with no. of respondents who identified diagnosing Lyme cases 
c1 respondent specified prior to administering the Lyme vaccine 
d10 respondents specified with 4Dx screening as part of annual exam or regular heartworm testing 
e1 respondent specified immune mediated thrombocytopenia (ITP)  





























Table 4.9. Summary of Lyme disease data: Testing, vaccination, frequency and type of tick 
prevention 
Lyme Disease Information No. of respondents 
(n=60) 
% of respondents 
Type of test used   
IDEXX SNAP 4Dx Test (in-clinic) 42/60 70 
Othera 20/60 33 
N/Ab 5/60 8 
Frequency of Lyme vaccination   
Never 21/60 35 
Only if the history of the pet warrants vaccination  35/60 58 
Every patient gets vaccinated for Lyme disease 1/60 2 
Otherc 3/60 5 
Frequency of tick prevention recommendation   
Always 37/60 62 
Usually 16/60 27 
Sometimes 2/60 3 
Rarely 0/60 0 
N/Ad 2/60 3 
Othere 3/60 5 
Type of prevention used (n=58)*   
Bravecto 41/58 71 
Nexguardf 39/58 67 
Simparicag 24/58 41 
Revolution 16/58 28 
Advantix 24/58 41 
Otherh 2/58 3 
a14 respondents specified using PDS, Antech or IDEXX laboratories for send out SNAP testing; 4 respondents specified using the Lyme 
Quant C6 Test from IDEXX; 1 respondent specified PCR testing and 1 respondent specified treatment trial 
bRepresents the 5 participants who never test for Lyme disease 
c2 respondents specified they only rarely recommend; 1 respondent specified that they always recommend but compliance is varied 
dTwo participants work outside of clinical practice and therefore recommending tick prevention is not applicable 
e3 respondents specified based on risk/lifestyle 
*n=58 because recommending tick prevention is not applicable for two participants 
fIncluding Nexguard Spectra 
gIncluding Simparica Trio 





















Table 4.10.  Proposed case definitions for several canine pathogens/diseases of public health 
concern based on information obtained from clinical veterinarians for the purposes of 
surveillance in the Prairie Provinces 
Pathogen/Disease Confirmed Case Definition Additional Comments 
Echinococcus spp.  
(multilocularis, 
granulosus) 
Any urban, rural or free-roaming dog residing in 
the provinces of AB, SK, or MB with a positive 
fecal coproantigen ELISA or PCR test result for 
Echinococcus multilocularis or E. granulosus 
Requires access to laboratory 
testing; only interested in 
transmission risk from dogs to 
humans (shedding of worm 
segments or eggs in feces) 
MRSA/MRSP Any urban, rural or free-roaming dog residing in 
the provinces of AB, SK, or MB with a positive 
MRSA/MRSP result on culture and sensitivity 
testing with resistance to one or more 
antibiotic(s) regardless of clinic signs 
Requires laboratory testing; 
consider the addition of any 





Any urban, rural or free-roaming dog residing in 
the provinces of AB, SK, or MB with a positive 
PCR test or fecal culture for Salmonella spp., 
Campylobacter spp., and/or E.coli regardless of 
clinical signs 
Requires laboratory testing; 
consider the addition of other 
enteric pathogens 
Lyme disease Any urban, rural or free-roaming dog residing in 
the provinces of AB, SK, or MB with a positive 
in-clinic 4Dx SNAP test or laboratory 
confirmed positive for Lyme disease regardless 
of clinical signs 
Including laboratory positives 
































CHAPTER 5: GENERAL DISCUSSION AND CONCLUSION 
5.1  Introduction 
The concept of One Health seeks to bridge the gap between human, animal, environmental, 
and ecosystem health by collectively assessing these drivers of disease spread1.  This is because 
the transmission of many diseases involves all four components. Companion animals, including 
but not limited to cats and dogs, are an important population of animals that pose a risk of disease 
transmission to humans when considering the One Health paradigm2,3.  Currently, there is minimal 
information on disease trends in companion animals from either an animal health or public health 
perspective, particularly in Canada2,4.  Pathogen prioritization and disease surveillance are two 
epidemiologic methodologies that can incorporate a One Health approach to understanding disease 
distribution and determinants.  With the rising popularity of domestic animal ownership, the 
potential zoonotic risk these animals pose to humans deserves greater attention.   
There is a clear need for further research on companion animal surveillance and pathogen 
prioritization for companion animal diseases in Canada.  Currently, The OAHN in Ontario is the 
only formal surveillance program in Canada to include companion animal health trends and 
diseases5.  The Prairie Provinces became the primary region of interest for this research because 
surveillance data on companion animal diseases is extremely limited in this region.  Similar 
climate, environments, socioeconomic factors, and anticipated pathogens of concern from a public 
health perspective also make the 3 Prairie Provinces a rational combined region for a companion 
animal surveillance initiative.    
This thesis sought to accomplish 3 main objectives.  The first objective was to create a 
comprehensive list of canine pathogens ever reported in the domestic dog and to condense this list 






acquire the disease, specific to Canada and the prairies.  The second objective was to then prioritize 
these pathogens using experts in the field of veterinary medicine, public health and epidemiology 
to identify the top 5 highest priority pathogens that would become the focus of a companion animal 
surveillance initiative.  Finally, the third objective was to explore the role of clinical veterinarians 
and veterinary clinics in a companion animal surveillance system, to develop case definitions for 
the canine pathogens of public health significance established in prior chapters for the purposes of 
surveillance, and to assess domestic dogs as sentinels for human health risk using Lyme disease 
as an example.  Data obtained from a companion animal surveillance program in the Prairie 
Provinces would be of benefit to both animal health and human health, however, the primary focus 
of this research was exploring canine zoonotic pathogens and companion animal surveillance from 
a public health perspective.    
5.2  Key Findings  
In Chapter 2, a comprehensive list of pathogens historically reported in the domestic dog 
(n=594) was recorded.  Using a stepwise approach formulated by the primary researchers, this list 
was pared down to include only those pathogens of public health interest, and where the dog plays 
a role in human disease, that were relevant to Canada and the prairies.  In total, 84 canine pathogens 
met these criteria and comprised the final canine pathogen shortlist.  Additionally, supplementary 
groups of pathogens were highlighted for their possible importance in future companion animal 
surveillance programming in Canada due to constantly changing environmental and social drivers.  
In Chapter 3, a prioritization exercise using experts in the field of veterinary medicine, 
public health, and epidemiology was performed to establish the top 5 highest priority pathogens 
from the initial shortlist developed in Chapter 2 upon which to focus a companion animal 






Echinococcus spp. (granulosus, multilocularis), MRSA, Salmonella spp., MRSP, and B. 
burgdorferi.  From a surveillance perspective and the realities of diagnostic testing for many of 
these high priority pathogens, the following groups of canine pathogens were proposed for 
consideration in  a companion animal surveillance program from a public health perspective: (1) 
Echinococcus spp., (2) AMR pathogens (including MRSA/MRSP), (3) enteric pathogens 
(Salmonella spp., E. coli, Campylobacter spp.), and (4) vector-borne diseases (B. burgdorferi, 
Anaplasma spp., Ehrlichia spp., D. immitis).  In addition, several non-zoonotic canine pathogens 
including parvovirus, distemper, and canine influenza were identified as significant pathogens for 
inclusion in the surveillance program from an animal health perspective.   
Finally, in Chapter 4, the utility of clinical veterinarians and veterinary clinics in a 
companion animal surveillance initiative was thoroughly examined.  The use and cooperation of 
veterinarians and veterinary clinics from all practice regions was deemed essential to the success 
of a companion animal surveillance program in the prairies.  This study also established that 
clinical veterinarians provide valuable sources of information needed for the development of case 
definitions for canine diseases intended for surveillance.  In addition, it was identified that in-clinic 
veterinary data, such as in-clinic IDEXX SNAP 4DX testing or results from in-house fecal testing, 
are under-utilized for the purposes of surveillance.   Finally, domestic dogs were identified as 
appropriate sentinels for assessing Lyme disease risk in humans in the prairies and may serve as 
sentinels for several other canine zoonotic diseases of interest, particularly vector-borne6 and 
parasitic diseases7,8.   
5.3  Limitations of Research 
 Several limitations were acknowledged throughout the course of this research.  In Chapter 






list was possible.  In fact, during the course of this research Sars-CoV-2 emerged and was 
subsequently added to the list.  In addition, it is important to recognize that the exhaustive canine 
pathogen list was pared down by only two investigators; therefore, pathogen categorization was 
the result of specific definitions determined by these individuals.  These definitions may change 
slightly depending on the investigator and stakeholder interests.  The final shortlist is therefore not 
definitive but is unlikely to change substantially if replicated.  If time and resources allow it, 
double-blinded methods for paring down the comprehensive canine list will decrease subjectivity. 
 A primary limitation from Chapter 3 was the small sample size.  Increased participation, 
particularly from public health stakeholders, would have been beneficial for pathogen scoring by 
a diverse range of experts.  In addition, this study was limited to a semi-quantitative prioritization 
approach due to a lack of pre-existing companion animal disease data9,10.  This created some level 
of subjectivity and bias in the results9,11.  Furthermore, additional considerations during data 
analysis for this research chapter included “weighing” participant scores.  For example, weights 
could be applied to scores from participants who classified themselves as “experienced” in canine 
zoonoses.  As a result, these participants would have a greater impact on final pathogen scores and 
therefore overall ranking.  Because only 4 respondents classified themselves as “experienced” and 
because this is a subjective consideration, their scores were not weighted more heavily.  Future 
exercises may benefit from weighing scores if a larger and more diverse sample size is achieved.  
Lastly, the supplemental chart provided to experts had the potential to bias a participant’s top 10 
pathogen selections.  To reduce this bias, only simple and consistent information was provided for 
each pathogen to aid the experts if a particular pathogen was unfamiliar to them.  Similarly, a 
larger sample size in Chapter 4 would have provided data from a wider range of veterinary 






because only current practice location was recorded for each participant, it could not be ruled out 
that a participant moved or practiced in multiple provinces within the past 5 years.  This could 
have affected the location of cases that were reported in the survey.   
A significant limitation of any companion animal surveillance program is that data 
gathered from veterinary clinics is not representative of the entire domestic animal population12.  
Data captured from companion animal surveillance will only provide information on those 
domestic animals that receive veterinary care and diagnostic testing.  In other words, companion 
animal surveillance data can only be collected from those animals that receive standard veterinary 
services, and additionally, owners must be willing to pursue diagnostic testing (to definitively 
diagnose the pathogens included in a surveillance initiative).  In particular, remote communities 
with limited access to veterinary services will be underrepresented in such a surveillance strategy.  
Alternative and more direct ongoing surveillance efforts on zoonoses from domestic cats and dogs 
will need to be established in remote regions throughout the prairies, including Indigenous 
communities13–15.  Despite these limitations, companion animal surveillance data collected from 
participating veterinarians and veterinary clinics will provide valuable baseline information on 
disease trends in a population of animals that can pose serious public health risks to humans. 
5.4  Future Investigations 
 This thesis focused primarily on the domestic dog.  Other companion animal species such 
as cats, exotic pets, small mammals, and domestic birds should also be considered for future 
research.  In particular, domestic feline pathogens will be the next group of pathogens assessed for 
this companion animal surveillance initiative.  The author also recognizes that several of the 
zoonotic pathogens identified over the course of this research are relevant to wild canids within 






provincial surveillance programs.  The methods applied in all three research chapters can be 
adapted for any of the above-mentioned species.   
In addition to participation from veterinary clinics, collaboration with veterinary diagnostic 
laboratory services, as well as better communication between various laboratory groups needs to 
be examined in order to retain, share, and act on companion animal surveillance data across the 
prairies.  Although there is currently no formal reporting in place for veterinary laboratory services, 
population based data has been previously reported on in North America, primarily from an animal 
health perpective20. In Canada, the use of veterinary laboratory data has been examined for the 
purposes of syndromic surveillance in a retrospective study21.  Further research on incentivization 
(including nonmonetary strategies), compliance, and sustainability of veterinary clinics in 
surveillance also needs further attention22,23.   
As with any surveillance program, pathogen prioritization, case definitions, and the 
surveillance program itself will need to be evaluated at regular intervals9,11,24,25 to ensure relevant 
companion animal pathogens are monitored in the program due to ever-changing environmental 
and social climates.  In addition, evaluations of the program will provide feedback from 
stakeholders and adjustments to improve the program can be made throughout its evolution.   
5.5  Conclusions 
 There is an evident need in both the animal health and public health sector for companion 
animal surveillance in the Prairie Provinces.  This thesis provided the foundation for such a 
companion animal surveillance initiative and the following outcomes were accomplished: canine 
pathogens upon which to focus surveillance were identified, a proportion of in-clinic veterinary 
data that is not currently captured for the purposes of surveillance was exposed, the willingness of 






several canine pathogens to be included in surveillance were proposed, and dogs were assessed as 
sentinels for pathogens of public health importance using Lyme disease as an example.  Overall, 
this thesis highlighted significant gaps in companion animal zoonotic disease and surveillance 
research within Canada and the prairies.  It should ignite the conversation that there is more work 
to be done to truly achieve One Health within the Prairie Provinces and that companion animal 
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Complete list of 594 pathogens identified in canines categorized by the following taxonomical groups: bacteria, ectoparasites, 
fungi, helminths, protozoa, rickettsia and viruses.  Pathogens categorized as zoonotic/sapronotic/anthroponotic have been bolded; 
sapronoses are specifically denoted by a !.  If the dog is involved in transmission, maintenance or detection of the pathogen it 
has been further underlined.  Of these, if the pathogen is reported in dogs in Canada (Tier 1) it has been denoted by an *.  If the 
pathogen is reported in Canada but canine-specific reports are lacking (Tier 2) it is marked with a C (see also Appendix C).  




Acinetobacter baumannii  
Actinobacillus  


















Aliarcobacter butzleri  C 
Aliarcobacter cryaerophilus C 
Anaerobiospirillum  
 succiniciproducens C 
Anaerobiospirillum thomasii D 
Archanobacterium pyogenes 
Bacillus anthracis C 
Bacillus circulans C 
Bacillus subtilis D 







Bartonella vinsonii subsp. 
 berkhoffii* 
Bartonella washoensis 
Bergeyella zoohelcum C 
Bordetella bronchiseptica* 
Bordetella pertussis 
Borrelia afzelii senso lato 
Borrelia burgdorferi senso 
 stricto* 
Borrelia garinii senso lato 
Borrelia turicatae 
Brachyspira alvinipulli-like 
Brachyspira canis  
Brachyspira intermedia 






















Chromobacterium spp.! D 
Chromobacterium violaceum! 
Citrobacter diversus 
Citrobacter freundii C 
Citrobacter spp. D 
Clostridium botulinum type C 




Clostridium spp. C 
Clostridium tetani C 
Corynebacterium auriscanis D 
Corynebacterium canis C 
Corynebacterium freiburgense C 
Corynebacterium spp. D 
Corynebacterium ulcerans C 
Corynebacterium urealyticum  
Coxiella burnetii* 
Cytobacillus firmus C 
Dermabacter hominis C 
Dermatophilus congolensis 
Eikenella corrodens C 
Enterobacter cloacae C 
Enterococcus avium C 
Enterococcus canintestini 
Enterococcus casseliflavus 




Enterococcus malodoratus D 
Enterococcus spp.* 
Erysipelothrix rhusiopathiae C 
Erysipelothrix tonsillarum 
 serovar  7 
Escherichia coli (EHEC, EPEC, 
 AIEC, UPEC, NTEC, 
 ETEC)* 
Eubacterium plautii D 
Eubacterium spp. C 
Flavobacterium spp. D 
Francisella philomiragia  
Francisella tularensis* 
Fusobacterium spp.* 
Gemella morbillorum C 
Haemophilus aphrophilus C 
Helicobacter bilis 
Helicobacter bizzozeronii 
Helicobacter canis D 
Helicobacter cinaedi 
Helicobacter cynogastricus 






Lactobacillus spp. C 
Lawsonia intracellularis  
Leptospira interrogans serovar 
 australis C 
Leptospira interrogans serovar 
 autumnalis* 
Leptospira interrogans serovar 
 bataviae D 
Leptospira interrogans serovar 
 bratislava* 
Leptospira interrogans serovar 
 canicola* 
Leptospira interrogans serovar 
 grippotyphosa* 
Leptospira interrogans serovar 
 hardjo* 
Leptospira interrogans serovar 
 icterohaemorrhagiae* 
 136 
Leptospira interrogans serovar 
 pomona* 
Leptospira interrogans serovar 
 zanoni D 





Methicillin resistant  
 CoNS strains (MRSS)  
Methicillin resistant  
 Staph aureus (MRSA)* 
Methicillin resistant  
 Staph pseudintermedius 
 (MRSP)* 
Micrococcus lylae D 
Micrococcus spp. C 
Moraxella spp.* 
Mycobacterium avium subsp 
 paratuberculosis! 
Mycobacterium avium- 
 intracellulare complex!  
Mycobacterium bovis 
Mycobacterium chelonae-
 abscessus group C 






















Neisseria animaloris C 
Neisseria canis C 
Neisseria dentiae D 
Neisseria spp. C 
Neisseria weaveri* 
Neisseria zoodegmatis C 
Nocardia brasiliensis C 
Nocardia farcinica C 
Nocardia nova C 
Nocardia otitidiscaviarum C 




Pediococcus spp. D 
Peptostreptococcus spp. C 
Plesiomonas shigelloides C 
Porphyromonas spp. D 
Prevotella spp. C 
Propionibacterium spp. C  
Proteus mirabilis C 




Pseudomonas oryzihabitans D 
Pseudomonas spp. C 
Ralstonia pickettii! 
Rhodococcus equi 
Riemerella anatipestifer C 





Staphylococcus epidermidis C 







Staphylococcus spp. D 
Staphylococcus xylosus C 
Stenotrophomonas maltophilia C 
Stomatococcus mucilaginosus C 
Streptobacillus moniliformis C 
Streptococcus agalactiae 





Streptococcus equi subsp. equi  
Streptococcus equi subsp. 
 zooepidemicus C 
Streptococcus Group D  
 commensals 
Streptococcus Group E 
Streptococcus Group L 
Streptococcus Group M 
Streptococcus intermedius  
Streptococcus mitis ("- 
 streptococcus) C 
Streptococcus pneumoniae 
Streptococcus pyogenes ("-
 streptococcus) C 
Streptococcus spp.* 
Streptococcus suis  
Tannerella forsythia D 
Ureaplasma canigenitalum 
Veillonella spp. C 
Wolbachia pipientis D 
Yersinia enterocolitica* 
Yersinia pestis* 
Yersinia pseudotuberculosis C 
 
Ectoparasites 











Sarcoptes scabiei var canis* 
Tunga penetrans 

























































































































Echinococcus vogeli D 
Echinostoma cinetorchus 
Echinostoma  hortense 













 hirudinaceus D 







































Strongyloides stercoralis C 
Taenia brauni D  
Taenia crassiceps C 
Taenia hydatigena 
Taenia krabbei 




Taenia solium  
Taenia spp.* 
Taenia taeniaeformis 
Thelazia californiensis D 










Acanthamoeba genotype T1! 
Babesia caballi 
Babesia canis canis 
Babesia canis rossi 
Babesia canis vogeli 
Babesia conradae 
Babesia gibsoni 
Babesia microti-like (Babesia 
 annae) 
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Balamuthia mandrillaris! C  











Giardia duodenalis  
 (assemblage A1)* 
Giardia duodenalis  
 (assemblage B)* 
Giardia duodenalis assemblage C 






























Trypanosoma brucei brucei 
Trypanosoma brucei gambiense 
















Neorickettsia risticii subsp. 
 atypicalis 
Orientia tsutsugamushi  
Rickettsia akari  
Rickettsia australis 
Rickettsia conorii subsp. conorii  
Rickettsia felis C 
Rickettsia japonica 
Rickettsia prowazekii  
Rickettsia rickettsii* 
Stellanchasmus falcatus  
 
Viruses 
African Horse Sickness 
Astrovirus 
Australian bat virus 
Barmah Forest virus 
Bluetongue virus 
Borna Disease virus 
Canine Acidophil Cell Hepatitis 
Canine Adenovirus 1  
Canine Adenovirus 2 
Canine Calicivirus (strain 48) 
Canine Coronavirus 
 group 1 type 1 
Canine Coronavirus  
 group 1 type 2 (pantropic 
 biotype) 
Canine Coronavirus  
 group 1 type 2 (subtype a 
 and b) 
Canine Distemper virus 
Canine Herpesvirus 1 
Canine Influenza virus (H3N8) 
Canine Norovirus 
Canine Oral Papillomavirus 
Canine Papillomavirus type 2 
Canine Papillomavirus type 3 
Canine Papillomavirus type 6 
Canine Papillomavirus type 7 
Canine Parainfluenza virus 
 (respiratory) 
Canine Parainfluenza virus 5 
 variant (non-respiratory) 
Canine Parvovirus 1 
Canine Parvovirus 2 
Canine Pneumovirus 
Canine respiratory coronavirus 
 group 2 (subtype a) 
Canine rotavirus group A 
 (G3P[3], G3P[8]) D 
Cowpox  









European bat virus 
Foot and Mouth Disease 
Hendra virus 
Hepatitis E virus 
Influenza virus A (Human; 
 subtypes H1N1, H3N2,  
 H5N1) 
Influenza virus B (Human) 
Influenza virus C (Human) 
Irkut virus 
Japanese encephalitis virus 
Kobuvirus 
La Crosse virus 
Lagos bat virus 
Louping ill 






Porcine Herpesvirus 1 
Powassan virus 
Rabies (genotype 1 phylogroup 1 
 subtype 1)* 
Reovirus MRV (Mammalian 
 Reovirus) serotype 1 
Reovirus MRV (Mammalian 
 Reovirus) serotype 2 
Reovirus MRV (Mammalian 
 Reovirus) serotype 3 
Rift Valley Fever 
Ross River virus 
Sapovirus 
Sars-CoV-2 (Covid-19) 
Sin Nombre virus 
St. Louis encephalitis 
Tenshaw (Tensaw) virus infection 
Tick borne encephalitis 
Unclassified enteroviruses 
Venezuelan equine encephalitis 
Vesicular exanthema 
West Nile virus 





The following list represents 29 zoonotic/anthroponotic pathogens denoted as Grey-Zone Pathogens.  These 
represent any pathogen where there is some evidence the dog is involved in transmission, maintenance or detection 
of the pathogen as it relates to human infection, but current research has not definitively proven the dog’s role at the 
time of this study.  There were no sapronoses in this group.  Of these pathogens, those that have been reported in 
Canada are marked with a 1.  Those pathogens that have the potential to occur in Canada but have not yet been 
reported are marked with a 2. 
 
Bacteria 
Acinetobacter baumannii 1  
Borrelia turicatae 1 
Campylobacter gracilis 1 
Campylobacter lari 1 
Helicobacter bizzozeronii 2 
Mycoplasma canis 2 
Mycoplasma maculosum 2 
Rhodococcus equi 1 




Encephalitozoon cuniculi 1 
Encephalitozoon intestinalis 2 




Ascaris lumbricoides 1 
Trichinella spiralis 1 





Babesia canis canis 
Babesia canis rossi 
Babesia canis vogeli 1 
Blastocystis hominis 1 
Blastocystis spp. 1 





Anaplasma platys 1 
Ehrlichia chaffeensis 2 




Reovirus MRV (Mammalian Reovirus) serotype 1 1 
Reovirus MRV (Mammalian Reovirus) serotype 2 1 
Reovirus MRV (Mammalian Reovirus) serotype 3 1 






















The following list represents 74 zoonotic/sapronotic pathogens where the dog is involved in transmission, 
maintenance, or detection of the pathogen and the pathogen has been reported to have historically occurred in 








Bacillus anthracis  
Bacillus circulans 
Bacteroides spp.  
Bergeyella zoohelcum 




















Leptospira interrogans serovar australis 
Leptotrichia buccalis 
Micrococcus spp. 
Mycobacterium chelonae-abscessus group (RGM) 
Mycobacterium fortuitum group (RGM) 










Peptostreptococcus spp.  
Plesiomonas shigelloides 
Prevotella spp.  










Streptococcus equi subsp. zooepidemicus 
Streptococcus mitis (⍺-streptococcus) 
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APPENDIX D 
The following list represents 31 zoonotic pathogens where the dog is involved in transmission, maintenance or 
detection of the pathogen that have the potential to occur in Canada, however, no definitive Canadian reports were 








Corynebacterium spp.  
Enterococcus malodoratus 




Leptospira interrogans serovar bataviae 






Pseudomonas oryzihabitans  
Staphylococcus spp. (warneri, cohnii, coagulase  
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APPENDIX E 
In alphabetical order, complete list of 594 pathogens identified in dogs and associated reference(s) used to determine whether a 
pathogen advanced to a subsequent step.  When a reference is not listed it means one was not found during literature search and 
thus the answer was deemed “no” or “maybe” due to lack of evidence or reporting.       
 
Pathogen Is the pathogen 
zoonotic/sapronotic/ 
anthroponotic? 
Is the dog involved in 
transmission, maintenance 
or detection of the 
pathogen? 
Is there a level of risk for 
occurrence of the 
pathogen in Canada? 




Absidia spp. Yes1 No1 -- -- 
Acanthamoeba castellanii Yes1 No1 -- -- 
Acanthamoeba culbertsoni Yes1 No1 -- -- 
Acanthamoeba genotype T1 Yes1 No1 -- -- 
Acanthocheilonema 
reconditum 
Yes1–3 Yes3,4 Yes5,6 Yes5,6 
Acholeplasma laidlawii No1,2 -- -- -- 
Acinetobacter baumannii  Yes1 Maybe1,7 Yes8 -- 
Acremonium hyalinulum Yes1 No1 -- -- 
Acremonium kiliense Yes1 No1 -- -- 
Actinobacillus              
actinomycetemcomitans 
Yes1 Yes1 Yes9 No 
Actinobacillus lignieresii Yes2,10 No11,12 -- -- 
Actinomyces bovis Yes1,4 No4 -- -- 
Actinomyces bowdenii No1,2 -- -- -- 
Actinomyces canis No1,2 -- -- -- 
Actinomyces catuli No1 -- -- -- 
Actinomyces coleocanis No1 -- -- -- 
Actinomyces hordeovulneris No1,2 -- -- -- 
Actinomyces hyovaginalis No1,2 -- -- -- 
Actinomyces israelii Yes2,4,13 No4 -- -- 
Actinomyces naeslundii Yes2,13 No -- -- 
Actinomyces neuii subsp. 
anitratus 
Yes1 Yes1,14 Yes15 No 
Actinomyces odontolyticus Yes2,13 No1 -- -- 
Actinomyces turicensis Yes16 No -- -- 
Actinomyces urogenitalis Yes17,18 No -- -- 
Actinomyces viscosus Yes1,13,19 Yes14,19,20 Yes21 Yes20 
Actinomyces weissii No22 -- -- -- 
African Horse Sickness No1 -- -- -- 
Alaria alata Yes4 Yes4 Yes23 Yes23 
Alaria americana Yes23 Yes23 Yes23 Yes23 
Alaria canis Yes4 Yes4 Yes24 Yes24 
Alaria marcianae Yes23 Yes23 Yes23 Yes23 
Alaria nasuae No23 -- -- -- 
Aliarcobacter butzleri   Yes1,2,25 Yes25 Yes26 No 
Aliarcobacter cryaerophilus Yes1,2 Yes25 Yes26,27 No 
Alternaria spp. Yes1 No1 -- -- 
Amphimerus pseudofelineus Yes23 Yes23 Maybe28,29 -- 
Anaerobiospirillum 
succiniciproducens 
Yes1 Yes1 Yes21 No 
Anaerobiospirillum 
thomasii 
Yes1 Yes1 Maybe -- 
Anaplasma 
phagocytophilum 
Yes1 Yes1 Yes1,30,31 Yes30–32 
Anaplasma platys  Yes33 Maybe1,33 Yes34,35 -- 
Ancylostoma braziliense Yes4 Yes4,23 No4,23 -- 
Ancylostoma caninum Yes4 Yes23,24 No4,36 -- 
Ancylostoma ceylanicum Yes4 Yes23 No37 -- 
Angiostrongylus vasorum  No4 -- -- -- 
Apophallus donicus Yes38 Yes38 Yes23 Yes39 
Archanobacterium pyogenes Yes2,40 No14 -- -- 
Ascaris lumbricoides Yes4 Maybe41 Yes42 -- 
Aspergillus deflectus Yes1 No43 -- -- 
Aspergillus flavipes Yes1 No43 -- -- 
Aspergillus flavus Yes1,2 No43 -- -- 
Aspergillus fumigatus Yes1,2 No43 -- -- 
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Aspergillus nidulans Yes1,2 No43 -- -- 
Aspergillus niger Yes1,2 No43 -- -- 
Aspergillus terreus Yes1,2 No43 -- -- 
Astrovirus No19,44,45 -- -- -- 
Australian Bat virus Yes1 No46 -- -- 
Babesia caballi No1,4 -- -- -- 
Babesia canis canis Yes1,4 Maybe47,48 No1,49 -- 
Babesia canis rossi Yes1,4 Maybe48,50 No1,51 -- 
Babesia canis vogeli Yes1,4 Maybe48,50 Yes34 -- 
Babesia conradae No1,4 -- -- -- 
Babesia gibsoni No1,4 -- -- -- 
Babesia microti-like 
(Babesia annae) 
No1,52 -- -- -- 
Bacillus anthracis  Yes1,4 Yes1,43,53,54,55 Yes56 No 
Bacillus circulans  Yes1 Yes1 Yes57 No 
Bacillus subtilis  Yes1 Yes1,58 Maybe -- 
Bacteroides spp. Yes1 Yes1 Yes21 No 
Balamuthia mandrillaris Yes1 Yes1 Yes59,60 No 
Balantidium coli Yes1 Yes1 Yes61,62 No 
Barmah Forest virus Yes1 No1 -- -- 
Bartonella clarridgeiae Yes1 No1,43 -- -- 
Bartonella elizabethae Yes1 No1,14 -- -- 
Bartonella henselae Yes1 Yes1,43 Yes63,64 Yes65 
Bartonella koehlerae Yes1 No1,14 -- -- 
Bartonella quintana Yes1 No1,14 -- -- 
Bartonella rochalimae Yes1 No1,14 -- -- 
Bartonella vinsonii subsp. 
berkhoffii 
Yes1 Yes1,14,43,66 Yes Yes66 
Bartonella washoensis Yes1 No1,14 -- -- 
Basidiobolus spp. Yes1,2 No1 -- -- 
Baylisascaris procyonis Yes4 Yes43,67 Yes67,68 Yes69 
Bergeyella zoohelcum Yes1 Yes43 Yes59 No 
Bipolaris spp. Yes1,2 No1 -- -- 
Blastocystis hominis Yes1,2 Maybe1 Yes70 -- 
Blastocystis spp. Yes1,2 Maybe1,71,72 Yes70 -- 
Blastomyces dermatitidis Yes1,4,19 Yes1,19 Yes1,73 Yes74 
Bluetongue virus No1 -- -- -- 
Bordetella bronchiseptica Yes1 Yes1,43 Yes64 Yes75 
Bordetella pertussis Yes19 No19 -- -- 
Borna Disease virus Yes1 No1 -- -- 
Borrelia afzelii senso lato  Yes1,4 No1,4,76,77 -- -- 
Borrelia burgdorferi senso 
stricto 
Yes1 Yes1,14 Yes64 Yes78 
Borrelia garinii senso lato Yes1,4 No1,4,76 -- -- 
Borrelia turicatae Yes1,2,4 Maybe79,80 Yes81 -- 
Brachyspira alvinipulli-like No1 -- -- -- 
Brachyspira canis  No1 -- -- -- 
Brachyspira intermedia No14 -- -- -- 
Brachyspira pilosicoli  Yes1 Yes82,83 Yes83 No 
Brachyspira pulli No14 -- -- -- 
Brevibacterium spp. Yes1 Yes1,84 Yes85 No 
Brucella abortus Yes1 No14 -- -- 
Brucella canis Yes1 Yes1,86 Yes64 Yes87 
Brucella suis Yes1 No14,88 -- -- 
Brugia malayi Yes23 No23 -- -- 
Brugia pahangi No23 -- -- -- 
Burkholderia mallei Yes1 No1 -- -- 
Burkholderia pseudomallei Yes1 No1 -- -- 
Campylobacter coli Yes1,19 Yes4,19 Yes89 Yes90 
Campylobacter gracilis Yes43 Maybe91 Yes21 -- 
Campylobacter helveticus No1,14,92 -- -- -- 
Campylobacter jejuni Yes1 Yes1,4 Yes89 Yes93 
Campylobacter lari Yes1,2,94 Maybe14,43 Yes95 -- 
Campylobacter upsaliensis Yes1 Yes1,43 Yes93 Yes93 
Candida albicans Yes2,96 No96 -- -- 
Candida famata Yes97 No1 -- -- 
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Candida glabrata Yes1,2,96 No1 -- -- 
Candida guilliermondii Yes2,96 No1 -- -- 
Candida krusei Yes2,96 No1 -- -- 
Candida parapsilosis Yes1,2,96 No1,98 -- -- 
Candida rugosa Yes1 No1 -- -- 
Candida tropicalis Yes2,96 No1 -- -- 
Candidatus Mycoplasma 
haematoparvum 
Yes99 No 99 -- -- 
Canine Acidophil Cell 
Hepatitis 
No1 -- -- -- 
Canine Adenovirus 1  No1 -- -- -- 
Canine Adenovirus 2 No1,19 -- -- -- 
Canine Calicivirus No1,100,101 -- -- -- 
Canine Coronavirus group 
1 type 1 
No1,19 -- -- -- 
Canine Coronavirus group 
1 type 2 (pantropic biotype) 
No1,19 -- -- -- 
Canine Coronavirus group 
1 type 2 (subtype a and b) 
No1,19 -- -- -- 
Canine Distemper Virus No1,19,102 -- -- -- 
Canine Herpesvirus 1 No1 -- -- -- 
Canine Influenza virus 
(H3N8) 
No1,19,103,104 -- -- -- 
Canine Norovirus No19,105–107 -- -- -- 
Canine Oral Papillomavirus No1 -- -- -- 
Canine Papillomavirus 
types 2 
No1 -- -- -- 
Canine Papillomavirus 
types 3 
No1 -- -- -- 
Canine Papillomavirus 
types 6 
No1 -- -- -- 
Canine Papillomavirus 
types 7 
No1 -- -- -- 
Canine Parainfluenza virus 
(respiratory) 
No19 -- -- -- 
Canine Parainfluenza virus 
virus 5 variant (non-
respiratory) 
No1,19,108 -- -- -- 
Canine Parvovirus 1 No1 -- -- -- 
Canine Parvovirus 2 No1,19 -- -- -- 
Canine Pneumovirus No1,4 -- -- -- 
Canine respiratory 
coronavirus group 2 
subtype a 
No1,19 -- -- -- 
Canine rotavirus group A  Yes1 Yes1,109 Maybe26,110,111 -- 
Capillaria aerophila Yes4 No23 -- -- 
Capnocytophaga 
canimorsus 
Yes1 Yes43,112 Yes43,64,113 Yes114 
Capnocytophaga cynodegmi Yes1 Yes43,115,116 Yes59 No 
Caryospora bigentica-like No1 -- -- -- 
Centrocestus armatus Yes23 Yes23 No23,117,118 -- 
Centrocestus formosanus Yes23 Yes23 No23,119,120 -- 
Cheyletiella parasitovorax Yes4 Yes121 Maybe4 -- 
Cheyletiella yasguri Yes4 Yes122,123 Yes124 Yes124 
Chlamydia abortus Yes4 No4 -- -- 
Chlamydia caviae No1,19 -- -- -- 
Chlamydophila felis Yes1,19 No1,19,43 -- -- 
Chlamydophila psittaci Yes1,4,19 No1,4,19,43 -- -- 
Chlorella spp. Yes1,125 No1,125 -- -- 
Chromobacterium spp. Yes1 Yes1,58 Maybe -- 
Chromobacterium 
violaceum 
Yes1 No1 -- -- 
Chrysosporium spp. Yes1 No1 -- -- 
Citrobacter diversus Yes126 No -- -- 
Citrobacter freundii Yes2,126 Yes127,128 Yes129 No 
Citrobacter spp. Yes19,128 Yes19,128 Maybe128,129 -- 
Cladophialophora bantiana Yes1 No1 -- -- 
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Cladophialophora spp. Yes1 No1 -- -- 
Cladosprorium xylohypha  Yes1 No1 -- -- 
Clonorchis sinensis Yes4 Yes4,23 No23,118,130 -- 
Clostridium botulinum C Yes1 No1,4,14,19 -- -- 
Clostridium botulinum D Yes1 No1,4,14,19 -- -- 
Clostridium difficile Yes1 Yes43 Yes64,131 Yes132,133 
Clostridium perfringens Yes1 Yes43,128,134,135 Yes131 Yes136 
Clostridium piliforme Yes1 No14 -- -- 
Clostridium spp. Yes1,43,137 Yes43 Yes131 No 
Clostridium tetani Yes1,19 Yes19 Yes138 No 
Coccidioides immitis Yes1,139,140 Yes1,141 No1 -- 
Coccidioides posadasii Yes1,139 Yes1,141 No1 -- 
Conidiobolus spp. Yes1 No1 -- -- 
Corynebacterium auriscanis Yes1 Yes1 Maybe -- 
Corynebacterium canis Yes1 Yes1 Yes59 No 
Corynebacterium 
freiburgense 
Yes1 Yes1 Yes59 No 
Corynebacterium spp.  Yes1 Yes1 Maybe -- 
Corynebacterium ulcerans Yes1 Yes43 Yes142,143 No 
Corynebacterium 
urealyticum 
Yes143 No143 -- -- 
Cowpox  Yes1 No1 -- -- 
Coxiella burnetii Yes1 Yes43 Yes43,64 Yes145 
Coxsackievirus A9, A20 Yes1 No1 -- -- 
Coxsackievirus B1 Yes1 No1 -- -- 
Coxsackievirus B3 Yes1 No1 -- -- 
Coxsackievirus B5 Yes1 No1 -- -- 
Cryptococcus albidus Yes1 No1,43 -- -- 
Cryptococcus gattii Yes1 Yes146,147 Yes146 Yes146 
Cryptococcus laurentii Yes1 No1,43 -- -- 
Cryptococcus neoformans Yes1 No1,43 -- -- 
Cryptocotyle lingua Yes2,4,148 Yes23 Yes4,149 Yes150 
Cryptosporidium canis Yes1,4 Yes43 Yes151 Yes152, 153 
Cryptosporidium muris Yes4 No43 -- -- 
Cryptosporidium parvum Yes43,154 Maybe43,155 Yes64,156 -- 
Ctenocephalides canis Yes23 Yes23 Yes157 Yes157 
Ctenocephalides felis Yes4,23 Yes43 Yes157 Yes157 
Curvularia spp. Yes1 No1 -- -- 
Cyclospora cayetanensis Yes1 No1 -- -- 
Cytobacillus firmus Yes1 Yes1,58 Yes158 No 
Cystoisospora canis No1 -- -- -- 
Cystoisospora ohioensis No1 -- -- -- 
Demodex canis No1,4 -- -- -- 
Dermabacter hominis Yes19,127,128,159 Yes19,127,128,159 Yes160 No 
Dermatophilus congolensis Yes1 No1,14 -- -- 
Dicrocoelium dendriticum Yes23 No23 -- -- 
Dioctophyma renale Yes23 No23 -- -- 
Diphyllobothrium spp. Yes4,23 Yes23 Yes161 Yes150 
Dipylidium caninum Yes4 Yes4,23 Yes150 Yes162 
Dirofilaria immitis Yes1,4 Yes23,43 Yes32 Yes32 
Dirofilaria repens Yes1,4 Yes23 Maybe -- 
Dracunculus insignis Yes23 No23 -- -- 
Dracunculus medinensis Yes23 No23 -- -- 
Eastern equine encephalitis Yes1 No1 -- -- 
Ebola virus Yes1 No1,163 -- -- 
Echidnophaga gallinacea Yes4,164 Yes162 Yes165 No 
Echinochasmus fujianensis Yes23 Yes23 No118,119,166 -- 
Echinochasmus japonicus Yes4 Yes23 No4,23,118 -- 
Echinochasmus liliputanus Yes23 Yes23 No23,118,119 -- 
Echinochasmus perfoliatus Yes23 Yes23 No119,167 -- 
Echinococcus granulosus Yes4 Yes4,43 Yes69 Yes168 
Echinococcus multilocularis Yes4 Yes4,43 Yes168 Yes168 
Echinococcus vogeli Yes4 Yes4,43 Maybe -- 
Echinostoma cinetorchus Yes23 Yes23,38 No23,38,118,169 -- 
Echinostoma hortense Yes4 Yes23 No38,118 -- 
Echinostoma ilocanum Yes4 Yes23 No23,119 -- 
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Echinostoma spp. Yes4 Yes23 No23,119 -- 
Echovirus 6 Yes1 No1 -- -- 
Echovirus 7 Yes1 No1 -- -- 
Ehrlichia canis  Yes1 Yes43 Yes32 Yes32 
Ehrlichia chaffeensis Yes1 Maybe1,43 Maybe170 -- 
Ehrlichia ewingii Yes1 Maybe1,43 Maybe34,171 -- 
Ehrlichia ruminantium No1,172,173 -- -- -- 
Eikenella corrodens Yes1 Yes1,174 Yes175 No 
Emmonsia parva   Yes2,176 No1,176 -- -- 
Encephalitozoon cuniculi Yes1,4 Maybe1,43 Yes177 -- 
Encephalitozoon hellem Yes1,4 No1,43 -- -- 
Encephalitozoon intestinalis Yes1,4,154 Maybe178,179 Maybe -- 
Encephalomyocarditis virus Yes4 No1,4 -- -- 
Entamoeba histolytica Yes1 No1 -- -- 
Enterobacter cloacae Yes1,2,180 Yes1 Yes85,181 No 
Enterococcus avium Yes1,2 Yes1 Yes182,183 No 
Enterococcus canintestini Yes184 No184 -- -- 
Enterococcus casseliflavus Yes185 No186 -- -- 
Enterococcus faecalis Yes1,2,19 Yes43,187 Yes182,188 No 
Enterococcus faecium Yes1,2,189 Yes43,187 Yes182,190 Yes191 
Enterococcus gallinarum Yes185 No186 -- -- 
Enterococcus hirae Yes2,184 No14 -- -- 
Enterococcus malodoratus Yes1 Yes1 Maybe128 -- 
Enterococcus spp. Yes1,2 Yes1,43,189 Yes192,193 Yes192,193 
Enterocytozoon bieneusi Yes1,4 Maybe43 Maybe43 -- 
Epidermophyton spp. Yes1 No1,4,194 -- -- 
Episthmium caninum Yes23 Yes23 No23,119 -- 
Erysipelothrix 
rhusiopathiae 
Yes1 Yes1 Yes59,195 No 
Erysipelothrix tonsillarum 
serovar 7 
Yes1 No1 -- -- 
Escherichia coli Yes1,4,19 Yes1 Yes196 Yes196 
Eubacterium plautii  Yes1 Yes1 Maybe128 -- 
Eubacterium spp. Yes19 Yes19 Yes21 No 
European bat virus Yes1,43 No1,197 -- -- 
Filaroides hirthi No2,4 -- -- -- 
Flavobacterium spp. Yes1 Yes1 Maybe128 -- 
Fonsecaea spp. Yes1 No1 -- -- 
Foot and Mouth Disease Yes4 No1 -- -- 
Francisella philomiragia  Yes198 No1,198 -- -- 
Francisella tularensis  Yes1 Yes1 Yes64 Yes63 
Fusarium spp. Yes1 No1 -- -- 
Fusobacterium spp. Yes1,19 Yes1,14,19 Yes64 Yes64,199 
Gemella morbillorum Yes1 Yes1 Yes200 No 
Geomyces spp. Yes1 No1,2 -- -- 
Geosmithia argillacea Yes1 No1,2 -- -- 
Geotrichum candidum Yes1 No1,2 -- -- 
Giardia duodenalis 
assemblage A1 
Yes1 Yes201–203 Yes204 Yes204 
Giardia duodenalis 
assemblage B 
Yes1 Yes201–203 Yes204 Yes204,153 
Giardia duodenalis 
assemblage C 
Yes205 No43,203,205 -- -- 
Giardia duodenalis 
assemblage D 
No1,205 -- -- -- 
Gnathostoma spinigerum Yes23 Yes23 No119,206–208 -- 
Haemophilus aphrophilus Yes1 Yes1,209–211 Yes212 No 
Hammondia heydorni No1 -- -- -- 
Haplorchis pumilio Yes23 Yes23,119 No23,119,213 -- 
Haplorchis taichui Yes23 Yes23,119 No23,119,213,214 -- 
Haplorchis yokogawai Yes23 Yes23,119 No23,119 -- 
Helicobacter bilis Yes215 No14,215 -- -- 
Helicobacter bizzozeronii Yes1,19 Maybe4,215–217 Maybe -- 
Helicobacter canis Yes19,218,219 Yes14 Maybe19 -- 
Helicobacter cinaedi Yes1,19,220 No19,215,221 -- -- 
Helicobacter cynogastricus No19,215,217 -- -- -- 
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Helicobacter felis Yes1,19 Yes217,222 Maybe19 -- 
Helicobacter fennelliae Yes215,220 No215 -- -- 
Helicobacter heilmannii Yes1 Yes1,215 Yes223,224 Yes224 
Helicobacter rappini Yes14,220 No -- -- 
Helicobacter salomonis Yes19,217 No217 -- -- 
Hendra virus Yes1,4 No1,4 -- -- 
Hepatitis E virus Yes1 No1 -- -- 
Hepatozoon americanum No1 -- -- -- 
Hepatozoon canis No1 -- -- -- 
Heterobilharzia americana Yes2,23 Yes4,23 No23,225–228 -- 
Heterophyes dispar Yes23 Yes23 No23,213,229 -- 
Heterophyes heterophyes Yes23 Yes23 No23,119,229 -- 
Heterophyopsis continua Yes23 Yes23 No23,213 -- 
Histoplasma capsulatum Yes1,2 Yes141,230 Yes1,231,232 Yes233 
Influenza virus A (Human; 
H1N1, H3N2, H5N1) 
Yes1,19 No103 -- -- 
Influenza virus B (Human) Yes1,2 No1 -- -- 
Influenza virus C (Human) Yes1,2 No1 -- -- 
Intrahepatic biliary 
coccidiosis 
No1 -- -- -- 
Intrapulmonary coccidiosis No1 -- -- -- 
Irkut virus Yes1,19 No1,234 -- -- 
Isospora burrowsi No1 -- -- -- 
Isospora neorivolta No1 -- -- -- 
Japanese encephalitis virus Yes1 No1 -- -- 
Klebsiella spp.  Yes1,19 Yes19,235 Yes85,193 Yes192 
Kobuvirus No19 -- -- -- 
La Crosse virus Yes4 No1,4 -- -- 
Lactobacillus spp. Yes1 Yes1 Yes21 No 
Lagenidium spp. Yes1 No1 -- -- 
Lagos bat virus Yes1,19 No1 -- -- 
Lawsonia intracellularis  No1,236 -- -- -- 
Leishmania amazonensis Yes2 No43 -- -- 
Leishmania braziliensis Yes1 No1,19 -- -- 
Leishmania donovani Yes2 Maybe237 No238,239 -- 
Leishmania infantum Yes1 Yes1,4,43 Yes240 Yes240,241 
Leishmania major Yes23 No43 -- -- 
Leishmania panamensis Yes2 No43 -- -- 
Leishmania peruviana Yes1 No43 -- -- 
Leishmania tropica Yes2 No43 -- -- 
Leptospira interrogans 
serovar australis 
Yes1 Yes1 Yes242 No 
Leptospira interrogans 
serovar autumnalis 
Yes1 Yes1 Yes43 Yes243 
Leptospira interrogans 
serovar bataviae 
Yes1 Yes1 Maybe -- 
Leptospira interrogans 
serovar bratislava 
Yes1 Yes1 Yes43 Yes243 
Leptospira interrogans 
serovar canicola 
Yes1 Yes1,43 Yes43 Yes243 
Leptospira interrogans 
serovar grippotyphosa 
Yes1 Yes1,43 Yes43 Yes243 
Leptospira interrogans 
serovar hardjo 
Yes1 Yes1 Yes242 Yes244 
Leptospira interrogans 
serovar icterohaemorrhagiae 
Yes1 Yes1 Yes43 Yes243 
Leptospira interrogans 
serovar pomona 
Yes1 Yes1 Yes245 Yes243 
Leptospira interrogans 
serovar zanoni 
Yes1 Yes1 Maybe -- 
Leptotrichia buccalis Yes1 Yes1 Yes21 No 
Listeria monocytogenes Yes1 No43 -- -- 
Louping ill Yes1 No1 -- -- 
Lymphocytic 
Choriomeningitis virus 
Yes1 No1 -- -- 
Macracanthorhynchus 
hirudinaceus 
Yes4 Yes4,246 Maybe4,246 -- 
 148  
Macracanthorhynchus 
ingens 
Yes246 Yes246 Yes247 No 
Madurella spp. Yes1 No1 -- -- 
Malassezia pachydermatis  Yes1 Yes1 Yes248 Yes248 
Mesocestoides spp. Yes2,23 Yes4,23 Yes249,250 Yes249 
Mesomycoplasma molare No251 -- -- -- 
Metagonimus yokogawai Yes2,23 Yes23 No23,118,119 -- 
Metamycoplasma gateae No251 -- -- -- 
Metamycoplasma spumans No251 -- -- -- 
Methicillin resistant 
infections CoNS strains  
Yes1,252 No1,252 -- -- 
Methicillin resistant 
Staphylococcus aureus 




Yes1 Yes1 Yes253 Yes253–255 
Metorchis albidus Yes23 Yes23 No23,118 -- 
Metorchis conjunctus Yes4,23 Yes23 Yes256 Yes256 
Micrococcus lylae Yes19 Yes19,58 Maybe -- 
Micrococcus spp. Yes1 Yes19,58 Yes85,257 No 
Microsporum canis Yes1 Yes1 Yes258,259 Yes64 
Microsporum gypseum Yes1 Yes1 Yes258 No 
Mokola virus Yes1,19 No1,260,261 -- -- 
Monocillium indicum Yes1 No1 -- -- 
Moraxella spp. Yes1,19 Yes19,64,262 Yes64 Yes64 
Mucor spp. Yes1 No1 -- -- 
Mumps virus Yes1 No1 -- -- 
Mycobacterium avium 
subsp paratuberculosis  
Yes1 No1 -- -- 
Mycobacterium avium-
intracellulare complex  
Yes1 No1,4 -- -- 
Mycobacterium bovis Yes1,4 No43 -- -- 
Mycobacterium chelonae-
abscessus group  
Yes1 Yes1 Yes263,264 No 
Mycobacterium fortuitum 
group  
Yes1 Yes1 Yes263,264 No 
Mycobacterium genavense  Yes1 No1 -- -- 
Mycobacterium goodii  Yes1,265,266 No1 -- -- 
Mycobacterium kansasii  Yes1 Yes1 Yes263,264 No 
Mycobacterium microti Yes1 No1 -- -- 
Mycobacterium smegmatis 
group  
Yes2,267 No1 -- -- 
Mycobacterium Canine 
Leproid Granulomas  
No1 -- -- -- 
Mycobacterium tuberculosis Yes1 No1, 43 -- -- 
Mycoplasma arginini Yes268,269 No268 -- -- 
Mycoplasma bovigenitalium No251 -- -- -- 
Mycoplasma canis Yes1,251 Maybe251,269,270 Maybe -- 
Mycoplasma cynos No251 -- -- -- 
Mycoplasma edwardii Yes271 Yes271 Yes272 No 
Mycoplasma feliminutum No251 -- -- -- 
Mycoplasma felis Yes251 No251,273 -- -- 
Mycoplasma haemocanis No251 -- -- -- 
Mycoplasma maculosum Yes1 Maybe274 Maybe -- 
Mycoplasma opalescens No251 -- -- -- 
Mycoplasma ovis Yes1 No19 -- -- 
Nanophyetus salmincola Yes4 Yes4,23 Yes4 Yes275 
Neisseria animaloris Yes1 Yes1 Yes59 No 
Neisseria canis Yes1 Yes1 Yes59 No 
Neisseria dentiae Yes1 Yes1 Maybe -- 
Neisseria spp. Yes1,19 Yes1,19 Yes59 No 
Neisseria weaveri Yes1,19 Yes1,19 Yes59 Yes276 
Neisseria zoodegmatis Yes1 Yes1 Yes59,277 No 
Neorickettsia elokominica No4,278,279 -- -- -- 
Neorickettsia helminthoeca No4,278,279 -- -- -- 
Neorickettsia risticii No1,4,278,279 -- -- -- 
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Neorickettsia risticii subsp 
atypicalis 
No1,4,278,279 -- -- -- 
Neospora caninum No1,280–282 -- -- -- 
Nipah Virus Yes1,4 No1,4,43 -- -- 
Nocardia brasiliensis Yes1,2 Yes4 Yes283 No 
Nocardia farcinica Yes1,2 Yes4 Yes283 No 
Nocardia nova Yes1,2,284 Yes4 Yes283 No19 
Nocardia otitidiscaviarum Yes1,2 Yes4 Yes283 No 
Notoedres cati Yes4 No4,285 -- -- 
Ochronconis spp. Yes1,2 No1 -- -- 
Oerskovia spp. Yes19 Yes19 Maybe -- 
Ollulanus tricuspis No4 -- -- -- 
Onchocerca lupi Yes286–288 No287,288 -- -- 
Oncicola canis No4 -- -- -- 
Opisthorchis felineus Yes4 Yes4,23 No23,118,289 -- 
Opisthorchis noverca Yes23 Yes23,289 No23 -- 
Opisthorchis viverrini Yes4 Yes4,23 No23,118,289 -- 
Orientia tsutsugamushi  Yes1 No1 -- -- 
Oslerus osleri No4 -- -- -- 
Otodectes cynotis Yes43,290 No43 -- -- 
Paecilomyces 
fumorsoroseus 
Yes1,2 No1 -- -- 
Paecilomyces lilacinus Yes1,2,19 Yes19 Yes291 No 
Paecilomyces variotii Yes1 No1 -- -- 
Paracoccidiodes 
brasiliensis 
Yes1,2 No1 -- -- 
Paragonimus africanus Yes23 Yes4,23 No23,292 -- 
Paragonimus heterotremus Yes23 Yes4,23 No23 -- 
Paragonimus hueit'ungensis Yes23 Yes23 No23,293,294 -- 
Paragonimus kellicotti Yes23 Yes4,23 Yes295 Yes296 
Paragonimus mexicanus Yes23 Yes4,23 No23,297,298 -- 
Paragonimus spp. Yes23 Yes23 No23 -- 
Paragonimus westermani Yes4 Yes4,23 No23,297 -- 
Pasteurella canis Yes19 Yes19 Yes248 Yes248 
Pasteurella multocida Yes1 Yes1 Yes248 Yes248 
Pasteurella spp. Yes1 Yes1 Yes64 Yes64 
Pediococcus spp. Yes19 Yes19,127 Maybe128 -- 
Penicillium spp.  Yes1 No1 -- -- 
Pentatrichomonas hominis Yes2,23,299 No23,299 -- -- 
Peptostreptococcus spp.  Yes1 Yes1 Yes21 No 
Phagicola longa Yes23 Yes23 Yes119 No 
Phaneropsolus bonnei Yes23 No23 -- -- 
Phialemonium spp. Yes1,2 No1 -- -- 
Phialophora spp. Yes1 No1 -- -- 
Physaloptera rara No4 -- -- -- 
Plagiorchis muris Yes23 Yes23 No23,118,119 -- 
Plesiomonas shigelloides Yes1 Yes1 Yes59,300 No 
Pneumocystis carinii Yes1,2 No1 -- -- 
Pneumocystis wakefieldae Yes1,2 No1 -- -- 
Pneumonyssoides caninum No4 -- -- -- 
Poliovirus 1 Yes1 No1 -- -- 
Porcine herpesvirus 1 No1 -- -- -- 
Porphyromonas spp. Yes1,19 Yes1,19,174 Maybe -- 
Powassan virus Yes1 No1,301 -- -- 
Prevotella spp.  Yes1,19 Yes1,19,174 Yes59,302 No 
Prohemistomum vivax Yes23 No23 -- -- 
Propionibacterium spp.  Yes1,19 Yes1,19,174 Yes21 No 
Prosthodendrium 
glandulosum 
Yes23 No23 -- -- 
Prosthodendrium obtusum Yes23 No23 -- -- 
Proteus mirabilis Yes1,2 Yes1,174 Yes85 No 
Proteus vulgaris Yes1,2 Yes303 Yes304 No 
Prototheca spp. Yes1,305 No1 -- -- 
Providencia alcalifaciens Yes1,2 No1 -- -- 
Providencia stuartii Yes2 No306 -- -- 
Pseudallescheria boydii Yes1,2 No1 -- -- 
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Pseudamphistomum 
truncatum 
Yes23 Yes23 No23,118,307,308 -- 
Pseudomicrodochium spp. Yes1,2 No1 -- -- 
Pseudomonas aeruginosa Yes1 Yes1 Yes248,304 Yes192 
Pseudomonas oryzihabitans Yes1 Yes1,84 Maybe -- 
Pseudomonas spp. Yes1,19 Yes1,19 Yes85,304,309 No 
Pulex irritans Yes310 Yes310,311 Yes312 Yes312 
Pulex simulans No4,246 -- -- -- 
Pygidiopsis summa Yes23 Yes23 No23,119,213 -- 
Pythium insidiosum Yes1 No1 -- -- 
Rabies  Yes1 Yes1 Yes313 Yes313 
Ralstonia pickettii Yes1 No1 -- -- 
Reovirus (Mammalian 
Reovirus) serotype 1 
Yes1,19,314 Maybe1,19 Yes315 -- 
Reovirus (Mammalian 
Reovirus) serotype 2 
Yes1,19,316 Maybe1,19 Yes315,316 -- 
Reovirus (Mammalian 
Reovirus) serotype 3 
Yes1,19,317 Maybe1,19 Yes315,318 -- 
Rhinosporidium seeberi Yes1,2 No1 -- -- 
Rhizomucor spp. Yes1 No1 -- -- 
Rhizopus spp. Yes1 No1 -- -- 
Rhodococcus equi Yes1 Maybe1,319,320 Yes321 -- 
Rhodotorula glutinis Yes1 No1 -- -- 
Rhodotorula mucilaginosa Yes1,2 No1 -- -- 
Rickettsia akari  Yes4 No4 -- -- 
Rickettsia australis Yes4 No1,4 -- -- 
Rickettsia conorii subsp. 
conorii  
Yes4 Yes23 No23,322 -- 
Rickettsia felis  Yes1,4 Yes1,43 Yes323 No 
Rickettsia japonica Yes4 No1 -- -- 
Rickettsia prowazekii  Yes4 No4 -- -- 
Rickettsia rickettsii  Yes4 Yes23 Yes23 Yes63–65 
Riemerella anatipestifer Yes1 Yes1 Yes324 No 
Rift Valley Fever Yes4 No1 -- -- 
Ross River virus Yes4 No1 -- -- 
Saksenaea spp.  Yes1 No1 -- -- 
Salmonella enterica 
(enteriditis, typhimurium) 
Yes1 Yes1,4,43,325 Yes196,326,327 Yes196,328,329 
Sapovirus No19,105 -- -- -- 
Sarcocystis aucheniae No1,4 -- -- -- 
Sarcocystis canis No1 -- -- -- 
Sarcocystis capracanis No1,4 -- -- -- 
Sarcocystis cruzi No1,4,330,331 -- -- -- 
Sarcocystis fayeri No1,4 -- -- -- 
Sarcocystis hircicanis No1,4 -- -- -- 
Sarcocystis meischeriana No1,4 -- -- -- 
Sarcocystis neurona No1 -- -- -- 
Sarcoptes scabiei var canis Yes4 Yes4 Yes64,332 Yes64,332 
Sars-CoV-2 (Covid-19) Yes333 No334,335 -- -- 
Schistosoma incognitum Yes23 Yes23,336 No23,118 -- 
Schistosoma japonicum Yes23 Yes23 No23,118 -- 
Schistosoma mansoni Yes23 No23 -- -- 
Schistosoma mekongi Yes23 Yes23 No23,118,337 -- 
Schistosoma rodhaini Yes23 No23,338 -- -- 
Schizophyllum commune Yes1 No1 -- -- 
Serratia spp. Yes1,339 No1,127,137 -- -- 
Shigella spp. Yes1 No1 -- -- 
Sin Nombre virus Yes1 No1 -- -- 
Spirocerca lupi  No4 -- -- -- 
Spirometra mansoni Yes23 Yes23 No23,340 -- 
Sporothrix schenckii Yes1 Yes1,43,209,341 Yes342 Yes343 
St. Louis encephalitis Yes1 No1 -- -- 
Staphylococcus aureus Yes1,19 Yes1,19,43,344,345 Yes74,346 Yes347 
Staphylococcus epidermidis Yes1 Yes1 Yes85 No 
Staphylococcus 
pseudintermedius 
Yes1,19 Yes1,19,345 Yes348 Yes348 
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Staphylococcus schleiferi 
coagulans 
Yes1 Maybe1,43 Yes254 -- 
Staphylococcus schleiferi 
schleiferi 
Yes43 No43 -- -- 
Staphylococcus sciuri Yes1 No1,43 -- -- 
Staphylococcus spp. Yes1 Yes1 Maybe -- 
Staphylococcus xylosus Yes1 Yes1 Yes349 No 
Stellanchasmus falcatus  No278,350 -- -- -- 
Stellantchasmus falcatus Yes23,119 Yes23,119 No23,119 -- 
Stellantchasmus 
pseudocirratus 
Yes38 Yes38,351 No351–353 -- 
Stenotrophomonas 
maltophilia 
Yes1 Yes1 Yes85 No 
Stictodora fuscata Yes23,119 Yes23 No23,119 -- 
Stomatococcus 
mucilaginosus 
Yes19 Yes19,84 Yes354 No 
Streptobacillus moniliformis Yes1 Yes1 Yes21 No 
Streptococcus agalactiae Yes1 No1,14 -- -- 
Streptococcus canis Yes19 Yes1,19,43,355 Yes356 Yes356 
Streptococcus dysgalactiae 
dysgalactiae 
Yes 14, 357 No1, 4, 14 -- -- 
Streptococcus dysgalactiae 
equisimilis 
Yes14,358 No4,358 -- -- 
Streptococcus equi subsp. 
zooepidemicus 
Yes1,4 Yes1,43,359 Yes360 No 
Streptococcus equi subsp. 
equi  
Yes1,361 No4,43 -- -- 
Streptococcus Group D 
commensals 
Yes362, 363 No1 -- -- 
Streptococcus Group E No1 -- -- -- 
Streptococcus Group L Yes364 No1,364 -- -- 
Streptococcus Group M No1,365 -- -- -- 
Streptococcus intermedius  Yes1,2 No1,366,367 -- -- 
Streptococcus mitis Yes19 Yes19 Yes368 No 
Streptococcus pneumoniae Yes1,2 No1 -- -- 
Streptococcus pyogenes Yes19 Yes19,84 Yes85 No 
Streptococcus spp. Yes1 Yes1,64 Yes64 Yes64 
Streptococcus suis  Yes1,4 No1,4 -- -- 
Strongyloides stercoralis Yes4 Yes43 Yes369–371 No 
Taenia brauni  Yes4 Yes43 Maybe4,23,43 -- 
Taenia crassiceps Yes4 Yes43 Yes4,372–374 No 
Taenia hydatigena No4 -- -- -- 
Taenia krabbei No4 -- -- -- 
Taenia multiceps Yes4 Yes4,43 Yes375 No 
Taenia ovis No4 -- -- -- 
Taenia pisiformis No4 -- -- -- 
Taenia serialis Yes4 Yes4, 43 Yes376 Yes162 
Taenia solium  Yes4 No43 -- -- 
Taenia spp. Yes4 Yes43 Yes69 Yes69 
Taenia taeniaeformis Yes2,377 No43 -- -- 
Tannerella forsythia Yes19 Yes19,378 Maybe -- 
4,379,380Tenshaw virus No1 -- -- -- 
Theileria annulata No4 -- -- -- 
Theileria equi No381 -- -- -- 
Thelazia californiensis Yes23 Yes23 Maybe4, 23 -- 
Thelazia callipaeda Yes23 Yes4, 23 Maybe382 -- 
Tick borne encephalitis Yes1 Yes4,379,380 No1,383 -- 
Toxascaris leonina Yes2,384 No23,43 -- -- 
Toxocara canis Yes4 Yes43 Yes69 Yes69 
Toxoplasma gondii Yes1 No43 -- -- 
Trichinella spiralis Yes4 Maybe385 Yes386 -- 
Trichoderma spp. Yes387 No194 -- -- 
Trichophyton spp. Yes1 Yes1 Yes258 Yes329,388 
Trichosporon cutaneum Yes1,2 No1 -- -- 
Trichuris vulpis Yes4 Maybe43 Yes372 -- 
Tritrichomonas foetus Yes1 No1,43 -- -- 
Trypanosoma brucei brucei Yes389 No389 -- -- 
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Trypanosoma brucei 
gambiense 
Yes1,4 Yes1 No4,390 -- 
Trypanosoma brucei 
rhodesiense 
Yes1 Yes1 No4,390 -- 
Trypanosoma caninum No19 -- -- -- 
Trypanosoma congolense No19,391 -- -- -- 
Trypanosoma cruzi Yes1,4 Yes1,43 Yes390,392,393 Yes240 
Trypanosoma evansi Yes394 No394 -- -- 
Tunga penetrans Yes4 Yes395 No4 -- 
Uncinaria stenocephala Yes4 Yes43 Yes43,376 Yes152,162,396 
Unclassified enteroviruses Yes1 No1 -- -- 
Ureaplasma canigenitalum No1,2 -- -- -- 
Veillonella spp. Yes1 Yes1,128,174 Yes21 No 
Venezuelan equine 
encephalitis 
Yes1 Yes1 No1,141 -- 
Vesicular exanthema No2,4 -- -- -- 
West Nile Virus Yes1 Maybe1,397,398,141 Yes399 -- 
Western equine encephalitis Yes1 No1 -- -- 
Wolbachia pipientis Yes1 Yes1 Maybe400 -- 
Xenopsylla cheopis Yes246,310 Yes401 Yes157,402 No 
Yersinia enterocolitica Yes1,4 Yes43 Yes327 Yes59 
Yersinia pestis Yes4 Yes43 Yes63,64 Yes63,64 
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List of 51 individual canine pathogens or pathogen/parasitic groups provided to experts for the pathogen 
prioritization exercise listed in alphabetical order. 
 
1. Acanthocheilonema reconditum 
2. Alaria spp. (alata, americana, canis, 
marcianae) 
3. Anaplasma phagocytophilum 
4. Apophallus donicus 
5. Bartonella spp. (henselae, vinsonii subsp. 
berkhoffii) 
6. Baylisascaris procyonis 
7. Blastomyces dermatitidis 
8. Bordetella bronchiseptica 
9. Borrelia burgdorferi senso stricto 
10. Brucella canis  
11. Campylobacter spp. (coli, jejuni, 
upsaliensis) 
12. Clostridium spp. (difficile, perfringens) 
13. Coxiella burnettii 
14. Cryptococcus gattii 
15. Cryptocotyle lingua 
16. Cryptosporidium canis 
17. Dermatophytes (Microsporum canis, 
Trichophyton spp.)  
18. Diphyllobothrium spp. 
19. Dipylidium caninum 
20. Dirofilaria immitis 
21. Dog bite pathogens [Actinomyces viscosus, 
Capnocytophaga canimorsus, 
Fusobacterium spp., Moraxella spp, 
Neisseria weaveri, Pasteurella spp. (canis, 
multocida), Staphylococcus spp. (aureus, 
pseudintermedius), Streptococcus spp.] 
22. Echinococcus spp. (granulosus, 
multilocularis) 
23. Ehrlichia canis 
24. Enterococcus spp. (faecium; VRE) 
25. Escherichia coli 
26. Fleas (Ctenocephalides canis, C. felis, Pulex 
irritans) 
27. Francisella tularensis 
28. Giardia duodenalis (assemblages A1, B) 
29. Helicobacter heilmannii 
30. Histoplasma capsulatum 
31. Klebsiella spp. 
32. Leishmania infantum  
33. Leptospira interrogans (serovars 
autumnalis, bratislava, canicola, 
grippotyphosa, hardjo, icterohaemorrhagiae, 
pomona) 
34. Malassezia pachydermatis 
35. Mesocestoides spp. 
36. Methicillin-resistant Staphylococcus aureus 
37. Methicillin-resistant Staphylococcus 
pseudintermedius  
38. Metorchis conjunctus 
39. Mites (Cheyletiella yasguri, Sarcoptes 
scabiei var canis) 
40. Nanophyetus salmincola 
41. Paragonimus kellicotti 
42. Pseudomonas aeruginosa 
43. Rickettsia rickettsia 
44. Salmonella enterica (enteritidis, 
typhimurium) 
45. Sporothrix schenckii 
46. Streptococcus canis 
47. Taenia spp. (serialis) 
48. Toxocara canis 
49. Trypanosoma cruzi 
50. Unicaria stenocephala 









Survey questions provided to experts for prioritization exercise using the platform SurveyMonkey. 
 
1) Which of the following best describes your current occupation? 
a. Public Health: Government (provincial or federal) 
b. Public Health: Research/Academia 
c. Veterinary Medicine: Government (provincial or federal) 
d. Veterinary Medicine: Research/Academia 
e. Veterinary Medicine: General or specialty practice companion animal 
f. Veterinary Medicine: General or specialty practice mixed animal  
g. Veterinary Medicine: General or specialty practice: Large animal 
h. Other (please specify): 
 










d. Other (please specify): 
 
4) Given the following list of 51 canine zoonotic/sapronotic/anthroponotic pathogens, please select your top 
10 pathogens from a public health perspective (you will be asked to rank your choices from 1-10 in the next 
question).  See attached table for supplementary information on each pathogen if needed.  
 
5) Please rank your selected pathogens from 1-10 with #1 being the MOST important from a public health 
perspective. 
 
6) Please describe what made you place a pathogen in your top 10 and deem it as an important canine 
pathogen in the Prairie Provinces from a public health perspective: 
 
7) Given the same list of 51 canine zoonotic/sapronotic/anthroponotic pathogens, please select your bottom 5 
pathogens from the entire list, ie. those canine pathogens you are the least concerned about from a public 
health perspective. These do not need to be ranked in a particular order. See attached table for 
supplementary information on each pathogen if needed.  
 
8) Please describe what made you place a pathogen in your bottom 5 and deem it as an unimportant canine 
pathogen in the Prairie Provinces from a public health perspective: 
 
9) For the taxonomical categories (bacteria, ectoparasites, fungi, helminths, rickettsia, viruses), do you:   
a. Place more weight on one or more categories in terms of importance?  If yes, elaborate on which 
and why: 
b. Place one or more category as least important?  If yes, elaborate on which and why: 
c. Place the same weight on all categories (no preference in terms of importance).  If yes, elaborate 
on why: 
 
10) Are there any canine zoonotic pathogens not included on the previous list that you would like to see in a 
companion animal surveillance system in the Prairie Provinces? If so, which pathogen(s) would you 









11) Are there any canine specific (non-zoonotic) diseases that you would like to see included in a companion 



















































The following table was provided to experts to use at his/her discretion and represents the list of 51 canine pathogens that are (1) 
zoonotic/sapronotic/anthroponotic, (2) involve the dog in transmission to humans either directly, through maintenance of the 
pathogen in the environment, or through detection of the pathogen as a sentinel for human exposure, and (3) have been reported 
in the canine population in Canada.   
Pathogen Additional Information 
Acanthocheilonema reconditum - Non-pathogenic subcutaneous filarial nematode of dogs; C. felis serves as intermediate host 
- Only one human case report of subconjunctival infection; source of infection presumed to be a flea 
- Historically reported in dogs in Canada through veterinary surveys 
- Largely controlled through heartworm medication1–4  
Alaria spp. (alata, americana, 
canis, marcianae) 
- Generally non-pathogenic trematode of dogs, rare in humans 
- Dogs act as definitive host and shed eggs in environment 
- Human infection occurs following ingestion of undercooked intermediate hosts (ex. wild boar)  
- Fatal human case has been reported in Canada after ingestion of infected frog legs; larva can penetrate 
stomach wall an migrate through various tissues1,5 
Anaplasma phagocytophilum - Transmitted to humans via Ixodes ticks (including Ixodes scapularis) 
- Dogs act as sentinels for human risk, not direct transmission 
- Non-specific clinical signs in dogs, low pathogenicity 
- Often self-limiting in humans6 
Apophallus donicus - Intestinal fluke; non-pathogenic in dogs; uncommon 
- Dogs act as a reservoir host 
- Human infection occurs from ingestion of raw or undercooked fish1,5,7 
Bartonella spp. (henselae, 
vinsonii subsp. berkhoffii) 
- Vector, bite or scratch transmission possible; handling of blood can also lead to human infection 
- Main reservoir host in B. henselae (cat scratch fever) is the cat; dog acts as incidental host; 
- Main reservoir host in B. vinosonii berkhoffii is the dog 
- Fever and lymphadenopathy in humans is most common, but other manifestations possible2,6  
Baylisascaris procyonis - Roundworm; causes visceral larva migrans and ocular larva migrans in humans, especially children 
- Racoons are the most common definitive host; dogs can act as both a definitive and intermediate host 
- Transmission to humans is from ingestion of parasitic eggs; dogs can shed eggs in environment or carry 
eggs on their coat 
- Disease is severe (eosinophilic meningoencephalitis, chorioretinitis, optic neuritis and atrophy, and 
blindness) and can be fatal1,2,8  
Blastomyces dermatitidis - Commonly known as blastomycosis; fungal infection 
- Shared environmental exposure; rare dog bite pathogen 
- Humans acquire infection from inhalation or from the soil; endemic areas where canine infection is also 
occurring - dogs act primarily as sentinels 
- Cutaneous and systemic infection in humans is possible2,6,9 
Bordetella bronchiseptica - Human infection in immunocompromised individuals has been reported 
- Commonly known as kennel cough; can be directly transmitted to humans from dogs 
- Diseases in humans range from upper and lower respiratory tract infections including sinusitis, bronchitis 
and pneumonia2,6 
Borrelia burgdorferi senso 
stricto 
- Causative agent of Lyme Disease; transmitted by Ixodes ticks (Ixodes scapularis, Ixodes pacificus) 
- Dogs and humans are incidental hosts; dogs serve as sentinels for human exposure 
- Positive dogs have experimentally re-infected ticks and could serve as a reservoir host 
- Dogs can introduce ticks into the household6 
Brucella canis  - Human acquired infections most common through direct contact with aborting bitches 
- Reproductive tissue, fluids, urine 
- Poses greatest risk to the immunocompromised  
- Severe disease in immunocompetent humans is uncommon2,6 
Campylobacter spp. (coli, jejuni, 
upsaliensis) 
- Causes enteric disease in humans 
- Oral-fecal direct transmission from dogs; food and water-borne sources also common 
- Has been identified as a dog bite isolate1,2  
Clostridium spp. (difficile, 
perfringens) 








- C. difficile is an important nocosomial and antimicrobial-associated cause of diarrhea in humans; reverse 
zoonosis (human to dog) also possible 
- C. perfringens has been isolated from dog bites; can be transmitted to humans through wound 
contamination in addition to ingestion2,6,10 
Coxiella burnetii - Agent of Q-fever; dogs are a less common source for human infection than other animals but still 
reported 
- Animals are usually non-clinical; severity of disease in humans is related to degree of exposure and 
results in flu-like illness; pneumonia and hepatitis is common 
- Arthropod (tick) and direct transmission through ingestion or inhalation possible; can be shed in feces, 
urine, milk, placenta and reproductive fluids2,6 
Cryptococcus gattii - Sapronotic fungus; environmental exposure leads to human infection 
- Inhalation most common source of infection, but transmission from ingestion and wound contamination 
are also reported 
- Dogs act as sentinels; common-source infection 
- Clinical illness most common in immunocompromised individuals and includes meningitis and systemic 
infections; granulomatous intracranial lesions and pulmonary nodules called cryptoccomas2,6 
Cryptocotyle lingua - Rare intestinal fluke; only one confirmed human case – diarrhea was a possible clinical sign (coinfection 
common in study participants); infection in humans can occur from ingesting undercooked or raw fish 
- Non-pathogenic in dogs; dogs act as a definitive host1,5,11,12 
Cryptosporidium canis - Fecal-oral transmission most common; contaminated food/water and inhalation also possible 
- Infection is often subclinical in dogs and immunocompotent individuals 
- More serious infections in immunocompromised individuals possible; enteric disease1,2 
Dermatophytes (Microsporum 
canis, Trichophyton spp.)  
- Causative agents of ringworm (fungal infection) 
- Dermal lesions in humans, often pruritic, result from direct contact with clinically affected or 
asymptomatic animals as well as contaminated environments1,6  
Diphyllobothrium spp. - Intestinal tapeworm; dogs act as definitive host and shed eggs into environment 
- Humans are infected from eating undercooked or raw fish 
- Human infection is usually asymptomatic; rare clinical signs include obstruction, diarrhea, abdominal 
pain and anemia1,5 
Dipylidium caninum - Common intestinal tapeworm; dogs are the definitive host and fleas are the intermediate host 
- Human infection is most common in children and occurs following ingestion of fleas 
- Adult tapeworms are generally non-pathogenic in dogs and humans but may cause peri-anal pruritis1,5 
Dirofilaria immitis - Agent of heartworm disease in dogs 
- Rare cause of human illness; granulomatous pulmonary nodules possible 
- Transmitted to humans from mosquito bites; humans act as a dead end host1,2,6 
Dog bite pathogens 
[Actinomyces viscosus, 
Capnocytophaga canimorsus, 
Fusobacterium spp., Moraxella 
spp., Neisseria weaveri, 
Pasteurella spp. (canis, 
multocida), Staphylococcus spp. 
(aureus, pseudintermedius), 
Streptococcus spp.] 
- Direct transmission; part of normal canine oral flora or skin and other mucosal surfaces  
- C. canimorsus can cause fatal septicemia in humans; bites, licking ulcers; veterinarians have also been 
infected during dental procedures  
- P. canis is one of the most common species isolated from dog bites; S. aureus is the most common 
Staphylococcal species isolated from dog bites2,6,13,14,15,16,17,18,19,20 
Echinococcus spp. (granulosus, 
multilocularis) 
- Dogs act as definitive host of this tapeworm; transmission to humans is through fecal-oral ingestion of 
parasitic eggs 
- E. granulosus causes space occupying cysts in the lungs and liver of humans (hydatid cyst disease) 
- E. multilocularis causes masses most commonly in the liver of humans (alveolar cyst disease)1,2 
Ehrlichia canis - Transmitted to humans through tick bites (Rhipicephalus sanguineus) 
- Dogs act as reservoir hosts 
- A subspecies of E. canis is suspected as the cause of Venezuelan human ehrlichiosis; flu-like 
symptoms2,6,21 
Enterococcus spp. (faecium; 
VRE) 
- Endogenous, normal flora of GI tract in dogs; becomes opportunistic infection 
- Highly resistant; important cause of nosocomial infections in humans 








- Also reported in dog bites2,6,22 
Escherichia coli - Opportunistic pathogen; shed in canine feces 
- Source of human infection by direct transmission; food, water-borne and dog bite transmission also 
possible 
- Multi-drug resistant strains1,6 
Fleas (Ctenocephalides canis, C. 
felis, Pulex irritans) 
- Direct contact with dogs; can serve as vectors for transmission of several other zoonotic pathogens 
- Clinical signs in humans results from flea bites and include erythema, pruritis and dermatitis5,23 
Francisella tularensis - Agent of Tularemia in humans; highly infectious 
- Transmission to humans through ticks; licking, scratches and dog bites also possible transmission routes 
- Clinical signs in humans range from fever, anorexia, skin lesions, lymphadenopathy, conjunctivitis and 
pneumonia2,6 
Giardia duodenalis (assemblage 
A1, assemblage B) 
- Surface water contamination is the most common source for human infection 
- Transmission from dogs to humans (uncommon) is likely to be indirect through environmental 
contamination 
- Dogs shed cysts in their feces which can survive in the environment for prolonged periods 
- Asymptomatic and self-limiting in most individuals but can cause enteric disease2,5,6 
Helicobacter heilmannii - Oral to oral transmission from dogs to humans; gastric Helicobacter species 
- Only rarely transmitted from pets; causes gastritis in humans6 
Histoplasma capsulatum - Sapronotic; environmental exposure leads to human infection via inhalation of soil-borne fungus 
- Dogs act as sentinels; common-source infection 
- Clinical illness in humans most common in immunocompromised individuals; pulmonary and systemic2,6 
Klebsiella spp. - Opportunistic pathogen; nasopharynx, GI, genitourinary and systemic infections possible 
- Cause of nosocomial infections in humans; has also been isolated as a dog bite pathogen 
- Canine multi-drug resistant urinary isolate6,14,24 
Leishmania infantum  - Dogs act as main reservoir host for human infection; increased prevalence in canine populations 
correlates with increases in human infection (poor socioeconomics is an important risk factor) 
- Vector-transmission through sandfly bites; fox hound prevalence study in Ontario could not find source 
of infection suggesting other transmission routes likely possible 
- Potentially fatal in both dogs and humans1,2,6,25 
Leptospira interrogans (serovars 
autumnalis, bratislava, canicola, 
grippotyphosa, hardjo, 
icterohaemorrhagiae, pomona) 
- Transmission through both direct and indirect contact; infected canine urine most common 
- Contaminated water, soil and food; dogs can excrete the pathogen for up to several months following 
infection (serovar canicola can be shed life-long in some cases but is a less common serovar)  
- Humans are incidental hosts; dogs may act as incidental or reservoir hosts 
- Disease in humans can range from mild signs to fatal2,6 
Malassezia pachydermatis - Commensal yeast of skin and mucous membranes in dogs; transmitted to humans through direct contact 
- Clinical signs most common in the immunocompromised or young children; skin lesions, dermatitis6 
Mesocestoides spp. - Tapeworm; dogs can serve as secondary intermediate host and definitive host 
- Human infection occurs from ingestion of uncooked blood/organ tonics of snakes and turtles; rare in 
Canada 
- Clinical signs in humans include diarrhea, abdominal pain and hunger1,5 
Methicillin-resistant 
Staphylococcus aureus 
- Opportunistic pathogen; transmission occurs through direct contact 
- Zoonotic transmission from dogs and reverse zoonotic transmission also suspected 




- Commensal bacteria that leads to opportunistic infections in dogs 
- Uncommon cause of clinical disease in humans but still possible 
- Transmission from dogs most likely associated with bites2,6 
Metorchis conjunctus - Non-pathogenic liver fluke in dogs; dogs are definitive hosts 
- Human infection is rare; transmission occurs from ingestion of raw fish 
- Can cause fever, abdominal pain and eosinophilia in humans1,5 
Mites (Cheyletiella yasguri, 
Sarcoptes scabiei var canis) 
- Transmission to humans from dogs is through direct contact or contaminated fomites 
- Causes pruritic skin lesions in humans 








Nanophyetus salmincola - Intestinal fluke responsible for transmission of rickettsial “salmon poisoning” agent that infects dogs  
- Dogs shed eggs in feces in environment; humans are infected from ingestion of undercooked or raw fish 
- Causes mild gastritis in humans1 
Paragonimus kellicotti - Lung fluke of dogs; humans affected only rarely  
- Humans infected from ingestion of undercooked crayfish or crab 
- Clinical illness in humans usually includes pulmonary signs1,5 
Pseudomonas aeruginosa - Opportunistic pathogen; has been isolated from dog bites 
- Nosocomial infections in human hospitals 
- Multi-drug resistant canine urinary isolate that can be shed into shared environments with humans6,26,27 
Rickettsia rickettsii - Agent of Rocky Mountain Spotted Fever; transmitted to humans through tick bites (Dermacentor 
variabilus, D. andersoni most common; Amblyomma americanum and R. sanguineus also possible) 
- Dogs and humans act as incidental hosts; dogs can serve as sentinels and also expose humans to ticks 
- Clinical signs in humans include upper respiratory, skin lesions, cardiac, and neurological signs; can be 
fatal2 
Salmonella enterica (enteritidis, 
typhimurium) 
- Foodborne infections common; fecal-oral transmission from dogs to humans 
- Handling of raw food diets and shedding in canine feces 
- Multi-drug resistant strains emerging2,28 
Sporothrix schenckii - Fungus; widely distributed in the soil; dogs become infected from penetrating wounds  
- Direct transmission to humans through bites and scratches or by direct contact with contaminated 
wounds 
- Human illness manifests as cutaneous lesions and systemic spread2,6,29 
Streptococcus canis - Direct transmission through dog bites or contact with open wounds on human skin 
- Has been reported to cause septicemia in humans; was also reported as the cause of endocarditis in a 
human (close contact with an infected dog, no bite history)2,6  
Taenia spp. (serialis) - Tapeworm; dogs are definitive hosts; infection rare in domestic dogs, more common in feral and shelter 
dogs 
- Fecal-oral transmission; human ingestion of eggs by contaminated water, soil and vegetation  
- Can lead to cystic disease in humans (subcutaneous tissue, muscle, eyes, and CNS)1,2 
Toxocara canis - Common canine roundworm; dogs shed eggs in feces; fecal-oral transmission 
- Visceral and ocular larva migrans possible in humans; most common in children1,2 
Trypanosoma cruzi - Causative agent of Chagas disease; “kissing bug” vector transmits pathogen to humans through 
contaminated bites; dogs act as a reservoir for the vector as well as the pathogen 
- Can act as sentinels for disease risk in humans; risk factor in developing countries is dogs in the home 
- Varying degrees of severity in humans; curable if treated early in infection, otherwise symptomatic 
treatment only and potentially life-long effects6,30 
Unicaria stenocephala - Canine hookworm; dogs shed eggs in feces; transmission to humans through L3 larva penetrating the 
skin 
- Can cause cutaneous larva migrans in humans; most common in children1,2 
Yersinia spp. (enterocolitica, 
pestis)  
- Dogs are a rare source of Y. enterocolitica infection; dogs can excrete in feces after ingestion of 
contaminated pork; causes gastroenteritis in humans 
- Y. pestis is the agent of Plague; transmitted to humans from flea bites, inhalation, bites/scratches or direct 
contact with open wounds; dogs are source of flea exposure to humans, but dogs can also become 
infected from ingestion of wildlife and harbor bacteria in the oropharynx and transmit directly 
- Flu-like syndrome in humans, lymphadenitis, pneumonia and sepsis; fatal if left untreated1,2 
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Survey questions provided to private veterinarians using the platform SurveyMonkey. 
 
DEMOGRAPHICS 




d. Other (disqualified from survey) 
2) How would you describe your current practice region? 
a. Urban (city or suburb; densely populated) 
b. Rural (countryside, town; low population density) 
c. Both (split time between both urban and rural) 
d. Other (please specify): 




c. Pocket pets (small mammals) 
d. Reptiles 
e. Pet birds 
f. Beef Cattle 




k. Small ruminants 
l. Game cervids 
m. Wildlife 
n. Other (please specify): 







Veterinary clinics are key to obtaining data concerning diseases in dogs and cats. Thus, surveillance for pathogens or 
events of interest will require the participation of veterinary clinics across the Prairie Provinces. Surveillance has not 
been a part of Companion Animal Practice in Canada; therefore, it is essential that we get a sense of willingness to 
participate. Answers to these questions are merely hypothetical and in no way commit you to participate in any 
future surveillance initiative. The purpose here is to design a feasible system by gauging the best methods to 
encourage participation.  
 
1) On a scale of 1-10 how would you rate your/your clinic's willingness to participate in a provincial 
companion animal surveillance program with 1 being no interest to participate and 10 being a strong 
interest to participate? 
2) On a scale of 1-10, how likely would you/your clinic be willing to participate in a companion animal 
surveillance program if you were required to input information yourself (or by a staff member), for 
example, into an online database with a login code? 
3) Why are you willing (or not willing) to participate in a companion animal surveillance system? 
4) With what frequency would you/your clinic be willing to report surveillance data?  Please rank the 












5) With what frequency would you/your clinic want to see updates from a companion animal surveillance 
system? Please rank the following from 1 being your most favorable option to 4 being your least favorable 
option. 
a. In real time (daily) 
b. Weekly reports 
c. Monthly reports 
d. Annual reports 
 
CANINE PATHOGENS OF INTEREST 
Our prior research identified the following zoonotic diseases as being of interest to veterinarians and public health 
experts for consideration in a companion animal surveillance program in the Prairie Provinces: echinococcosis, 
antimicrobial resistance (MRSA/MRSP), salmonellosis, and Lyme disease.  Therefore, this companion animal 
surveillance initiative may involve such pathogens.  The following questions relate to these diseases specifically. 
 
1) Have you diagnosed a dog in the past 5 years with Echinococcus spp. (granulosus, multilocularis)? 
a. Yes  
b. No 
2) What testing do you use to diagnose gastrointestinal parasites, such as tapeworms, roundworms or other 
helminths (choose all that apply)? 
a. Fecal flotation 
b. Fecal wet mount 
c. ELISA/CELISA 
d. PCR 
e. Other (please specify): 
f. None (I don’t test for helminths) 
3) What reasons would prevent you from submitting laboratory samples if any? 
4) Do you perform fecal flotations in clinic or send your sample(s) to a third party (external to your clinic) 
laboratory for fecal flotation? (only prompted to this Q if selected ‘fecal flotation’ above) 
g. In clinic  
h. Laboratory  
i. Both (case dependent) 
5) What third party (external to your clinic) diagnostic laboratories do you/your clinic use for these sample 
submissions? (choose all that apply) (only prompted to this Q if selected ‘laboratory’ or ‘both’ above) 
j. Prairie Diagnostic Services (PDS) 
k. IDEXX Laboratories 
l. Other (specify): 
6) What canine preventatives do you promote for tapeworms? (choose all that apply) 
m. Drontal Plus 
n. Dolpac 
o. Interceptor Plus 
p. Other (please specify): 
q. None 
7) How often are you recommending deworming medication? (Q is skipped if ‘none’ selected above) 
r. Monthly 
s. Every 3 months 
t. Every 6 months 
u. Annually 
v. Case dependent (specify): 









CANINE PATHOGENS OF INTEREST CONT’D (AMR) 
1) Please indicate whether you have personally diagnosed a dog in the past 5 years with any of the following 
pathogens: (choose all that apply)  
a. MRSA 
b. MRSP 
c. Other antimicrobial resistant pathogens (specify):  
d. None of the above 
 
MRSA/MRSP (this page will only appear if MRSA or MRSP was selected above)  
The following questions are in regard to your previous selection for a diagnosis of MRSA or MRSP in a canine 
patient within the last 5 years. 
 
1) What symptoms did the dog(s) present to your clinic with if any? 
2) What diagnostic laboratories do you/your clinic use for culture and sensitivity testing? (choose all that 
apply) 
a. Prairie Diagnostic Services (PDS) 
b. IDEXX Laboratories 
c. Other (specify): 
3) Are there any other important pieces of information about MRSA/MRSP you would like to mention here? 
 
CANINE PATHOGENS OF INTEREST CONT’D (GI PATHOGENS) 
1) Please indicate whether you have personally diagnosed a dog in the past 5 years with any of the following 
pathogens: (choose all that apply)  
a. Salmonella spp. 
b. Campylobacter spp. 
c. Escherichia coli 
d. None of the above 
 
SALMONELLOSIS (this page will only appear if ‘Salmonella spp.’ was selected above)  
The following questions are in regard to your previous selection for a diagnosis of salmonellosis in a canine patient 
within the last 5 years. 
 
1) What symptoms did the dog(s) present to your clinic with if any? 
2) What diagnostic test(s) did you use to diagnose the dog(s) with salmonellosis? 
3) What third party (external to your clinic) diagnostic laboratories do you/your clinic use for these sample 
submissions? (choose all that apply) 
a. Prairie Diagnostic Services (PDS) 
b. IDEXX Laboratories 
c. Other (specify): 
 
CANINE PATHOGENS OF INTEREST CONT’D (VECTOR-BORNE) 
1) Please indicate whether you have personally diagnosed a dog in the past 5 years with any of the following 
pathogens: (choose all that apply)  
a. Borrelia burgdorferi (Lyme disease) 
b. Ehrlichia spp. 
c. Anaplasma spp. 
d. Other vector-borne diseases (please specify): 
e. None of the above 
 
LYME DISEASE   
Your answers to the following questions will be used as an exercise to help establish a case definition for Lyme 








disease.  Answers to the following questions will also allow us to assess the use of domestic dogs as sentinels for 
Lyme disease.  





2) How often are you testing dogs for Lyme disease? (choose all that apply) 
a. As part of routine wellness appointment 
b. At request of owner 
c. If dog is exhibiting symptoms 
d. If there is travel related history 
e. Never 
f. Other (please specify): 
3) If you are testing for Lyme disease, what test(s) are you using? (choose all that apply)  
a. IDEXX SNAP 4Dx Test (in-clinic) 
b. Other (please specify): 
c. N/A 
4) What symptoms do you see in your canine patients who do test positive for Lyme disease?  If you typically 
see asymptomatic cases, please specify this: (this Q will only appear for individuals who responded with 
>0 cases of Lyme in the past 5 years above) 
5) How often are you vaccinating dogs against Lyme disease? 
a. Never 
b. Only if the history of the pet warrants vaccination (example: travel history, owner request etc.) 
c. Every patient gets vaccinated for Lyme disease 
d. Other (please specify): 
6) What are your reasons for not vaccinating against Lyme disease? (this question will only appear if 
individuals selected ‘never’ above) 
7) How often are you recommending tick prevention to your clients during tick season (regardless of whether 






f. Other (please specify) 
8) What canine tick prevention are you using in your clinic? (choose all that apply): (Q is skipped if ‘never’ 
selected above) 
a. Bravecto 




f. Other (please specify): 
 
FINAL THOUGHTS 
Note: Additionally, some canine specific pathogens (non-zoonotic) may be added to the surveillance program, such 
as parvovirus, canine distemper, and canine influenza.  Feline pathogens will also be explored and included in the 
future. 
 
1) Do you have any additional comments to add regarding a companion animal surveillance program specific 
to the Prairie Provinces of Canada? 
 
